CURRICLUM VITAE

NORBERT GLEICHER, MD

Revised: 10/9/2019

CURRICULUM VITAE Norbert Gleicher, MD (email: ngleicher@thechr.com) Address The Center for Human Reproduction

21 E. 69th Street, New York, NY 10021 Telephone 212-994-4400 Date of Birth August 20, 1948 Place of Birth Cracow, Poland Citizenship United States Academic Background 1954-1966 Grammar and high school, Vienna, Austria

1966-1970 Vienna University School of Medicine

1970-1973 Tel-Aviv University School of Medicine, Tel-Aviv, Israel - MD Degree

1973-1974 Rotating internship, Ihilov Municipal Hospital, Tel-Aviv, Israel

1/1975-6/1975 Research Fellow, Department of Obstetrics & Gynecology, Mount Sinai Medical Center, New York (GYN-Tumor Immunology)

1975-1978 Residency in Obstetrics & Gynecology, Mount Sinai Medical Center, New York; Chairman, S.B. Gusberg, MD

1978-6/1981 Assistant Professor, Department of Obstetrics & Gynecology, Mount Sinai School of Medicine of the City University of New York

1981-1986 Assistant Professor of Immunology and Microbiology, Rush Medical College, Chicago, Illinois

1981-1990 Professor of Obstetrics and Gynecology, Rush Medical College, Chicago, Illinois

1987-1990 Associate Professor of Immunology and Microbiology, Rush Medical College, Chicago, Illinois

1991-04/1996 Professor of Obstetrics and Gynecology and Professor of Immunology, Microbiology, the University of Health Sciences/Chicago Medical School, North Chicago, Illinois

04/1996-09/1999 Clinical Professor of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, Illinois

2000-2002 Adj. Clinical Professor of Obstetrics and Gynecology, New York University School of Medicine, New York, NY

2003-23011 Vis. Professor of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT

5/2015-6/2017 Professor (Adjunct), Laboratory Stem Cell Biology and Molecular Embryology, Rockefeller university, New York, NY

3/2016-Present Professor (Adjunct), Department of Obstetrics & Gynecology, Medical University Vienna, Vienna, Austria

6/2017-Present Guest Investigator, Laboratory Stem Cell Biology and Molecular Embryology, Rockefeller university, New York, NY

Medical Licenses E.C.F.M.G. #2024628

State of New York #131555-1 (active)

State of Virginia #28644

State of Illinois #036-062902 (active)

State of Indiana #01042178

State of California #A38772 (active)

State of Connecticut

State of Florida

Specialty Boards Diplomat, The American Board of Obstetrics and Gynecology 1981 Voluntary recertification 1999 Certifications Fellow, American College of Obstetricians and Gynecologists (FACOG) Fellow, American College of Surgeons Advanced Council for Gynecologic Endoscopy, Inc., Certification for advanced operative laparoscopy and hysteroscopy. The American Board of Obstetrics and Gynecology, 1981; Voluntary Recertification, 1998. Professional Appointments 1/1979-6/1981 Assistant Professor, Department of Obstetrics and Gynecology, Mount Sinai School of

Medicine of the City University of New York, New York, New York Director, Laboratory of Reproductive Immunology. Assistant Attending, Department of Obstetrics and Gynecology, Mount Sinai Services at Elmhurst General Hospital, Queens, New York Member, Student Promotions Committee, Mount Sinai School of Medicine, New York Member, Curriculum Committee, Mount Sinai School of Medicine, NewYork

1/1979-1/1981 Course Director of Reproduction Course (2nd year Medical School Curriculum); Director of Medical Education, Department of Obstetrics and Gynecology Mount Sinai School of Medicine; Course Director, Reproduction Section, Pathophysiology Course, CUNY. New York

2/1979-6/1981 Director, Division of Reproductive Immunology, Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York

7/1980-1/1981 Chairman, Medical Education Committee, Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York

7/1980-6/1981 Chairman, Subcommittee D of the Curriculum Committee, Mount Sinai School of Medicine, New York

1981-2002 Chairman, The Center for Human Reproduction, Illinois 6/1981-1990 Chairman, Department of Obstetrics and Gynecology, Mount Sinai Hospital Medical

Center, Chicago, Illinois 6/1981-1990 Member and Chairman of many committees, Mount Sinai Hospital Medical Center,

Chicago, Illinois. Full list available on request. 1990-1994 Attending, Department of Obstetrics and Gynecology, Mount Sinai Hospital Medical

Center, Chicago, Illinois 1987-Present President, The Foundation for Reproductive Medicine 1990-2004 Attending, Department of Obstetrics and Gynecology, Michael Reese Hospital Medical

Center, Chicago, Illinois 1990-2004 Attending, Department of Obstetrics and Gynecology, Grant Hospital, Chicago,

Illinois 1992-1993 Attending, Department of Obstetrics and Gynecology, St. Francis Hospital of

Evanston, Evanston, Illinois 1993-2004 Consultant, Department of Obstetrics and Gynecology, St. Francis Hospital of

Evanston, Evanston, Illinois 1995-1996 Consultant, Department of Obstetrics and Gynecology, Mount Sinai Hospital Medical

Center, Chicago, Illinois 1996-3/1997 President, CEO and Chairman of the Board, GynCor Inc. 3/1997-9/1998 CEO and Chairman of the Board, GynCor, Inc. 1998-1999 Chief Medical Officer and Chairman of the Board, GynCor, Inc. 1999-2004 Chairman, President, and Medical Director, The Center for Human Reproduction, IL 1999-Present Chairman, President and Medical Director, Medical Offices for Human Reproduction,

New York 9/1999-Present Attending, Department of Obstetrics and Gynecology, Lenox Hill Hospital, New York,

New York Editorial Boards 1979-1982 Editorial Board, The Mount Sinai Journal of Medicine 1990 Editor, “Seminars in Reproductive Medicine,” The Mount Sinai Journal of Medicine l980-2001 Editor-in-Chief, American Journal of Reproductive Immunology and Microbiology,

official organ of The American Society for the Immunology of Reproduction 1983-2007 Editor-in-Chief, Journal of In Vitro Fertilization and Embryo Transfer; renamed

Journal of Assisted Reproduction and Genetics, 1992 1984-1990 1984-1990 Contributing Editor, The Mount Sinai Journal of Medicine 2008-Present Member, Expert Review in Obstetrics & Gynecology 2008 – Present Editorial Board Member, International Journal of Obstetrics and Gynecology

2009-2014 Editorial Board Member, RBMOnline 2012-Present Editorial Board Member, Asian Pacific Journal of Reproduction 2012-Present Faculty Member, Faculty of 1000 2014-Present Academic Editor, PLoS ONE Editorial Board 2015-Present Editorial Board Member, Endocrine

Book Editorships

1. Gleicher N (ed): Reproductive Immunology. Progress in Clinical and Biological Research, Volume 70. Alan R. Liss, Inc., New York, New York 1982.

2. Elkayam U, Gleicher N (eds): Cardiac Problems in Pregnancy. Diagnosis and Management of Maternal and Fetal Disease. Alan R. Liss, Inc., New York, New York, 1982.

3. Gleicher N (ed.): Principles of Medical Therapy in Pregnancy. Plenum Publishing Corporation, New York, New York; 1985.

4. Elrad H, Friberg J, Giglia R, Gleicher N, Mayden K (eds.): Handbook of Realtime Ultrasonography in Obstetrics and Gynecology. Plenum Publishing Corporation New York, New York; 1985.

5. Gleicher N (ed): Reproductive Immunology. Immunology and Allergy Clinics in North America. W.B. Saunders Company, Philadelphia, Pennsylvania, 1989.

6. Elkayam U, Gleicher N (eds): Cardiac Problems in Pregnancy Diagnosis Management of Maternal and Fetal Disease, 2nd edition. Alan R. Liss, Inc., New York, New York, 1990.

7. Gleicher N (ed): Principles And Practice of Medical Therapy in Pregnancy, 2nd edition. Appleton & Lange, Norwalk, Connecticut, 1992.

8. Gleicher N (ed): Tubal Catheterization Procedures, Wiley-Liss, New York, New York, 1992.

9. Gleicher N (ed): Autoimmunity in Reproduction. Immunology and Allergy Clinics in North America. W.B. Saunders Company, Philadelphia, Pennsylvania, 1994.

10. Elkayam U, Gleicher N. (eds): Cardiac Problems in Pregnancy, 3rd edition. Wiley-Liss, Inc.; New York, New York, 1998.

11. Gleicher, N (ed): Managed Care: Infertility and Reproductive Medicine Clinics of North America. W.B. Saunders Company, Philadelphia, Pennsylvania, January 1998.

12. Gleicher N (ed): Principles & Practice of Medical Therapy in Pregnancy, 3rd edition. Appleton & Lange, Stamford, Connecticut, 1998.

Guest Editorships

1. Reproductive Immunology: “Festschrift in honor of Saul B. Gusberg, M.D., D.SC”, Mount Sinai J Med l980; 47:5.

2. Reproductive Immunology: Immunology & Allergy Clinics of North America 1990; 10:1:W.B. Saunders Company, Philadelphia, Pennsylvania, February 1990.

3. Autoimmunity in Reproduction: Immunology & Allergy Clinics of North America; 14:4; W.B. Saunders Company, Philadelphia, Pennsylvania, November 1994.

4. Managed Care: Infertility & Reproduction Medicine Clinics of North America; 9:1; W.B. Saunders Company, Philadelphia, Pennsylvania, January 1998.

Memberships American Association of Gynecologic Laparoscopists American College of Obstetrics and Gynecologists (ACOG) American College of Physician Executives American College of Surgeons American Federation for Clinical Research American Institute of Ultrasound in Medicine American Medical Association American Medical Society of Vienna American Society for the Immunology of Reproduction American Society for Reproductive Medicine (formerly AFS) American Society of Abdominal Surgeons Association of Professors of Gynecology and Obstetrics (until 1990) Central Association of Obstetricians and Gynecologists Chicago Association of Gynecologic Endoscopists Falloppius International Society (FIS) Federation of American Societies for Experimental Biology GynecoRadiology Society (now Special Interest Group – Imaging, ASRM) Illinois Perinatal Association International Association of Private Assisted Reproductive Technology Clinics and Laboratories International Society for Gynecologic Endoscopy

International Society for the Study of Hypertension in Pregnancy Israel Medical Society Reproductive Biology Professional Group of the American Society for Assisted Reproductive Technology Society for Male Reproduction and Urology of the American Society for Reproductive Medicine Society for Reproductive Investigation Society for Reproductive Medicine Society of Obstetric Medicine The American Association of Immunologists The Chicago Gynecological Society The Endocrine Society The New York Academy of Sciences The New European Surgical Academy Yale Obstetrical and Gynecological Society World Association of Medical Editors (WAME) Grants In addition to the continuous support from the Foundation for Reproductive Medicine: 07/79-06/80 Lalor Foundation Fellowship 07/79 The Beckman Company 07/80-06/81 Lalor Foundation Fellowship (renewal) 01/82-12/82 Development and Research Contract, Kontron Medical

Instruments 1982-1983 Family Focus Grant, State of Illinois 1983-1984 Family Focus Grant, State of Illinois (Renewal) 1983-1984 Family Planning Center Grant 1985-1987 Institutional Grant, Mount Sinai Hospital 1986-1987 Sears, Cesarean Section Community Grant 1988 Blue Cross/Blue Shield of Illinois

Cesarean Section Reduction Initiative Grant 1988 Blue Cross/Blue Shield of Illinois Consultation Services Grant 1988 Estrogen Equivalence Study, PBI, Denver, CO 80223 1988-1990 Transvaginal Balloon Tuboplasty Study, Multicenter Study with Mount

Sinai Hospital Medical Center as lead center. C.R. Bard, Inc., Billerica, MA 01821

1988-1994 Consultation Contract and Development Support; Bard Reproductive Systems, Billerica, MA 01821

Honors and Awards 06/79 “The Dr. Solomon Silver Award in Clinical Medicine,” presented by “The Richard and

Hilda Rosenthal Foundation” at the Mount Sinai Medical Center, New York, New York. 06/80 Program Director, The First S. B. Gusberg Seminar on Reproductive Immunology, New

York, June 26 and 27, l980. 06/80-1983

Vice-President, American Society for the Immunology of Reproduction.

12/80 Co-Director, Mount Sinai Update: Medical and Surgical Complications of Pregnancy. Postgraduate Course of the Mount Sinai School of Medicine, New York, December ll and l2, l980.

06/8l Program Chairman, The Second International S. B. Gusberg Symposium 01/82 Board Member, Professional Education Committee, American Cancer Society, Chicago

Unit, Chairman, Physicians’ Subcommittee. 05/82 Member, The International Coordination Committee for the Immunology of

Reproduction. 06/82 Session Chairman, Third Annual International Symposium on the Immunology of

Reproduction, Winston-Salem, North Carolina, June 23-26, 1982. 1982 Reviewer, National Institutes of Health (Site visit team). 10/82 Invited Panelist, The Third World Congress of the International Society for the Study of

Hypertension 03/83 Co-Director, A Seminar on In Vitro Fertilization, Chicago, Illinois. 06/83 Moderator: Immunology—Infections, Fourth Annual Chicago Area Schools of

Medicine Review Course in Obstetrics and Gynecology, June 6-11, 1983. 06/83 Moderator: Immunologic Environment of the Uterus and Mammary Gland. Fourth

International Symposium of the American Society for the Immunology of Reproduction. Park City, Utah, June 8-11, 1983.

11/83 Program Director: Medical Complications of Pregnancy. Postgraduate Course, Chicago, Illinois, November 11-12, 1983.

11/83 Program Director: Basic and Advanced Realtime Ultrasonography in Obstetrics and Gynecology, Chicago, Illinois, November 30 - December 2, 1983

01/84 Session Chairman: Diagnosis and Management of Maternal and Fetal Heart Disease. A Postgraduate Course, sponsored by the University of Southern California, Beverly Hills, California, January 13-14, 1984.

05/84 Session Chairman, 3rd World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 14-17, 1984.

11/84 Program Director: Medical Complications of Pregnancy Postgraduate Course, Chicago, Illinois, November 9-10, 1984.

5/85 Session Chairman, The 6th International Symposium on the Immunology of Reproduction, Varna, Bulgaria, May 31 - June 2, 1985.

06/85 Reviewer, National Institutes of Health, (site visit team), Study Section HDMC. 08/85 Member, Special Study Section, NICHD for RFA. 09/85 Special Outside Consultant, NICHD. 10/85 Official invited discussant of the Annual PrizePaper of the Central Association of

Obstetrician and Gynecologist: Branch et al: The lupus anticoagulant: A recently recognized and treatable cause of recurrent abortion and fetal death. New Orleans, October 10, 1985.

11/85 Boler L., Zbella EA, Gleicher N: Quantitation of proteinuria in pregnancy. The use of single voided urine samples. American College of Surgeons Meeting, Chicago Chapter, November 30, 1985 (2nd prize paper).

03/86 Chairperson, Special Study Section NICHD, RFA, Mechanisms of Immunologic Infertility.

04/86 Session Chairman, Future Aspects in Human In Vitro Fertilization Congress, Vienna

Austria, April 2-4, 1986. 04/86 Official Guest Visitor of the Bulgarian Academy of Sciences, Sofia, Bulgaria, April 7-

10, 1986. 04/86 Session Chairman, New Aspects in Clinical IVF. At the Future Aspects in Human In

Vitro Fertilization Congress, Vienna Austria, April 2-4, 1986. 09/86 Session Chairman, Free Communications. At the Fourth Annual Meeting of the Society

for the Advancement of Contraception, Chicago, IL, September 23-26, 1986. 10/86 Visiting Professor, Tokyo University, Tokyo, Japan. 10/87 Invited Honorary Speaker, Annual Meeting of the Korean Association of Obstetricians

and Gynecologists, Seoul, South Korea, October 16 and 17, 1987 10/87 Visiting Professor, Niigata University, Japan, October 19 - 21, 1987. 10/87 Visiting Professor, Nagoya University, Japan, October 22 -25, 1987. 10/87 Chairman, Workshop, Immunodiagnosis and Immunotherapy in Reproduction, 6th

World Congress on Human Reproduction, Tokyo, Japan, October 25 - 30, 1987. 10/87 Invited Plenary Speaker, Symposium on Immunology of Pregnancy. Idem. 11/87 Visiting Professor, Department of Obstetrics and Gynecology, Wayne State University,

November 24, 1987. 08/88 Invited Panelist, Immunotherapy of Recurrent Spontaneous Abortion. Immunological

Obstetrics Symposium. Indianapolis, Indiana, August 5-7, 1988. 08/88 Moderator: Autoimmunity in Pregnancy. Immunological Obstetric Symposium.

Indianapolis, Indiana, August 5-7, 1988. 12/88 Course Director, Postgraduate Course on Recent Developments in Obstetrics and

Gynecology. Chicago, Illinois, December 8-10, 1988. 04/89 Invited speaker, 6th World Congress of In Vitro Fertilization and Alternate Assisted

Reproduction, Jerusalem, Israel, April 2-7, 1989. 04/89 Co-chairman, Session on Male Infertility, 6th World Congress of In Vitro Fertilization

and Alternate Assisted Reproduction, Jerusalem, Israel, April 6, 1989. 04/89 Co-chairman, International Meeting on Pregnancy Loss, Tel-Aviv, Israel, April 9-12,

1989. 04/89 Invited speaker, International Meeting on Pregnancy Loss, Tel-Aviv, Israel, April 9-12,

1989. 07/89 Invited Workshop Chairman: 4th International Congress of Reproductive Immunology.

Kiel, FRG, July 26-29, 1989. 10/89 Visiting Professor, Department of Obstetrics and Gynecology, Keio University, Tokyo,

Japan. 10/89 Visiting Professor, Department of Obstetrics and Gynecology, Nagoya University,

Nagoya, Japan. 11/89 Transcervical Balloon Tuboplasty: A Multicenter Study. Price paper of the General

Program of The 45th Annual Meeting of The American Fertility Society, San Francisco, CA, November 13, 1989.

01/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal Occlusion - Transcervical Balloon Tuboplasty (T.B.T).” Chicago, Illinois, January 26-27, 1990.

02/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal Occlusion - Transcervical Balloon Tuboplasty (T.B.T.).” Los Angeles, California, February 23, 1990.

03/90 Session Chairman and Invited Speaker. Workshop on Retrograde Tubal Catheterization, Centre Francais du Commerce Eterieur, Paris, France, March 2-3, 1990.

03/90 Course Director, Postgraduate Course on “The Modern Approach to Tubal Occlusion - Transcervical Balloon Tuboplasty (T.B.T.).” New York, New York, March 30 -31, 1990.

06/90 Program Chairman, Tenth Anniversary Meeting of the American Society for the Immunology of Reproduction. Chicago, Illinois, June 20-23, 1990.

06/90 Session Co-chairman, Plenary session on workshop reports. Idem. 06/90 Session Co-chairman, Immunology of Reproduction. 7th World Congress on Human

Reproduction. Helsinki, Finland, June 2 - July 1, 1990. 06/90 Session Co-chairman, Technical advances. Idem. 08/90 International Advisory Committee of The International Conference on Rheumatic

Disease in Pregnancy, Jerusalem, Israel, May 17-22, 1992. 10/90 Moderator, Gynecology/Obstetrics Panel Discussion. “What’s New in In Vitro

Fertilization and Other Assisted Reproductive Technologies?” 1990 Clinical Congress of the American College of the American College of Surgeons. San Francisco, October 7-12, 1990 (10/8/90).

10/90 Moderator, Surgical Forum on Gynecology and Obstetrics: Idem (10/10/90). 10/90 Panelist, Gynecology and Obstetrics Panel Discussion: Management of Recurrent

Pregnancy Loss. Idem (10/11/90). 10/90 Formal discussant of Martin Jr., JN et al: The Natural History of HELPP Syndrome:

Patterns of Disease Progression and Regression. 58th Annual Meeting of The Central Association of Obstetricians and Gynecologists. Louisville, Kentucky, October 11-13, 1990 (10/12/90).

10/90 Chairman Roundtable Luncheon: Transcervical Balloon Tuboplasty (T.B.T.). 46th Annual Meeting of the American Fertility Society, Washington, D.C., October 13-18, 1990 (10/17/90).

05/91 Ehrenkreutz fur Wissenschaft und Kunst. The Knight’s Cross of the Order of the Arts & Sciences of the Republic of Austria.

07/91 Panelist, Is There One Best Way For Sperm Processing: 4th Annual In Vitro Fertilization and Embryo Transfer – UCLA School of Medicine, Santa Barbara, California, July 28-31, 1991.

10/91 Chairman Roundtable: Transvaginal Tubal Catheterization Procedures. 1991 Annual Meeting of the American Fertility Society, Orlando, FL, October 20-25, 1991 (10/21/91).

10/91 Member of International Scientific Advisory Committee, 8th World Congress on In Vitro Fertilization & Alternate Assisted Reproduction, Kyoto, Japan, Sept.12-15, 1993. Symposium Participant: Immunobiology of Pregnancy.

10/91 State of Illinois Senate Resolution No. 772 offering the congratulations of the 87th General Assembly on receiving The Ehrenkreutz fur Wissenschaft und Kunst of the Republic of Austria.

11/91 Invited speaker, The Society for Minimally Invasive Therapy, Third International Meeting, Boston, MA; November 10-12, 1991.

01/92 Invited speaker, 13th Japan Endometriosis Symposium, Tokyo, Japan; January 24-25, 1992.

04/92 Invited speaker: Third Conference, Endocrinology and Metabolism in Human Reproduction: The Fallopian Tube. The Royal London Hospital, London, UK, April 1-3,1992.

05/92 Visiting Professor, Department of OB/GYN, University of Heidelberg; Germany; May 14, 1992.

05/92 Invited lecturer “International Conference on Rheumatic Diseases in Pregnancy”, Jerusalem, Israel, May 17 to 22, 1992.

05/92 Invited lecturer “Update in Obstetrics and Gynecology”, University of Missouri-Kansas City School of Medicine; Kansas City, Missouri, May 27- 29, 1992.

08/92 Session Chairman, 5th International Congress of Reproductive Immunology, Rome, Italy, August 30 to Sept 3, 1992.

10/92 Invited Panel Moderator “Tubal Cannulation: A New Horizon,” 1992, American College of Surgeons 78th Annual Clinical Congress; New Orleans, Louisiana, October 11-16, 1992.

10/92 Invited lecturer, “Reducing Cesarean Section Rates”, Evergreen Hospital Medical Center, Kirkland, Washington, October 20, 1992.

11/92 Invited lecturer, “Abnormal Autoimmunity and Endometriosis,” 14th World Congress on Fertility and Sterility, Caracas, Venezuela, November 24, 1992.

1992-1994

President, GynecoRadiology Society (Precursor organization to Imaging in Reproductive Medicine Special Interest Group of ASRM)

04/93 Invited lecturer, “Immunologic Theories of Endometriosis: Role of Humoral Immunity,” VIIIth World Congress on Human Reproduction. Joint IVth World Conference on Fallopian Tube in Health and Disease, Bali Indonesia, April 5, 1993.

05/93 Invited Speaker, “Surgery in the Pregnant Cardiac Patient” Women and Heart Disease, Creighton University School of Medicine, Cardiology Division, Continuing Medical Education Division, Creighton Cardiac Center, Omaha, Nebraska, May 22, 1993.

06/93 Invited Panelist, In Vitro Fertilization, Artemisia News – editoriale di cultura medica – June 1993.

09/93 Invited lecturer, “The Immune System in ART,” 8th World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 13, 1993.

09/93 Invited lecturer, “Gynecoradiology: A New Approach to the Investigation and Treatment of Infertility,” International Symposium of New Reproductive Technology - Endoscopic Transcervical Approaches, Tokyo Japan, September 16-19, 1993.

1993 Secretary/Treasurer, World Academy for Medical Education, Vienna, Austria. 04/94 Visiting Professor, Department of OB/GYN, St. Louis University, St. Louis, MO, April

7, 1994. 05/94 Session Chairman, “New Trends in the Immunologic Aspect of Endometriosis,” 4th

World Congress on Endometriosis, Salvador, Bahia, Brazil, May 26, 1994. 05/94 Permanent Panelist “Second Opinion,” weekly TV program on CNBC in affiliation with

AMA and JAMA, George D. Lundberg, editor. 10/94 Invited Plenary Key Note Speaker 13th Annual Scientific Meeting of the Fertility

Society of Australia, Brisbane, Australia, October 3-7, 1994. 10/94 Session Chairman, Combined Fertility Society of Australia and Australian

Gynecological Endoscopy Society, 4th Annual Scientific Meeting, Brisbane, Australia, October 6, 1994.

11/94 Co-Chairman, Conference “New Health Care Horizons for Europe. Defining and Managing Change,” sponsored by the World Academy for Medical Education, and the Federal Government of Austria, Vienna, Austria, November 25-27, 1994.

11/94 Grand Rounds-CHR, Michael Reese Hospital and Medical Center, “Gynecoradiology: A New Diagnostic and Therapeutic Approach to Infertility,” Chicago, Illinois, November 30, 1994.

03/95 Chairman Session 3: Ultrasound Diagnosis of Ectopic Pregnancy, Fifth Conference Endocrinology and Metabolism in Human Reproduction.

03/95 Ectopic Pregnancy: Advances in Diagnosis and Treatment. Royal College of Obstetricians and Gynecologists, March 27-29, 1995, London, England

04/95 Member International Scientific Advisory Committee, 9th World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995.

04/95 Chairman, Session on Preimplantation Genetic Diagnosis, 9th World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995.

04/95 Keynote Speaker, “What Infertility Patients Thins about Multi-conceptions: Is it time to Re-Evaluate Current Practice Patterns?” 9th World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995.

04/95 Invited Speaker, “Ovarian Stimulation and Hyperstimulation ,” Satellite Symposium of the 9th World Congress on IVF and Assisted Reproduction, Budapest, Hungary, April 7-9, 1995.

05/95 Invited Speaker, “Overview of Reproductive Immunology,” 197th Annual Meeting of the Medical and Chirurgical Faculty of Maryland, College Park, May 6, 1995.

05/95 Consultant to the Ministry of Health, Peoples Republic of China, May 8 - 13, 1995. 05/95 Speaker, “The Role of Outcome Studies in Allergy & Clinical Immunology” 197th

Annual Meeting of the Medical and Chirurgical Faculty of Maryland, College Park, May 26, 1995

06/95 Speaker, “A Dialogue With the Austrian Medical Legal Mission,” sponsored by the Illinois Department of Public Health, James R. Thompson Center, Chicago, Illinois, June 1, 1995.

07/95 Session Chairman, “Response to signals: Late pregnancy,” Joint meeting of the American Society for Reproductive Immunology and The International Society for Immunology of Reproduction, Washington, D.C., July 19-23, 1995.

09/95 Invited Speaker, “Cost Containment & Utilization Containment in OB/GYN,” Illinois Association of Health Maintenance Organizations,” Ritz Carlton Hotel, Chicago, Illinois, September 21, 1995.

10/95 Invited Speaker, “Active Labor/C Section,” Grand Rounds-CHR, North Shore University Medical School, Manhasset, Long Island, New York, October 25, 1995.

12/95 Advisory Board, The Turkish Health & Therapy Foundation. 01/96 Invited Speaker, “Corticosteroid and Immunosuppressive Therapy in Reproductive

Autoimmune Failure Syndrome,” International Conference on Recurrent Abortion, Rome, Italy, January 27, 1996.

01/96 Session Chairman, International Conference on Recurrent Abortion, Rome, Italy, January 27, 1996.

03/96 Invited Speaker, “Developing Winning Strategic Alliances” Physician Practice Management Companies Seminar, Ambassador West Hotel, Chicago, Illinois, March 14, 1996.

03/96 Invited Speaker, “The Physician Perspective: The Pros and Cons of Affiliating with a PPMC” Physician Practice Management Companies Seminar, Ambassador West Hotel, Chicago, Illinois, March 15, 1996.

04/96 Faculty Position, “Tubal Cannulation,” International Society for Gynecologic Endoscopy, Chicago, Illinois, April 17, 1996.

05/96 Invited Speaker, “Immunology of Implantation,” Organon Symposium on Assisted Reproductive Immunology, Chicago, Illinois, May 2, 1996.

05/96 Invited Speaker, “The Changing World of Infertility in an ERA of Managed Care,” Assisted Reproduction: State-of-the-Art Then and Now, Chicago, Illinois, May 2-4, 1996.

09/96 Grand Rounds-CHR, University of South Florida College of Medicine, “Clinical Relevance of Reproductive Immunology,” Tampa, Florida, September 11, 1996.

09/96 Invited Speaker, Smith Barney Second Annual Conference on Emerging Sectors in Healthcare, “Managed Care” Plaza Hotel, New York, NY, September 25, 1996.

09/96 Invited Panel Moderator Sonography- International Congress of Sonography, AAGL 25th Annual Meeting, Chicago, Illinois, September 26, 1996.

09/96 Invited Panel Chairman, “Managed Care,” International Congress of Gynecologic Endoscopy, AAGL 25th Annual Meeting, Chicago, Illinois, September 27, 1996.

09/96 Invited Discussant, Ultrasound and Fetoscopy, AAGL 25th Annual Meeting, Chicago, Illinois, September 28, 1996.

09/96 Co-chair of Technical Exhibits Committee, AAGL 25th Annual Meeting, Chicago, Illinois, September 25-29, 1996.

10/96 Invited Speaker, “Autoantibodies as an Infertility Factor,” 5th World Congress on Endometriosis, Yokohama, Japan, October 21, 1996.

11/96 Seminar Leader, “Infertility for Managed Care,” American Society for Reproductive Medicine 52nd Annual Meeting, Boston, Massachusetts, November 2-6,1996.

02/97 Invited Speaker, “GynCor, Inc.: The Management Challenge in Reproductive Medicine”, Smith Barney’s Fifth Annual Health Care Services Conference, Plaza Hotel, New York City, February 10-14, 1997.

02/97 Co-Moderator, “Diagnosis and Therapeutic Radiologic Intervention”, American Association of Gynecologic Laparoscopists, “Managed Care and Reimbursement for Fertility Surgery”, First Trimester Pregnancy Loss” Squaw Valley, California, February 20-23, 1997.

05/97 International Advisory Committee. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, B.C., Canada, May 24-28, 1997.

05/97 Co-Chair, “Ovarian Hyperstimulation Syndrome”, 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, B.C., Canada, May 24-28, 1997.

08/97 Grand Rounds-CHR, University of Illinois at Chicago College of Medicine, “Impact of Managed Care on Obstetrics and Gynecology,” Columbia-Michael Reese Hospital and Medical Center, August 13, 1997.

09/97 International Advisory Committee and Faculty: Second International Symposium on Preimplantation Genetics, Chicago, Illinois, September 18-21, 1997.

01/98 Session Co-Chair: “Oocyte Manipulation Techniques,” Treatment of Infertility: The New Frontiers. Boca Raton, Florida, January 1998.

03/98 Scientific Committee: International Association of Private Assisted Reproductive Technology Clinics and Laboratories.

10/98 Organizing Committee: 7th International Congress of Reproductive Immunology, New Delhi, India, October 27-30, 1998.

10/98 Session Co-Chair: “Immunobiology of Pregnancy,” 7th International Congress of Reproductive Immunology, New Delhi, India, October 27-30, 1998.

10/98 Session Co-Chair: “Role of Lymphomyeloid Cells, HLA-G and Antibodies in Pregnancy,” VII International Congress of Reproductive Immunology, New Delhi, India, October 27-30, 1998.

10/99 Organizing Committee: 3rd International Congress on Autoimmunity, Geneva, Switzerland, February 20-24, 2002.

1999 Ground Rounds – CHR, Lenox Hill Hospital, 1999 2000 Reviewer for PIER, the Physicians Information and Education Resource, a project of the

American College of Physicians – American Society of Internal Medicine 01/01 Chicago Magazine – Best physician (Reproductive Endocrinology/Infertility – Year

2000) 1999 Scientific Committee: International Association of Private Assisted Reproductive

Technology Clinics and Laboratories. 07/01 Session Co-Chair: “The Reproductive Autoimmune Failure Syndrome, (RAFS),” VIII

International Congress of Reproductive Immunology, Opatija, Croatia, July 2-6, 2001 09/01 Session Co-Chair: “Ovulation Induction and Insemination,” 2nd World Congress on

Controversies in Obstetrics Gynecology & Infertility Paris, France, September 6-9, 2001 09/01 Invited Speaker, “Forget About Ovulation Induction Proceed Directly to IVF!” 2nd

World Congress on Controversies in Obstetrics Gynecology & Infertility, Paris, France, September 8, 2001.

11/01 Scientific Committee, First World Congress on Men’s Health and the Board of the International Society on Men’s Health, Vienna, October 25–27, 2002

10/04 Member of the International Board of the New European Surgical Academy, Berlin, Germany, October 29, 2004

11/04 Session Chair and Advisory Board Member, Asian Pacific Congress on Controversies in Obstetrics, Gynecology, and Infertility, Bangkok, Thailand, November 25-28, 2004

05/05 International Advisory Committee Member, 13th World Congress on In Vitro Fertilization, Assisted Reproduction & Genetics, Istanbul, Turkey, May 26-29, 2005

05/06 Invited Key Note Speaker, The International Ovarian Conference, Yokohama, Japan, May 13, 2006

09/06 Invited Speaker, “Selected Research Update at CHR”; Grandrounds, Department of Ob/Gyn, Sheba Medical Center, Tel Haschomer Hospital, Sackler School of Medicine of Tel Aviv University, September 26, 2006.

09/06 Invited Speaker, “Selected Research Update at CHR”; Grandrounds, Department of Ob/Gyn, Ashkelon Medical Center, Ben Gurion University School of Medicine, September 27, 2006.

10/06 Invited Roundtable Speaker, “Pitfalls of hysterosampingography”; 62nd Annual Meeting of the Society for Reproductive Medicine, New Orleans, October 25, 2006

03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, NYU Medical Center of NYU School of Medicine, New York

03/07 Invited Discussant, “Is PGD Indicated for Everybody?”; World Congress of Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-25, 2007

03/07 Expert Panel, “Controversies in IVF”; World Congress of Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-25, 2007

03/07 Chairman, “Session on Ovarian Stimulation”; World Congress of Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-25, 2007

03/07 Chairman, “Session on Gamete and Ovarian Cryopreservation”; World Congress of Controversies in Obstetrics and Gynecology, Barcelona, Spain, March 22-25, 2007

03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn, Hadassah Hospital and Hebrew University School of Medicine, Jerusalem, Israel, March 26, 2007.

03/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn, Assuta Hospital, Tel Aviv, Israel and Sackler School of Medicine, Tel-Aviv University, Israel, March 27, 2007.

04/07 Invited Speaker, “The Aging Ovary”; Grandrounds, Department of Ob/Gyn. Allgemeubes Krankenhaus and Vienna University School of Medicine, April 5, 2007.

05/07 Invited Speaker, “Premature Ovarian Aging”; Grandrounds, Department of Ob/Gyn and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, May 3, 2007.

05/07 Invited Speaker, “The Aging Ovary”; 1st International Symposium in Genetics and Assisted Reproduction Techniques, King George Palace Hotel, Athens, Greece, May 5, 2007.

05/07 Invited Speaker, “Gynecoradiology”; Grandrounds, Southern California Reproductive Center, Beverly Hills, California, May 25, 2007.

09/07 Invited Speaker, “Twins in ART- A desirable outcome?”; 14th World Congress on In Vitro Fertilization and 3rd World Congress on In Vitro Maturation, Montreal, Canada, September 15-19, 2007.

09/07 Invited Speaker, “IVF in Older Women”; 23rd Annual Congress of the Austrian Society for Reproductive Medicine and Endocrinology, Innsbrick, Austria, September 20-22, 2007.

11/07 Invited Speaker, The International Ovarian Conference, Hakone, Japan, November 2-3 2007.

11/07 Invited Speaker, International Symposium, Genetics and Immunology of Reproduction, Buenos Aires, Argentina, November 7-8, 2007.

11/07 Member Advisory Committee (SAC), Assisted Reproductive Techniques Outcome Registry of Argentina (ARTORA).

06/08 Chosen to deliver 2009 Annual Patrick Steptoe Memorial Lecture of the British Fertility Society. Keynote lecture title: “Infertility Treatment 2009: as good as it gets.”

10/08 Invited Speaker, “The FMR1 Gene as a Fertility Test”; Grandrounds, Yale University School of Medicine, New Haven, Connecticut, October 30, 2008.

11/08 Advisory Board Member, IVF-Worldwide.com. 11/08 Chairman, Session on Assessment of Ovarian Reserve, 11th World Congress on

Controversies in Obstetrics and Gynecology, Paris, France, November 27-30, 2008. 11/08 Panelist, Round Table Discussion: Clinical Aspects of ART, 11th World Congress on

Controversies in Obstetrics and Gynecology, Paris, France, November 27-30, 2008. 11/08 Panelist, Session on Multiple Pregnancies and Embryo Transfer (ET), 11th World

Congress on Controversies in Obstetrics and Gynecology, Paris, France, November 27-30, 2008.

01/09 Gleicher N. Infertility treatment 2009: as good as it gets? Patrick Steptoe Memorial Lecture; Fertility 2009, Bi-Annual Combined Meetings of the British Fertility Society, The Association of Clinical Embryologists and Society for Reproduction and Fertility; Edinburg International Conference Center.

01/09 Gleicher N. Should we ever make a diagnosis of unexplained infertility? Fertility 2009, Bi-Annual Combined Meetings of the British Fertility Society, The Association of Clinical Embryologists and Society for Reproduction and Fertility; Edinburg International Conference Center.

01/09 Gleicher N. The FMR1 gene as a fertility test. Masterclass in Reproductive Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg.

01/09 Gleicher N. An update on DHEA supplementation. Masterclass in Reproductive Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg.

02/09 Gleicher N. “Can we possibly affect follicular recruitment?” New Frontiers in Fertility. Serono Symposia International Foundation, Lisbon, Portugal, February 13-14, 2009.

11/09 Co-Chair, Session Polycystic Ovarian Syndrome (PCOS) in the Asia-Pacific Region. Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG). The 3rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility, Beijing, China, November 12-15, 2009.

12/09 Invited Speaker, The International Ovarian Conference 2009, Tokyo, Japan, December 5, 2009.

12/09 Invited Speaker, Meeting of the Japan Infertility Study Group (ISG), Tokyo, Japan, December 6, 2009.

2/10 Chairman, Opening Session, First International Congress on Cardiac Problems in Pregnancy, Valencia, Spain, February 25-28, 2010

2/10 Invited Faculty, First International Congress on Cardiac Problems in Pregnancy, Valencia, Spain, February 25-28, 2010

11/10 Invited speaker: Gleicher N. Poor responders: what’s new? Tecnobios Procreazione Symposium 2010. Bologna, Italy, Nov. 24-25, 2010.

9/11 Invited speaker: Gleicher N. Are twins an adverse outcome after infertility treatments? Fifth Isala Fertility Symposium. Zwolle, the Netherlands, Sep. 23, 2011.

11/11 Invited speaker: Gleicher N. Genetic issues related to the oocyte: the FMR1 gene. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.

11/11 Invited speaker: Gleicher N. Rejuvenating ovarian function: DHEA improves IVF outcomes and reduces aneuploidy. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.

11/11 Chairperson, Session “Ovarian aging: Assessment, Implications and New Technologies.” First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.

11/11 Chairperson, Session “What can we do to improve implantation?” 4th Asia Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility. Bangkok, Thailand, November 24-24, 2011.

03/12 Invited speaker: Gleicher N. “The Most Important, Largely Unknown Gene in Reproductive Medicine and Beyond: the FMR1 Gene.” Greater Toronto Area Reproductive Medicine Rounds, Toronto, Canada, March 22, 2012.

09/12 Member, International Scientific Board, New European Surgical Academy Palmaplanas Innovation Days, Palma de Mallorca, Spain, September 13-15, 2012.

05/12 Chairperson, How can we diagnose and improve the endometrium in infertile patients. The World Congress on Building Consensus in Gynecology, Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.

05/12 Invited speaker: Gleicher N. “Chromosomes and autoimmunity: The FMR1 gene.” American Autoimmune Related Diseases Association’s Scientific Colloquium “Sex, Gender and Autoimmunity through the Lifespan.” Chicago, IL, USA, May 17, 2012.

05/12 Member, Advisory Board, Congress on Cardiac Problems in Pregnancy, Berlin, Germany, May 17-20, 2012.

05/12 Invited speaker: Gleicher N. “Improvements in infertility techniques leading to increased incidence of pregnancies in women with congenital or acquired heart disease.” Congress on Cardiac Problems in Pregnancy, Berlin, Germany, May 17-20, 2012.

06/12 Invited speaker: Gleicher N. “Twins are ethically and clinically desirable outcome of infertility treatment.” Fertility Treatment and Multiple Births: Ethical and Policy Issues Workshop, White Plains, New York, June 20-21, 2012.

07/12 Keynote speaker: Gleicher N. “Decreased ovarian reserve and early menopause: Can you do something, doctor?” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Invited speaker: Gleicher N. “IVM does not offer any advantage over current IVF practice, and the associated risks are unknown. The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Invited speaker: Gleicher N. “Developing international standards for cross border services, whose responsibility is it?” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Invited speaker: Gleicher N. “Can we improve pregnancy rates for patients with DOR by better stimulation? Better protocol can improve stimulation and pregnancy rates.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Invited speaker: Gleicher N. “EBM has limited value in daily clinical care and cannot replace clinical judgement.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Chairperson, “There are ever-growing indications of the need for an effective, reliable freezing method for oocytes and embryos. The many possible techniques require elucidation of the best approach.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

07/12 Panelist, “Hot controversies on ART clinical issues.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

11/12 Panelist, “What clinicians and biologists should know about each other’s work.” The 17th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Lisbon, Portugal, November 8-11, 2012.

11/12 Chairperson, “The Fertilization Process.” Ovarian Club II, Prague, Czech Republic, November 8-11, 2012.

10/13 Chairperson, “Basic and technical challenges or ART.” The 18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Vienna, Austria, October 25-27, 2013.

10/13 Chairperson, “Anti-Müllerian hormone.” The 18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Vienna, Austria, October 25-27, 2013.

10/13 Chairperson, “Improving results in IVF and male factor infertility.” The 18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Vienna, Austria, October 25-27, 2013.

11/13 Member, Organizing Committee, Ovarian Club III – The Inverse Pyramid: Regulating Follicle Number and Oocyte Quality, Paris, France, November 14-17 2013.

11/13 Chairperson, “Ovarian Stimulation, Follicular Development and Effects on Pregnancies.” Ovarian Club III – The Inverse Pyramid: Regulating Follicle Number and Oocyte Quality, Paris, France, November 14-17 2013.

11/14 Member, Organizing Committee, Ovarian Club IV – Blastocysts Development and the Process of Implantation, Paris, France, November 15 – 16, 2014.

3/14 Moderator, Oncofertility Session, World Symposium on Endometriosis, Atlanta, GA, March 27-29, 2014.

5/14 Induction by the Mumbai Obstetrical & Gynecological Society, Mumbai, India, May 34, 2014.

5/14 Induction by the Pune Obstetrical & Gynecological Society, Pune, India, June 1, 2014. 11/14 Session Chair, “New advances in development and implantation,” Ovarian Club

Meeting IV, Paris, France, November 7-8, 2015. 11/14 Session Chair, “Adjuvants for poor-responding patients,” COGI Vietnam, Ho Chi Min

City, Vietnam, November 20-22, 2014. 11/14 Session Chair, “Preimplantation genetic diagnosis and screening – what is it all about?”

COGI Vietnam, Ho Chi Min City, Vietnam, November 20-22, 2014. 5/15 Session Chair, “Improved implantation and luteal support,” 21st COGI Congress,

Guilin, China, May 7-10, 2015. 5/15 Session Chair, “Fertility Preservation in Cancer Patients,” 21st COGI Congress, Guilin,

China, May 7-10, 2015. 5/15 Session Chair, “Social Freezing: good news or bad news for women?” 21st COGI

Congress, Guilin, China, May 7-10, 2015. 5/15 Session Chair, “Preparation for IVF” 21st COGI Congress, Guilin, China, May 7-10,

2015. 5/15 Session Chair, “Does time lapse provide better results?” 21st COGI Congress, Guilin,

China, May 7-10, 2015. 5/15 Member, Organizing Committee for the 21st COGI Congress, Frankfurt, Germany, May

14-16, 2015. 5/15 Session Chair, “Are we reaching the time when science meets wishful thinking?,” 21st

COGI Congress, Frankfurt, Germany, May 14-16, 2015. 7/15 ASRM Star Award, 7/17/2015 9/15 Session Co-Chair, “Is it risk free? Is ISCI safe and effective enough to treat all ART

patients?” 22st COGI Congress, Budapest, Hungary, Sept. 17-19, 2015. 9/15 Session Chair, “Fibroids are encountered in increasing frequency in IVF patients as the

mean age of patients rises. Do we have to treat them all?” 22st COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.

11/15 Member, Organizing Committee for Ovarian Club VI, Barcelona, Spain, November 14-15, 2015.

11/16 Organizing committee member, Ovarian Club VIII, Paris, France, November 4-6, 2016. 11/16 Session chair, “Stimulation of the ovary and the ovulation process,” Ovarian Club VIII,

Paris, France, November 4-6, 2016. 11/16 Session Chair, “Fertility preservation for cancer patients,” 24th World Congress on

Controversies in Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the Netherlands. November 10-13, 2016.

11/16 Session Chair, “PGS: A friend or a foe of the patients?” 24th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the Netherlands. November 10-13, 2016.

11/16 Conference chair, Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

11/16 Session chair, “The future of fertility care,” Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

4/17 Winner, Presidential Award for Best Poster, Annual 2017 Meeting of the Endocrine Society (ENDO 2017)

10/18 Fertility & Sterility Journal Club participant, The Pros and Cons of Preimplantation Genetic Testing for Aneuploidy (PGT-A): Clinical and Laboratory Perspectives.

Consultant – Journals Advances in Therapy Archives of Gynecology and Obstetrics American Journal of Managed Care American Journal of Obstetrics and Gynecology American Journal of Reproductive Immunology Annals of the Rheumatic Diseases Annals of Internal Medicine Biology of Reproduction BioMed Research International British Journal of Obstetrics and Gynaecology British Journal of Rheumatology BMJ Case Reports Cell & Tissue Research Cellular and Molecular Neurobiology Clinical & Diagnostic Laboratory Immunology Clinical Endocrinology Clinical Immunology and Immunopathology Clinical Medicine & Research Computers in Biology and Medicine Current Women’s Health Reviews Endocrine Endocrinology European Journal of Obstetrics and Gynecology European Journal of Obstetrics & Gynecology and Reproductive Biology Expert Review in Obstetrics & Gynecology Faculty of 1000 Fertility & Sterility Genetics in Medicine Genetics Research

Gynecologic and Obstetric Investigation Gynecological Endocrinology Gynecology & Obstetrics Hormones Human Molecular Genetics Human Reproduction Human Reproduction Update International Archives of Allergy and Immunology International Journal of Endocrinology International Journal of Molecular Sciences Journal of Assisted Reproduction and Genetics Journal of Clinical Endocrinology & Metabolism Journal of Clinical Metabolism & Diabetes Journal of Fertilization: In Vitro Journal of Human Genetics Journal of Hypertension Journal of Immunology Journal of IVF-Worldwide: Reproductive Medicine, Genetics and Stem Cell Biology Journal of Medical Genetics Journal of Molecular Endocrinology Journal of Obstetrics and Gynaecology Journal of Obstetrics and Gynaecology Research Journal of Ovarian Research Journal of Postgraduate Medicine Journal of Reproductive Immunology Journal of Rheumatology Journal of the American Medical Association Journal of Women’s Health Life Sciences Lupus Mayo Clinic Proceedings Medical Principles and Practice Medical Science Monitor Mount Sinai Journal of Medicine New England Journal of Medicine Nutrition & Metabolism Obstetrics & Gynecology Obstetrics & Gynecology International RBM Online Reproductive Biology Reproductive Biology and Endocrinology Reproductive Sciences PLoS ONE Rheumatology Journal Saudi Medical Journal Scandinavian Journal of Obstetrics & Gynecology

Southern Medical Journal Stem Cell Research Steroid Biochemistry & Molecular Biology The Endocrine Society The Lancet Translational Pediatrics Trends in Molecular Medicine Vascular Cell Consultant – Professional Blue Cross/Blue Shield of Illinois Blue Cross/Blue Shield of California Blue Cross/Blue Shield of Rochester, New York Carle Clinic, Urbana-Champaign, Illinois Health Care Compare, Downers Grove, Illinois National Blue Cross/Blue Shield Association Rush/Prudential Health Plan, Illinois Presentations

1. Gleicher N: Immunology of pregnancy and cancer. The American College of Surgeons, District Meeting; New York, September 19, 1979.

2. Roboz J, Wu K, Chahinian P, Gleicher N, Holland J: Applications of adriamycin analysis in human malignant effusions and amniotic fluid by high performance liquid chromatography. International Liquid Chromatography Symposium; Boston, October 11-12, 1979.

3. Gleicher N: Immunodiagnostic techniques: Reality or promise? Gynecologic Oncology Post-Graduate Course, The Department of Obstetrics and Gynecology, The Page and William Black Postgraduate School of the Mount Sinai School of Medicine (CUNY) in cooperation with the American Cancer Society, New York Division; Mount Sinai Medical Center, New York, March 6, l980.

4. Gleicher N: Maternal heart disease in pregnancy. In Current Concepts of Fetal Maternal Medicine, The Department of Obstetrics and Gynecology, and the Page and William Black Postgraduate School of Medicine of the Mount Sinai School of Medicine (CUNY), Postgraduate Course; New York, March 27, l980.

5. Beers PC, David S, Reyniak JV, Gleicher N: Antibodies to autologous gonadotropins. Society for Gynecologic Investigation, Denver, Colorado, March l9-22, l980.

6. Gleicher N: The immunologic concept of EPH-gestosis. First S.B. Gusberg Seminar on Reproductive Immunology; New York, New York, June 26, l980.

7. Gleicher N: Common denominators of pregnancy and malignancy. First S.B. Gusberg Seminar on Reproductive Immunology; New York, New York, June 27, l980.

8. Siegel I, Gleicher N: Red cell immune adherence in pregnancy and malignancy. First S.B. Gusberg Seminar on Reproductive Immunology; New York, New York, June 27, l980.

9. Gleicher N: Introduction to intercurrent disease in pregnancy. In Mount Sinai Update: Medical and Surgical Complications of Pregnancy, The Department of Obstetrics and Gynecology, and the Page and William Black Postgraduate School of Medicine of the

Mount Sinai School of Medicine (CUNY), Postgraduate Course, New York, December ll-l2, l980.

10. Gleicher N: Hypertensive disease of pregnancy. In Mount Sinai Update: Medical and Surgical Complications of Pregnancy, The Department of Obstetrics and Gynecology, and the Page and William Black Postgraduate School of Medicine of the Mount Sinai School of Medicine (CUNY), Post-Graduate Course, New York, December ll-l2, l980.

11. Gleicher N: The maternal immune response in pregnancy. In Applied Clinical Immunology in Obstetrics and Gynecology, The Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Las Vegas, Nevada, April 28-30, 1980.

12. Gleicher N: Immune complex disease in pregnancy and toxemia. In Applied Clinical Immunology in Obstetrics and Gynecology, The Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Las Vegas, Nevada, April 28-30, l98l.

13. Gleicher N: Update in reproductive immunology. In Mount Sinai Update in Obstetrics and Gynecology, The Department of Obstetrics and Gynecology and The Page and William Black Post-Graduate School of Medicine of the Mount Sinai School of Medicine of the City University of New York, Post-Graduate Course, New York, June ll, l981.

14. Smolen J, Chused T, Leiserson W, Weintraub B, Gleicher N, Steinberg A: T cell phenotypes in pregnant patients with autoimmune diseases. Second International S.B. Gusberg Symposium on Reproductive Immunology, New York, June l8, l98l.

15. Gleicher N, Adelsberg B, Siegel I, Siegal F, Liu TL: Immune complex disease in pregnancy. Second International S.B. Gusberg Symposium on Reproductive Immunology, New York, June l8, l98l.

16. Siegel I, Liu TL, Gleicher N: Red cell immune adherence (RCIA) in the developing rabbit. Second International S.B. Gusberg Symposium on Reproductive Immunology, New York, June l9, l98l.

17. Adelsberg B, Liu TL, Phillips R, Cederquist L, Siegel I, Gleicher N: Immune complexes in all stages of pregnancy. Second International S.B. Gusberg Symposium on Reproductive Immunology, New York, June l9, l98l.

18. Gleicher N: Immunology of reproduction. Staff Meetings, Gottlieb Hospital, Chicago, Illinois, February 15, 1982.

19. Gleicher N: Immune complexes in normal and abnormal pregnancy. In Basic and Applied Immunology for the Obstetrician, Gynecologist, and Perinatologist, The 30th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Dallas, Texas, April 24-25, 1982.

20. Gleicher N: Autoimmunity in pregnancy. In Basic and Applied Immunology for the Obstetrician, Gynecologist, and Perinatologist,The 30th Annual Clinical Meeting of the American College of the American College of Obstetricians and Gynecologists, Dallas, Texas, April 24-25, 1982.

21. Toder V, Blank M, Gleicher N, Voljovich I, Machiah S, Nebel H: The suppression of natural killer (NK) activity by pregnancy. 5th Symposium on the Immunology of Reproduction, Varna, Bulgaria, May 25-29, 1982.

22. Gleicher N: Clinical reproductive immunology. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Prentice Women’s Hospital, Northwestern University, June 16, 1982.

23. Toder V, Nebel L, Gleicher N: Interferon activation of natural killer (NK) lymphocyte precursors in human pregnancy. Third Annual Symposium of the American Society for the Immunology of Reproduction, Bowman Gray School of Medicine, Winston-Salem, North Carolina, June 24-26, 1982.

24. Siegel I, Lubicz S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA (red cell immune adherence) by oxygen. Third Annual Symposium of the American Society for the Immunology of Reproduction, Bowman Gray School of Medicine, Winston-Salem, North Carolina, June 24-26, 1982.

25. Siegel I, Liu TL, Gleicher N: Enhanced red cell immune function in early development. Third Annual Symposium of the American Society for the Immunology of Reproduction, Bowman Gray School of Medicine, Winston-Salem, North Carolina, June 24-26, 1982.

26. Toder V, Nebel H, Elrad H, Blank M, Gleicher N: Human natural killer (NK) activity: Regulatory effect of some pregnancy markers. Third Annual Symposium of the American Society for the Immunology of Reproduction, Bowman Gray School of Medicine, Winston-Salem, North Carolina, June 24-26, 1982.

27. Siegel I, Lubicz S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA (red cell immune adherence) by oxygen. ACOG, District VI Meeting, Chicago, Illinois, September 22-25, 1982.

28. Gleicher N, Elrad H, Toder V: Suppressive effect of some pregnancy substances on human natural killer activity. ACOG, District VI Meeting, Chicago, Illinois, September 22-25, 1982.

29. Gleicher N: The direct diagnosis of unruptured ectopic pregnancy by realtime ultrasonography. Inaugural Thesis, The Chicago Gynecological Society Chicago, Illinois, October 15, 1982.

30. Gleicher N: Immunologic factors in hypertension of pregnancy. International Society for the Study of Hypertension in Pregnancy, Dallas, Texas, October 24-27, 1982.

31. Gleicher N, Toder V: Comparison of natural killer activity in normal pregnancy and EPH-gestosis. International Society for the Study of Hypertension in Pregnancy, Dallas, Texas, October 24-27, 1982.

32. Gleicher N, Siegel I: Additional evidence for an immunologic etiology of the preeclampsia/eclampsia syndrome (EPH-gestosis). International Society for the Study of Hypertension in Pregnancy, Dallas, Texas, October 24-27, 1982.

33. Gleicher N: Clinical reproductive immunology, Grand Rounds-CHR, The Chicago Lying-In Hospital, University of Chicago, Chicago, Illinois, November 4, 1982.

34. Gleicher N: Establishing the first in vitro fertilization program in Illinois, presented at a Seminar on In Vitro Fertilization, Chicago, Illinois, March 6, 1983.

35. Gleicher N: To enter or not, presented at a Seminar on In Vitro Fertilization, Chicago, Illinois, March 6, 1983.

36. Gleicher N: Egg retrieval, presented at a Seminar on In Vitro Fertilization, Chicago, Illinois, March 6, 1983.

37. Siegel I, Liu TL, Gleicher N: The effects of lipids upon the immune system - The immune adherence connection, FASEB Meeting, Chicago, Illinois, April 4, 1983.

38. Gleicher N, Dmowski P, Siegel I, Liu TL, Toder V: Peripheral white cell subsets in endometriosis, C.A.R.E. meeting, Chicago, Illinois, April 5, 1983.

39. Gleicher N: Ultrasonographic diagnosis of ectopic pregnancy. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Rush Presbyterian St. Luke’s Medical Center, April 14, 1983.

40. Gleicher N: Immunology of reproduction. Ravenswood Hospital Medical Center, Continuing Medical Education, Chicago, Illinois, April 1983.

41. Gleicher N: Immunology of pregnancy and lactation, presented at a postgraduate course in Reproductive Immunology for Obstetricians and Gynecologists, University of Health Sciences, The Chicago Medical School, Hektoen Institute of Research, Cook County Hospital, Chicago, Illinois, April 22, 1983.

42. Gleicher N: Clinical applications of immunology during normal and abnormal pregnancy, presented at a postgraduate course in Reproductive Immunology for Obstetrics and Gynecologists, University of Health Sciences, Hektoen Institute of Research, Cook County Hospital, Chicago, Illinois, April 22, 1983.

43. Gleicher N: Immunology for the clinician, Fourth Annual Obstetrics and Gynecology Review Course, Chicago Area Schools of Medicine, Chicago, Illinois, June 9, 1983.

44. Gleicher N, Dmowski W, Siegel I, Liu TL, Toder V: Peripheral white blood cell subsets in endometriosis, Fourth Annual International Symposium of the American Society for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.

45. Siegel I, Liu TL, Gleicher N: Regulation of red cell immune adherence (RCIA) and neutrophil immune adherence (NIA) by dietary lipids, Fourth Annual International Symposium of the American Society for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.

46. Siegel I, Liu TL, Elrad H, Gleicher N: Defense against infection - A selective role for unsaturated fatty acid, Fourth Annual International Symposium of the American Society for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.

47. Siegel I, Liu TL, Wissner R, Gleicher N: Red cell immune adherence (RCIA) co-factors in adult and cord serums, Fourth Annual International Symposium of the American Society for the Immunology of Reproduction, Park City, Utah, June 8-11, 1983.

48. Friberg J, Gleicher N, Fullen N: Seminal bacteria and embryonic development in an in vitro fertilization/embryo transfer program, Recent Progress in Human In Vitro Fertilization, Congress I, Vienna, June 22-24, 1983.

49. Gleicher N, Friberg J: Alternative approaches to egg retrieval, Recent Progress in Human In Vitro Fertilization, Congress I, Vienna, June 22-24, 1983.

50. Gleicher N: Clinical reproductive immunology. Visiting Lectureship, Department of Obstetrics and Gynecology, Methodist Hospital, Indianapolis, Indiana, August 10, 1983.

51. Gleicher N: Official discussion of paper: The HELLP Syndrome. A unique variant of preeclampsia/eclampsia, by Weinstein L. 51st Annual Meeting of the Central Association of Obstetrics and Gynecologists, Colorado Springs, Colorado, October 14-16, 1983.

52. Gleicher N: Principles of medical therapy in pregnancy, Medical Complications of Pregnancy, A Postgraduate Course, Chicago, Illinois, November 11, 1983.

53. Gleicher N: Pulmonary hypertension and Eisenmenger’s syndrome, Idem. 54. Gleicher N: Hypertensive diseases of pregnancy, Idem. 55. Gleicher N: SLE and autoimmunity in pregnancy, Idem. 56. Gleicher N: Introduction to Real-Time Ultrasonography. In Basic and Advanced Real-

Time Ultrasonography in Obstetrics and Gynecology - A Postgraduate Course, Chicago, Illinois, November 30 - December 2, 1983.

57. Gleicher N: Congestive heart failure and non-immunologic hydrops, Idem. 58. Gleicher N: Ectopic pregnancy, Idem. 59. Gleicher N: The ovary - normal and pathology; Follicular sonography and sonographic

egg retrieval, Idem. 60. Gleicher N: Immunology of endometriosis. Endometriosis ‘83, A Postgraduate course

sponsored by Rush Medical College, December 2 and 3, 1983. 61. Toder V, Elrad C, Durdana A, Gleicher N: Natural killer lymphocytes in newborns. Proc.

of the First Joint Meeting of the Israeli Soc for Life Sciences, 1983, A141. 62. Gleicher N: Intrauterine dysrythmias; A diagnostic and therapeutic approach, Diagnosis

and Management of Maternal and Fetal Heart Disease. A Postgraduate Course sponsored by the University of Southern California School of Medicine, Postgraduate Division, Beverly Hills, California, January 13-14, 1984.

63. Gleicher N: Hypertensive pregnancy; Diagnosis, prognosis and management, Idem. 64. Gleicher N: Management of hypertension in pregnancy, Annual Scientific Sessions of the

American College of Cardiology, Dallas, Texas, March 25-29, 1984, (by invitation). 65. Gleicher N: Official discussant of inaugural thesis, Hobart, J.M: Perinatal Outcome in

Ultrasonically Determined Post Term Pregnancy, 963rd Meeting of the Chicago Gynecological Society, January 20, 1984.

66. Gleicher N: Hypertension diseases; Grand Rounds-CHR, Gottlieb Memorial Hospital, Melrose Park, Illinois, January 16, 1984.

67. Gleicher N: Immunology of endometriosis, Washtenaw Obstetrical and Gynecological Society, Michigan, January 18, 1984.

68. Gleicher N: Autoimmunity in obstetrics and gynecology, Grand Rounds-CHR, The University of Michigan Medical Center, Ann Arbor, Michigan, January 19, 1984.

69. Gleicher N: Cesarean section rates in the USA: The short term failure of the Consensus Development Conference. 31st Annual Meeting of the Society for Gynecologic Investigation, San Francisco, March 21-24, 1984.

70. Siegel I, Gleicher N: Effects of short-term dietary restriction on survival of mammary ascites tumor bearing rats. Idem.

71. Gleicher N: Management of hypertension in pregnancy. Symposium on Pregnancy in the Patient with Cardiac Disease. Invited Speaker to the 33rd Annual Scientific Session of the American College of Cardiology, Dallas, Texas, March 25-29, 1984.

72. Gleicher N: The profession of obstetrics and gynecology. At a Career Seminar for Medical Students, Chicago Medical Society Student Branch, Chicago, April 14, 1984.

73. Gleicher N: Gynecologic sonography. Departmental Teaching Day, Department of Obstetrics and Gynecology, Loyola University Medical School, April 25, 1984.

74. Friberg J, Gleicher N: High dose human menopausal gonadotropin therapy for successful ovulation induction for IVF program in perimenopausal women. 3rd World Congress for IVF-ET, Finlandia Hall, Helsinki, Finland, May 14-17, 1984.

75. Gleicher N, Friberg J: The effect of aspiration needles on oocyte recovery rates and the need for follicular irrigation. Idem.

76. Siegel I, Elrad H, Gleicher N: Toxicity of term amniotic fluid to human red cells. 5th Annual Meeting of the American Society for the Immunology of Reproduction, Durham, North Carolina, June 13-15, 1984.

77. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: Chain reaction (CR) fatty acid toxicities affecting human red cells and human sperm cells. Idem.

78. Gleicher N: Immunology in reproduction. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Lenox Hill Hospital and New York Medical College, New York, NY, August 1, 1984.

79. Gleicher N: Immunology in OB/GYN. Grand Rounds-CHR, Christ Hospital, Oak Lawn, Illinois, August 27, 1984.

80. Gleicher N: In vitro fertilization: The Current Status, Great Lakes Research Conference; Invited Speaker, Nordic Hills Resort, Itasca, Illinois, September 23-25, 1984.

81. Gleicher N: Intrauterine diagnosis of congenital heart disease. Idem. 82. Gleicher N: Autoimmunity and pregnancy. Invited Speaker, International Symposium on

the Immunology of Reproduction, Tel Aviv, Israel, October 21-25, 1984. 83. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: The effect of free fatty acids on human

sperm cells. International Symposium on the Immunology of Reproduction, Tel Aviv, Israel, October 21-25, 1984.

84. Siegel I, Gleicher N: The selective toxicities of non-saturated fatty acids upon mammary ascites tumor cells. Idem.

85. Gleicher N: Autoimmunity in pregnancy. Invited Keynote Speaker, 2nd Annual Symposium on Research at Mount Sinai Hospital. November, 1984, Chicago, Illinois.

86. Gleicher N: Immunology of endometriosis. 17th Annual Symposium on Obstetrics and Gynecology. North Memorial Medical Center, Minneapolis, Minnesota, November 30, 1984.

87. Gleicher N: Intrauterine dysrhythmias and heart failure. Invited Speaker, Meeting Internazionale Fisiopathologia Clinica Prenatale, Oggi, Rome, Italy, November 23-24, 1984.

88. Gleicher N: Treatment of cardiovascular and hypertensive diseases in pregnancy. Semmelweis-Waters Obstetrical and Gynecological Conference, Atlantic City, New Jersey, March 29, 1985.

89. Gleicher N: Role of sonography in IVF. In In Vitro Fertilization. The State of the Art. The Chicago Gynecological Society, Chicago, Illinois, April 19, 1985.

90. Confino E, Friberg J, Dudkiewicz A, Gleicher: Intrauterine inseminations with washed human spermatozoa in couples with circulating sperm agglutinating antibodies. 6th Meeting of the American Society for the Immunology of Reproduction, Ann Arbor, Michigan, June 12-15, 1985.

91. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: The effect of 18 carbon saturated and unsaturated fatty acids (FFA) on sperm motility. Idem.

92. Confino E., Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed human spermatozoa. 41st Annual Meeting of the American Fertility Society, Illinois, September 28-October 2, 1985.

93. Confino E, Frank J, Dudkiewicz A, Gleicher N, Friberg J: The effect of ejaculation frequency on sperm quality. Idem.

94. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.

95. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed human spermatoza. Idem.

96. Gleicher N: A follow-up on maternal cesarean section rates. ACOG District VI Annual Meeting, Milwaukee, Wisconsin, September 25-28, 1985.

97. Dudkiewicz A, Friberg J, Gleicher N, et al.: In vitro fertilization program at Mount Sinai Hospital, Chicago, Phase II. Idem.

98. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.

99. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine insemination with washed human spermatozoa. 41st Annual Meeting of The American Fertility Society, Chicago, Illinois, September 27- October 2, 1985.

100. Sonographic oocyte retrieval for IVF. Video Presentation.Idem. 101. Confino E, Vermesh M, Thomas W, Gleicher N: An unilateral rabbit uterus

transplantation model. Video Presentation. Idem. 102. Confino E, Frank, Dudkiewicz A, Gleicher N, Friberg J: The effect of ejaculation

frequency on sperm quality. Idem. 103. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG beta

subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem. 104. Confino E, Dudkiewicz, A, Friberg J, Gleicher N: Combined tuboplasty, oocyte

retrieval and embryo transfer. Fourth World Conference on In Vitro Fertilization, Melbourne, Victoria, Australia, November 18-22, 1985.

105. Mayden K, Confino E, Eden R, Miller C, Friberg J, Gleicher N: Decreased gestational sac volumes in hMG induced pregnancies. Idem.

106. Confino E, Demir R, Friberg J, Gleicher N: The predictive value of hCG B subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer. Idem.

107. Gleicher N: Functional changes of the fetal heart. Diagnosis management and treatment. In Present Trends of Ultrasounds in Clinical Problems of Gynecology and Obstetrics. University “G.D. Annunzio”, Chieti, Italy, Dec. 12-13, 1985.

108. Gleicher N, El-Roeiy A: Autoantibodies in follicular fluids of IVF patients. Future Aspects in Human In Vitro Fertilization Congress, Vienna, Austria, April 2-4, 1986.

109. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo loss in in vitro fertilization? Idem.

110. Gleicher N: Reproductive failure due to autoantibodies. Bulgarian Academy of Sciences, Sofia, Bulgaria, April 8, 1986.

111. Gleicher N: Autoimmunity in pregnancy. Sofia Medical Faculty, Sofia, Bulgaria, April 9, 1986.

112. Gleicher N: Reproductive failure due to autoantibodies. Perinatal/Neonatal Grand Rounds-CHR, Cook County Hospital, Chicago, Illinois, April 21, 1986.

113. El-Roeiy A, Gleicher N, Isenberg D, Kennedy R, Goldenberg M, Mashiach S, Shoenfeld Y: Autoantibodies and common anti-DNA idiotype in pregnancies of mothers with systemic lupus erythematosus. 3rd International Congress of Reproductive Immunology, Toronto, Ontario, Canada, July 4, 1986.

114. Gleicher N, El-Roeiy A, Confino E, Friberg J: Abnormal antibodies in endometriosis: Is endometriosis an autoimmune disease? Idem.

115. Confino E, El-Roeiy A, Demir R, Friberg J, Gleicher N: Thrombelastogram, lupus anticoagulant and antinuclear antibodies in patients with endometriosis and repeated abortions. Idem.

116. Gleicher N: Cesarean section - What are the issues? At: Cesarean Section Conference, Mount Sinai Hospital Medical Center of Chicago, July 23, 1986.

117. Gleicher N: Vaginal birth after cesarean section (VBAC). Idem. 118. Vermesh M, Confino E, Boler LR, Friberg J, Gleicher N: Acute salpingitis in

sterilized women. Fourth Annual Meeting of the International Medical and Scientific Conference on Contraception, Society for the Advancement of Contraception, Palmer House, Chicago, IL, September 26, 1986.

119. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embyro loss in in vitro fertilization? An international collaborative study. 42nd Annual Meeting of the American Fertility Society/18th Annual Meeting of the Canadian Fertility and Andrology Society, Toronto, Ontario, Canada, September 30, 1986.

120. Confino E, Friberg J, Gleicher N: Transcervical Balloon Tuboplasty (TBT). Idem. 121. Confino E, Vermesh M, Boler L, Friberg J, Gleicher N: Acute salpingitis in

sterilized women. Fourth Annual Meeting of the Society for the Advancement of Contraception, Chicago, Illinois, September 26, 1986.

122. Gleicher N: Reducing the incidence of cesarean section. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Gottlieb Memorial Hospital, Melrose Park, Illinois, November 17, 1986.

123. Gleicher N: Autoantibodies in reproduction. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Rush-Presbyterian - St. Luke’s Hospital, Chicago, Illinois, December 4, 1986.

124. Gleicher N: Reproductive failure due to autoantibodies. Grand Rounds-CHR, Department of Immunology/Microbiology, Rush-Presbyterian - St. Luke’s Hospital, Chicago, Illinois, February 4, 1987.

125. Gleicher N: Cesarean section reduction initiative. Continuing Medical Education Conference, Ravenswood Hospital Medical Center, Chicago, Illinois, February 5, 1987.

126. El-Roeiy A, Myers S, Gleicher N: Autoantibodies in normal pregnancy: Comparison to non-pregnant patients. Seventh Annual Meeting of the Society of Perinatal Obstetricians, Lake Buena Vista, Florida, February 5-7, 1987.

127. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile and hypertensive and normotensive pregnancy. Idem.

128. Myers S, Gleicher N: A prospective program to reduce cesarean section rates: A preliminary report. Idem.

129. Gleicher N: Endometriosis associated antibodies. Infertility Treatment Options, Elkhart General Hospital, YWCA, Women’s Resource Center, Indiana RESOLVE, Inc, Elkhart, Indiana, February 21, 1987.

130. Gleicher N, El-Roeiy A, Friberg J: Autoantibodies in patients with unexplained infertility. Annual Meeting of the Society of Gynecological Investigation, Hyatt Regency, Atlanta, Georgia, March 18-21, 1987.

131. Gleicher N, El-Roeiy A, Myers S, Friberg J: Autoantibodies in patients with idiopathic recurrent pregnancy loss. Idem.

132. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with unexplained infertility and recurrent pregnancy loss. Idem.

133. El-Roeiy A, Myers S, Gleicher N: Comparison of the autoantibody profile of hypertensive and normotensive pregnancy. Idem.

134. Dudkiewicz A, Friberg J, Confino E, Madanes A, Gleicher N: The relationship between zona-free hamster egg penetration and human fertilization in vitro. Fifth World Congress on In Vitro Fertilization and Embryo Transfer, Scope Convention Center,

135. Gleicher N: Cesarean section reduction initiative. Continuing Medical Education Program, Alexian Brothers Medical Center, Elk Grove Village, Illinois, April 21, 1987.

136. Gleicher N: Autoimmunity and the role of phospholipid antibodies in reproduction. Seventh Annual Meeting of the American Society for the Immunology of Reproduction, Indianapolis Hilton, Indianapolis, Indiana, June 24-26, 1987.

137. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of hypertensive and normotensive pregnancy. Idem.

138. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune failure syndrome (RAFS). Idem.

139. Confino E, Friberg J, Gleicher N: Cervical mucus-uterine fluid cross penetration spermatozoa in patients with circulating sperm agglutinating antibodies. Idem.

140. Gleicher N: Autoimmunity in Reproduction. 6th Annual Symposium on Obstetrics and Gynecology, University of Maryland School of Medicine, Ocean City, Maryland, June 4-6, 1987.

141. Gleicher N: Autoimmunity in reproduction. Grand Rounds-CHR, Department of Obstetrics and Gynecology, Mercy Hospital, University of Maryland, School of Medicine, Baltimore, Maryland, June 4, 1987.

142. Gleicher N: Reversing the cesarean trend. CPM, 3rd International Convention, LeMoyne College, Syracuse, New York, August 22, 1987.

143. Friberg J, Confino E, Dudkiewicz A, Gleicher N: Motion picture: Laparoscopic cannulation of the fallopian tubes for GIFT. Forty - third Annual Meeting of the American Fertility Society, Reno, Nevada, September 27 - September 30, 1987.

144. El-Roeiy A, Dmowski W, Friberg J, Binor Z, Gleicher N: Abnormal autoantibodies in reproductive failure: Habitual abortion versus endometriosis. Forty-third Annual Meeting of the American Fertility Society, Reno, Nevada, September 28-30, 1987.

145. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon tuboplasty (TBT). Forty - third Annual Meeting of the American Fertility Society, Reno, Nevada, September 28-30, 1987.

146. Confino E, Gleicher N, Friberg J: Cervical mucus-uterine fluid cross penetration of spermatoza. Forty - third Annual Meeting of the American Fertility Society, Reno, Nevada, September 28-30, 1987.

147. Gleicher N: Immunoregulatory mechanism in normal and abnormal pregnancies. Annual Meeting, Korean Association of Obstetricians and Gynecologists, Seoul, South Korea, October 16 - 17, 1987.

148. Gleicher N: Transcervical balloon tuboplasty. Department of Obstetrics and Gynecology, Chulalongkorn Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, November 3, 1987.

149. Gleicher N: The reproductive autoimmune failure syndrome (RAFS). Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan, October 19 - 21, 1987.

150. Gleicher N: The reproductive autoimmune failure syndrome (RAFS). Department of Obstetrics and Gynecology, Nagoya City University Medical School, Nagoya, Japan, October 22 - 25, 1987.

151. Gleicher N: The reliable detection of autoantibodies in patients with reproductive autoimmune failure (RAFS). Workshop “Immunodiagnosis and immunotherapy in reproductive medicine”, VIth World Congress on Human Reproduction, Tokyo, Japan, October 26, 1987.

152. Gleicher N: Reproductive failure due to autoantibodies: The reproductive autoimmune failure syndrome. 6th World Congress on Human Reproduction, Tokyo, Japan, October 28, 1987.

153. Gleicher N: Reproductive failure due to autoimmunity. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Hutzel Hospital, Detroit, Michigan, November 24, 1987.

154. Gleicher N: Abnormal autoimmunity and pregnancy. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Hutzel Hospital, Detroit, Michigan, Detroit, Michigan, November 24, 1987.

155. Gleicher N: Retrograde tubal canalization: An alternative approach to IVF and GIFT. Obstetrics Gynecology Devices Panel of the FDA, 33rd Meeting, Hubert H. Humphrey Building, Washington D.C., January 29, 1988.

156. Gleicher N: The reproductive autoimmune failure syndrome. Hadassah Medical School of the Hebrew University, Jerusalem, February 2, 1988.

157. Gleicher N, El-Roeiy A: Autoantibody profiles in normal females and males. Society for Gynecology Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore, Maryland, March 17-20, 1988.

158. El-Roeiy A, Saling P, Menge A, Friberg J, Gleicher N: Cross reactivity of monoclonal anti-sperm antibodies, inhibition with specific antigens and anti-idiotypes. Society for Gynecologic Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore, Maryland, March 17-20, 1988.

159. El-Roeiy A, Dmowski WP, Gleicher N, Binor Z, Radwanska E, Tummon I: Effect of Danazol and GnRH agonist (GnRH-a) on the immune system in endometriosis. Society for Gynecologic Investigation, 35th Annual Meeting, Hyatt Regency, Baltimore, Maryland, March 17-20, 1988.

160. Gleicher N: Cesarean topics. The Illinois Chamber’s Health Care Management Committee, Illinois State Chamber of Commerce, Chicago, Illinois, March 9, 1988.

161. Gleicher N: Cardiac diseases in pregnancy. Invited speaker, Panel for American College of Cardiology, 37th Annual Scientific Session, Atlanta, Georgia, March 29, 1988.

162. Gleicher N, Perisee D: Everything you always wanted to ask your doctor but were afraid to ask? Women’s Health Congress, Mount Sinai Hospital, Chicago, Illinois, April 22, 1988.

163. Gleicher N, Harlow L, El-Roeiy A: The correlation between autoantibodies in women with reproductive failure. 9th Annual International Symposium of the American Society for the Immunology of Reproduction, Prout’s Neck, Maine, June 15-19, 1988.

164. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and autoantibodies. Idem.

165. Confino E, Harlow L, Friberg J, Gleicher N: The correlation between serum and peritoneal fluids autoantibody levels in patients with endometriosis. Idem.

166. Gleicher N: Mammography in a private practice. Seminar on in- office mammography, Marriot Hotel, O’Hare International Airport, Chicago, Illinois, June 28, 1988.

167. Gleicher N: Mammography in a private practice. Seminar on in-office mammography, Embassy Suites, Brookfield, Wisconsin, September 13, 1988.

168. Gleicher N: Mount Sinai cesarean section initiative. Lutheran General Hospital, Park Ridge, Illinois, Department of Obstetrics and Gynecology, Grand Rounds-CHR, September 20, 1988.

169. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure due to autoantibodies: Unexplained infertility and pregnancy wastage. 56th Annual Meeting of The Central Association of Obstetricians and Gynecologists, The Marriot, Salt Lake City, Utah, September 22-24, 1988.

170. Gleicher N: Cesarean section initiative. Grand Rounds-CHR, Michael Reese Hospital, Chicago, Illinois, Department of Obstetrics and Gynecology, September 28, 1988.

171. Gleicher N: Cutting the c-section rate in half: It can be done. National Association of Directors of Women’s Health Programs, 1st Annual Conference, Women’s Health: Making a difference. The Westin Hotel, Chicago, Illinois, October 27-28, 1988.

172. Gleicher N: Active management of labor and vaginal birth after cesarean. 3rd Annual Intensive One Day Obstetrics and Gynecology Review Course, Northwest Community Hospital, Arlington Heights, Illinois, November 19, 1988.

173. Gleicher N: Mount Sinai’s cesarean section initiative. Postgraduate course on Recent Developments in Obstetrics and Gynecology, Hotel 21 East, Chicago, Illinois, December 8, 1988.

174. Gleicher N: Pregnancy loss due to abnormal autoimmune function. Idem. 175. Gleicher N: Infertility and endometriosis. Idem. 176. Gleicher N: Mammography in obstetrics and gynecology. Idem. 177. Gleicher N: Breast ultrasound. Idem. 178. Gleicher N: The multicenter TBT study. Idem. 179. Gleicher N: How to evaluate breast disease. Idem. 180. Gleicher N, Myers S: A successful program to lower cesarean section rates.

Society of Perintal Obstetricians, 1988. 181. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen

parameters from sequentially produced ejaculates. 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988.

182. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy. 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988.

183. Myers S, Gleicher N: A successful program to lower cesarean section rates. Society of Perinatal Obstetricians, 1988.

184. Gleicher N: Recent advances in infertility. 45th Annual Midwest Clinical Conference, Hilton and Towers, Chicago, Illinois, February 24-26, 1989.

185. Gleicher N: Mammography in obstetrics and gynecology. CREOG/APGO Annual Meeting, New Orleans, Louisiana, March 8-11, 1989.

186. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Gleicher N: A GnRH-agonist/hMG/hCG stimulation protocol for IVF increases pregnancy rates by widening the implantation window. The Annual Meeting of the Society for Gynecologic Investigation, March 1989, San Diego, California.

187. Confino E, DeCherney A, Coulam C, Friberg J, Haas G, Herbert C, Katz E, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A multicenter study. 36th Annual Meeting of the Society for Gynecologic Investigation, San Diego, CA, March 15-18, 1989.

188. Tur-Kaspa I, Dudkiewicz A, Friberg J, Confino E, Logan R, Gleicher N: Pooled sequential ejaculates - a way to increase total number of motile spermatoza from oligozoospermic males. VI World Congress In Vitro Fertilization and Alternate Assisted Reproduction, April 1989, Jerusalem, Israel.

189. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: The implantation window and early pregnancy loss. International Meeting on Pregnancy Loss, April 1989, Tel-Aviv, Israel.

190. Gleicher N: IVF and immunological infertility. 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989.

191. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: GnRH-agonist/HMG/HCG stimulation for IVF increases endometrial receptiveness for embryos. Idem.

192. Dudkiewicz A, Novotny M, Friberg J, Gleicher N: Biochemical enhancement of sperm penetration: Effects on subsequent development. Idem.

193. Gleicher N: Medical complications causing pregnancy loss. International Meeting on Pregnancy Loss, Tel-Aviv, Israel, April 9-12, 1989.

194. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: Low pregnancy wastage in IVF-ET pregnancies achieved with a GnRH-agonist/hMG/hCG stimulation protocol. International Meeting on Pregnancy Loss, Tel-Aviv, Israel, April 9-12, 1989.

195. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-R) gene expression in cultured human trophoblast cells. 45th Annual Meeting of The American Fertility Society, November 11-16, 1989, San Francisco, CA.

196. Gleicher N: The physiological role of autoantibodies in reproduction. 4th International Congress of Reproductive Immunology. Kiel, FRG, July 26-29, 1989.

197. Confino E, Tur-Kaspa I, Gleicher N: Opening pressure of normal and proximally obstructed fallopian tubes. Presented at the 45th Annual Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA.

198. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-R) gene expression in cultured human trophoblast cells. Presented at the 45th Annual Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA.

199. Confino E, Tur-Kaspa I, Friberg J, Gleicher N: Sonographic transcervical balloon tuboplasty. Presented at the 45th Annual Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA.

200. Confino E, Gleicher N, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Tur-Kaspa I, Haas G, Katz E, Vermesh M: Trancervical balloon tuboplasty: Description of a technique to recanalize proximal tubal obstruction. Presented at the 45th Annual Meeting of The American Fertility Society, November 13-16, 1989, San Francisco, CA. (video presentation).

201. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E, Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A

multicenter study. Price paper of the General Program of The 45th Annual Meeting of the American San Francisco, CA, November 13-16, 1989.

202. Gleicher N: The Mount Sinai cesarean section reduction initiative. Grand Rounds-CHR, Albert Einstein College of Medicine, Bronx, New York, November 14, 1989.

203. Gleicher N: The Mount Sinai cesarean section reduction initiative. The S.B. Gusberg Society of the Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York, NY, November 15, 1989.

204. Gleicher N: Mammography in obstetrics and gynecology. Grand Rounds-CHR, Cook County Hospital, Chicago, IL, January 22, 1990.

205. Gleicher N: “Giving away the house”. Meeting of the OB/GYN physicians of West Michigan, The Peninsular Club, Grand Rapids, Michigan, February 20, 1990.

206. Gleicher, N: Fetal rate and rhythm disorders. Visiting Professor Lectureship of The Grand Rapids Area Medical Education Center, Saint Mary’s Hospital, Grand Rapids, Michigan, February 21, 1990.

207. Gleicher N: C-section crises. Idem. 208. Gleicher N: Transcervical balloon tuboplasty: Description of technology to

recanalize proximal tubal obstruction. Workshop on Retrograde Tubal Catheterization, Centre Francais du Commerce Exterieur, Paris, France, March 23, 1990.

209. Gleicher N: Transcervical balloon tuboplasty: A multicenter study. Idem. 210. Gleicher N: Pregnancy as an autograft. Tenth Anniversary Meeting of American

Society for the Immunology of Reproduction. Chicago, Illinois, June 20-23, 1990. 211. Gleicher N: Autoimmunity and reproductive failure. VII World Congress on

Human Reproduction. Helsinki, Finland, June 26 - July 1, 1990. 212. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas

G, Katz E, Vermesh H, Gleicher N: Transcervical balloon tuboplasty: A multicenter study. Idem.

213. Gleicher N: What is new in infertility? Grand Rounds-CHR, West Suburban Hospital, Oak Park, Illinois. August 8, 1990.

214. Gleicher N: Immunologic causes of recurrent pregnancy loss: 1990 Congress of the American College of Surgeons, San Francisco, October 7-12, 1990.

215. Zilberstein M, Harlow L, Gleicher N: Human sera containing antiphospholipid autoantibodies (APA) inhibit phospholipase induced hCG secretion in human term placenta villi explants. 46th Annual Meeting of the American Fertility Society, Washington, D.C., October 13-18, 1990.

216. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G, Katz E, Vermesh M, Gleicher N: Follow up of the multicenter transcervical balloon tuboplasty (TBT) study. Idem.

217. Confino E, Tur-Kaspa I, Gleicher N: Selective ultrasound- salpingography (SVS). Idem.

218. Dudkiewicz A, Confino E, Friberg J, Tur-Kaspa I, Novotny M, Wright J, Gleicher N: What can we learn from chemical pregnancies. Idem.

219. Gleicher N, Pratt D, Novotny M, Parrilli M, Dudkiewicz A: The Benefit of estradiol substitution in the luteal phase of IVF cycles. 7th World Congress on In Vitro Fertilization & Assisted Procreation, Paris, France, June 30 - July 3, 1991.

220. Gleicher N, Pratt D, Parrilli M: The routine utilization of transvaginal tubal catheterization for infertility. Idem.

221. Gleicher N: Antisperm antibodies - impact on ART. Fourth Annual In Vitro Fertilization and Embryo Transfer Postgraduate Course, the Department of Continuing Education in Health Sciences, UCLA Extension, and the Department of Obstetrics and Gynecology, UCLA School of Medicine, Santa Barbara, CA July 28-31, 1991.

222. Gleicher N: Immunologic aspects of implantation. Idem. 223. Gleicher N: Update on tubal catheterization techniques, technologies and

applications. CARE Meeting, Chicago, IL September 24, 1991. 224. Gleicher N: Biomedical ethics & the court’s choices. Thirteenth Annual

Conference, National Association of Women Judges, Chicago, IL, October 13, 1991. 225. Gleicher N, Dudkiewicz A, Parrilli M, Pratt D: Do low luteal phase estradiol (E)

levels prevent implantation in IVF cycles? 47th Annual Meeting of the American Fertility Society, Orlando, Fl, October 20 - 24, 1991.

226. Gleicher N, Parrilli M, Redding L, Pratt D: Hysterosalpingography (HSG) and selective salpingography (SS) as therapeutic procedures. (Poster) Idem.

227. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson E, Tur-Kaspa I, Vermesh M: Transcervical balloon tuboplasty: multicenter study conclusions and follow up. 47th Annual Meeting of the American Fertility Society, Orlando, FL, October 22, 1991.

228. Gleicher N: What’s new in surgery. 1991 Clinical Congress of the American College of Surgeons, Chicago, IL, October 25, 1991.

229. Gleicher N: The non-surgical approach to tubal obstruction. The Society for Minimally Invasive Therapy Third International Meeting, Boston, MS, November 10-12, 1991.

230. Gleicher N: Abnormal autoimmunity and endometriosis. 13th Japan Endometriosis Symposium, Tokyo, Japan, January 24-25 1992.

231. Gleicher N: Transcervical balloon tuboplasty seminar. Kyoto University, Kyoto, Japan, January 27, 1992.

232. Gleicher N: Attend TBT case. Nihon University Itabashi Hospital, Tokyo, Japan, 233. Gleicher N: Assisted reproductive technologies. Nagoya City University, Nagoya,

Japan, January 29, 1992. 234. Gleicher N: Abnormal autoimmunity and endometriosis. Osaka University, Osaka,

Japan, January 30, 1992. 235. Gleicher N: Proximal tubal disease. 3rd Conference, Endocrinology and

Metabolism in Human Reproduction: The Fallopian Tube. The Royal London Hospital, London UK; April 2, 1992.

236. Gleicher N: Autoimmunity in normal and abnormal pregnancies. International Conference on Rheumatic Diseases in Pregnancy, Jerusalem, Israel; May 19, 1992.

237. Gleicher N: Vaginal approach to the breech infant. In Update in Obstetrics and Gynecology - Postgraduate Course, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, May 28, 1992.

238. Gleicher N, Pratt D, Kaberlein G, Dudkiewicz A: Danazol does not suppress sperm antibodies in males. 12th National Meeting of the American Society for the Immunology of Reproduction, Charleston, South Carolina; June 10-13, 1992.

239. Mathur S, Chihal H, Isaacson K, Gleicher N, Patrick R, Bleiler J: Endometrial autoimmunity in endometriosis: Immunogenicity and specificity of the target antigens. Idem.

240. Gleicher N, Pratt D, Kaberlein G, Honea K, Dudkiewicz A. The correlation of IL-4 and IL-6 levels to the presence of autoantibodies in infertile females. Idem.

241. Gleicher N: Gyneco-Radiologic Diagnosis and Treatment of Tubal Disease. At Comprehensive Operative Laparoscopy, Hysterectomy & Hysteroscopy. Operative Endoscopy Workshop for Gynecologists, Scommenga A, Nezhat CR, course directors. Chicago, IL, July 9-11, 1992.

242. Gleicher N: Antibody abnormalities and reproductive failure. 5th International Congress of Reproductive Immunology, Rome Italy, August 30 to September 3, 1992.

243. Gleicher N: New developments in gynecoradiology. CARE Meeting, Chicago, IL, September 22, 1992.

244. Gleicher N: Reducing cesarean rates. Evergreen Hospital Medical Center, Kirkland, Washington, October 20, 1992.

245. Gleicher N, Liu H, Rosenwaks Z, Pratt D: Antibody Profiles as Predictors of IVF Success. 48th Annual Meeting of the American Fertility Society, New Orleans, LA, November 3, 1992.

246. Gleicher N, Parrilli M, Pratt D: A trial of guide wire cannulation of proximal tubal occlusion. Idem.

247. Gleicher N, Redding L, Gurniak R, Parrilli M, Pratt D: The presentation of ampullary tubal pregnancies during salpingography. Idem.

248. Gleicher N: Abnormal autoimmunity and endometriosis. 14th World Congress on Fertility and Sterility, Caracas, Venezuela, November 24, 1992.

249. Gleicher N: Gynecoradiology: A new approach to infertility care. Grand Rounds-CHR Sinai-Samaritan Medical Center, Milwaukee Campus of the University of Wisconsin, Department of OB/GYN, March 17, 1993.

250. Gleicher N: Gynecoradiology: A new approach to infertility care. Madison OB/GYN Society, Madison, WI, March 17, 1993.

251. Gleicher N: Endometriosis: Time to reevaluate. Grand Rounds-CHR, Department of OB/GYN, University of Wisconsin, Madison Campus, Madison, WI, March 18, 1993.

252. Gleicher N: Immunologic Theories of Endometriosis: Role of Humoral Immunity. 8th World Congress on Human Reproduction Joint IVth World Conference on Fallopian Tube in Health and Disease, Bali - Indonesia, April 5, 1993.

253. Gleicher N: Cesarean Section Rates. Blue Cross/Blue Shield Illinois Medical Director’s Roundtable Chicago, IL - July 13, 1993.

254. Gleicher N: Clinical Aspect of ART. Abbott Laboratories Seminar Chicago, IL - July 21, 1993.

255. Gleicher N: The bubble test: A new tool in the diagnosis of endometriosis. CARE Meeting, Chicago, IL, September 28, 1993.

256. Gleicher N: The Immune System in ART. 8th World Congress on In Vitro Fertilization and Alternate Assisted Reproduction Kyoto, Japan, September 13, 1993.

257. Gleicher N: Gynecoradiology: A new approach to the investigation and treatment of infertility. International Symposium of New Reproductive Technology - Endoscopic Transcervical Approaches, Tokyo Japan September 16, 1993.

258. Gleicher N: The bubble test: A new diagnostic test for endometriosis (video). The American Fertility Society Annual Meeting, Montreal Canada, October 11, 1993.

259. Gleicher N, Pratt DE: How important is gynecoradiology for the evaluation of the infertile couple? Second Annual Meeting of the GynecoRadiology Society, Montreal, Canada, October 13, 1993.

260. Karande V, Pratt D, Gleicher N: The reduction of elevated perfusion pressures by guidewire catheterization of fallopian tubes. Second Annual Meeting of the GynecoRadiology Society, Montreal, Canada, October 13, 1993.

261. Gleicher N: Outcome analysis of C-Section rates. Grand Rounds-CHR. St. Anthony Medical Center, Crown Point, IN, February 1, 1994.

262. Gleicher N: Overall perspective: Cesarean section in the 1990’s, Blue Cross Blue Shield Managed Care Roundtable Agenda, March 11, 1994.

263. Gleicher N: Gynecoradiology: A new diagnostic and therapeutic appproach towards infertility. Grand Rounds-CHR, Department of OB/GYN, St Louis University, St. Louis, MO, April 7, 1994

264. Gleicher N: “Immune dysfunction - A potential target treatment in endometriosis,” 4th World Congress on Endometriosis, Salvador Bahia Brazil, May 25 -28, 1994.

265. Gleicher N: “Alterations of cell-mediated immunity in endometriosis.” Idem. 266. Gleicher N: “The bubble test and other diagnostic tools.” Idem. 267. Gleicher N: “Gynecoradiology: A new tool to diagnose and treat causes of

infertility.” Grand Rounds-CHR, Department of OB/GYN, St. Francis Hospital, Evanston, IL, Sept. 9, 1994.

268. Gleicher N: “How many embryos to transfer? Patient desires and approaches.” CARE meeting, Chicago, IL, Sept. 20, 1994.

269. Gleicher N: “Some new ideas about endometriosis,”Fertility Society of Australia Meeting, Brisbane, Australia, Oct. 4-7, 1994.

270. Gleicher N: “Tubal perfusion pressures in women with endometriosis.” Idem. 271. Gleicher N: “Cesarean section reduction,” Grand Rounds-CHR, Department of

OB/GYN, Hinsdale Hospital, Hinsdale IL, Oct. 27, 1994. 272. Gleicher N, Karande V, Rabin D, Dudkiewicz A, Pratt D: “Abnormalities in IgG

subclasses in a female infertility population with gammaglobulinemias,” American Fertility Society 50th Annual Meeting, San Antonio, TX, Nov. 5-10, 1994.

273. Gleicher N, Campbell D, Chan G, Karande V, Dudkiewicz A, Pratt D: “The attitude of infertility patients towards multiple gestations.” Idem.

274. Gleicher N, Karande V, Rabin D: “Outcome assessment in infertility therapy:Patient dropout rate after initial consultation.” Idem.

275. Gleicher N, Campbell DP, Chan GCL, Karande V, Dudkiewicz A, Pratt D: “The attitude of infertility patients towards multiple gestations: Influence of age, parity and length of infertility.” Idem.

276. Gleicher N, Parrilli M, Karande V, Dudkiewicz A, Pratt D: “Is prematurity due to multiple conceptions in an implantation problem?”. Idem

277. Dudkiewicz A, Kaberlein G, Novotny M, Dudkiewicz C, Favero L, Pratt D, Karande V, Gleicher N: “Can sperm motility elucidate media deficiencies not detected by mouse two-cell culture?” Idem.

278. Gleicher N: Endometriosis - Immunology and other facets. XIII Annual Scientific Meeting of the Fertility Society of Australia, Brisbane, Australia, October 5, 1994.

279. Gleicher N: Future evaluation of tubal function. Idem, October 7, 1994.

280. Gleicher N: Radiology. Fifth Conference Endocrinology and Metabolism in Human Reproduction, Ectopic Pregnancy: Advances in Diagnosis and Treatment. Royal College of Obstetricians and Gynecologists, London, England, March 27-29, 1995.

281. Gleicher N: What infertility patients think about multiple conceptions: Is it time to reevaluate current practice patterns. 9th World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995.

282. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B: Intracytoplasmic sperm injection (ICSI) for oocyte factors results in lower pregnancy rates with in-vitro fertilization (IVF). Idem, April 3-7, 1995.

283. Gleicher N: Ovarian stimulation and overstimulation. Ovarian Stimulation and Hyperstimulation, the Satellite Symposium of the 9th World Congress on IVF and Assisted Reproduction, Hungary Academy of Sciences, Budapest, Hungary.

284. Gleicher N: Overview of reproductive immunology. 197th Annual Meeting of the Medical and Chirurgical Faculty of Maryland. University of Maryland, College Park, May 6, 1995.

285. Gleicher N: A Dialogue with the Austrian Medical Legal Mission, Sponsored by the Illinois Department of Public Health, James R. Thompson Center, Chicago, Illinois, June 1, 1995.

286. Gleicher N: Cost containment and utilization containment in OB/GYN, Illinois Association of Health Maintenance Organizations, Ritz Carlton Hotel, Chicago, Illinois, September 21, 1995.

287. Gleicher N: Active labor/C Section, Grand Rounds-CHR, North Shore University Medical School, Manhasset, Long Island, New York, October 25, 1995.

288. Gleicher N: Corticosteroid and immunosuppressive therapy in reproductive autoimmune failure syndrome, International Conference on Recurrent Abortion, Rome, Italy, January 27, 1996.

289. Gleicher N: Tubal cannulation, International Society for Gynecologic Endoscopy, Stauffers Renaissance Hotel, Chicago, IL, April 17, 1996.

290. Gleicher N: “Managed care”, Smith Barney, Second Annual Conference on Emerging Sectors in Health Care, Plaza Hotel, New York, NY, September 25, 1996.

291. Gleicher N: Sonography - International Congress of Sonography, AAGL 25th Annual Meeting, Chicago, Illinois, September 26, 1996.

292. Gleicher N: Ultrasound and fetoscopy, AAGL 25th Annual Meeting, Chicago, Illinois, September 28, 1996.

293. Gleicher N: Autoantibodies as an infertility factor in endometriosis, 5th World Congress on Endometriosis,Yokahama, Japan, October 21, 1996.

294. Gleicher N, Karande V, Pratt D, Morris R, Vanderlaan B: Surgical utilization and outcome in infertile HMO and PPO populations, American Society for Reproductive Medicine, Fifty-Second Annual Meeting, Boston, Massachusetts, November 2-7, 1996.

295. Rao R, Karande V, Balin M, Levrant S, Pratt D, Ferguson R, Gleicher N: The association of cytomegalovirus (CMV) with immunological abnormalitites in a female infertility population undergoing ART. American Society for Reproductive Medicine, Idem. November 2-7, 1996.

296. Morris R, Ferguson R, Dudkiewicz A, Brown T, Minhas B, Rao R, Balin M, Levrant S, Pratt D, Gleicher N: The risk of multiple pregnancy in assisted reproduction is

inversely related to age. American Society for Reproductive Medicine, Idem, November 2-7, 1996.

297. Morris R, Ferguson R, Ewing C, Dudkiewicz A, Gleicher N: Single Folicle Stimulating Hormone Levels are Not Predictive of Subsequent Levels and Variation is Highly Dependant on Age. American Society for Reproductive Medicine, Idem, November 2-7, 1996.

298. Gleicher N: “GynCor, Inc.: The management challenge in reproductive medicine”, Smith Barney’s Fifth Annual Health Care Services Conference, Plaza Hotel, New York City, New York, February 10-14, 1997.

299. Gleicher N: Managed care and reimbursement for fertility surgery. American Association of Gynecologic Laparoscopists, Squaw Valley, California, February 20-23, 1997.

300. Gleicher N: First trimester pregnancy loss. American Association of Gynecolgoic Laparoscopists, Squaw Valley, California, February 20-23, 1997.

301. Gleicher N: Diagnosis and therapeutic radiologic intervention. American Association of Gynecologic Laparascopists, Squaw Valley, California, February 20-23, 1997.

302. Levrant S, Wang L, Miller C, Rinehart J, Karande V, Coulam C, Pratt D, Gleicher N: Human leukocyte antigen DQA1 genotyping in women with endometriosis. The 17th Annual Meeting of the American Society of Reproductive Immunology, Vancouver, Canada, May 6, 1997.

303. Gleicher N: GynCor, Inc.: A company update. Smith Barney’s 1997 Third Annual Conference on Emerging Sectors in Healthcare. Plaza Hotel, New York City, September 26, 1997.

304. Gleicher N (Chair): How to adjust to a changing world in reproductive medicine. 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, Ohio, October 20, 1997.

305. Gleicher N (Panelist): The GynCor model. Society of Reproductive Endocrinology: Network Development Workshop. 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, Ohio, October 22, 1997.

306. Gleicher N: Balloon tuboplasty; Endometriosis pressure profilometry. (Telesurgery workshop relayed via satellite from Chicago), International Congress on Fallopian Tubes, Bombay, India, February 7, 1998.

307. Gleicher N: Adverse obstetrical outcome as a consequence of infertility treatment. BlueCross BlueShield of Illinois Roundtable. Oakbrook Terrace, Illinois, February 11, 1998.

308. Gleicher N (Panelist): Reproductive health. UBS Securities Second Annual Women’s Health Conference, The Pierre Hotel, New York, New York, February 19, 1998.

309. Gleicher N: Multifetal pregnancies: Should we reduce or continue? The Center for Human Reproduction’s First Annual Post-Graduate Course, IVF Hot Topics, The Drake Hotel, Chicago, Illinois, March 22-22, 1998

310. Gleicher N: The role of the immune system in the development of endometriosis. The 13th Congress of theEuropean Association of Gynecologists and Obstetricians,

311. Gleicher N: A contrarian’s viewpoint on the antiphospho-lipid syndrome. The 30th International Congress on Patho-physiology of Pregnancy, Jerusalem, Israel, May 13-15, 1998.

312. Gleicher N: What is driving the demand for women’s health care services? Fulcrum Information Services National Conference on Women’s Health Care Services, The Grand Hyatt, New York, New York, June 11-12, 1998.

313. Gleicher N: GynCor, Inc.: Practice management in reproductive medicine. Salomon Smith Barney Second Annual Women’s Health Care Conference, The Plaza Hotel, New York, New York, June 25, 1998.

314. Gleicher N: Immunological theories in the treatment of infertility. RESOLVE of Illinois Educational Program, Lutheran General Hospital, Park Ridge, Illinois, August 11, 1998.

315. Gleicher N: GynCor and women’s healthcare. Salomon Smith Barney Fourth Annual Emerging Sectors in Healthcare Services Conference, The Plaza Hotel, New York, New York, September 25, 1998.

316. Gleicher N: Is there value to a utilization review program (URP) for injectable fertility medications? Clinical Female Infertility and Gynecology Session, 54th Annual Meeting of the ASRM, San Francisco, California, October 5, 1998.

317. Gleicher N: What is the real utilization of infertility services in an average patient population with generous infertility benefits? Clinical Female Infertility and Gynecology Session, 54th Annual Meeting of the ASRM, San Francisco, California, October 5, 1998.

318. Gleicher N: (Program Chair): Contracting for infertility. Gyncor, Inc. and The Center for Human Reproduction’s Symposium on the Economics of Infertility Care, Mariott Hotel, San Francisco, California, October 6, 1998.

319. Gleicher N: The routine use of hMG stimulation for standard ovulation induction results in pregnancy rates superior to results obtained from routine use of FSH products. Reproductive Endocrinology Session, 54th Annual Meeting of the ASRM, San Francisco, California, October 8, 1998.

320. Gleicher N: Autoantibodies in reproduction. VII International Congress of Reproductive Immunology. New Delhi, India, October 27-30, 1998.

321. Karande V, Chapman C, Gleicher N: Is there any value in splitting sibling oocytes between intracytoplasmic sperm injection (ICSI) and conventional in vitro fertilization? Assisted Reproduction Technology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 28, 1999.

322. Karande V, Chapman C, Gleicher N: A prospective of the value of blastocyst transfer in low responders undergoing IVF-ET. Assisted Reproductive Technology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 28, 1999.

323. Gleicher N, Kaberlein G, Pratt D, Rinehart J, Morris R, Rao R, Karande V: Definition of high-risk patients for high-order multiple pregnancies with ovarian stimulation by gonadotropins. Clinical Female Infertility and Gynecology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.

324. Pratt D, Coulam C, Karande V, Gleicher N: What are the true cumulative pregnancy rates of patients entering a standard treatment algorithm for infertility? Reproductive Endocrinollgy Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.

325. Gleicher N, Rinehart .J, Pratt D, Morris R, Rao R, Balin M, Karande V: How does age affect medication utilization in IVF? Assisted Reproductive Technology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 28, 1999.

326. Gleicher N, Coulam C, Pratt D, Rinehart J, Morris R, Rao R, Balin M, Karande V: Comparison of utilization patterns in consecutive years: Is there value in a formal utilization review program for infertility services? Clinical Female Infertility and Gynecology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.

327. Gleicher N, Kaberlein G, Rinehart J, Morris R, Pratt D, Rao R, Balin M, Karande V, High-order multiples, A preventable or unpreventable complication of controlled Ovarian stimulation with gonadotropins? Reproductive Indocrinology Session, Conjoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.

328. Chapman C, Karande V, Rinehart J, Gleicher N: Does the production of blastocysts from supernumerary embryos predict pregnancy outcome after day 3 ET? Reproductive Laboratory Session, Conoint Annual Meeting of the ASRM/CFAS, Toronto, Ontario, September 29, 1999.

329. Gleicher N: What is the most cost effective algorithm for infertility treatment. Second World Conference of APART, Budapest, Hungary, September 14-17, 2000.

330. Gleicher N, Oleske D., Tur-Kaspa I., Vidali A., Karande V.: Criteria for the Prevention of High Order Multiple Births Following Ovulation Induction with Gonadotropins.

331. Gleicher N., Tur-Kaspa I., Chapman C., Karande V., Hazlett D., Skoog W.: Can We

332. Gleicher N. Tur-Kaspa I., Vidali A., Karande V.: The Changing Practice Pattern of

333. Gleicher N., Caruso, A: Treating Infertility in Men & Women Over 40. RESOLVE, Reaching for Resolution Symposium Program, Chicago, IL, May 5, 2001.

334. Gleicher N: The Reproductive autoimmune Failure Syndrom, (RAFS). VIII International Congress of Reproductive Immunology, Opatija, Croatia, July 4, 2001

335. Gleicher N: Forget About Ovulation Induction! Proceed Directly to IVF! 2nd World Congress on Controversaires in Obstetrics Gynecology & Infertility, Paris, France, September 6-9, 2001.

336. Gleicher N: Reproductive Autoimmune Failure Syndrom. ASRI, Reproductive Immunology in Chicago, June 9-12, 2001.

337. Gleicher N: “Is There Something Like Immunological Infertility and Pregnancy Loss After All?” Grand Rounds-CHR, Russian Tea Room (restaurant), New York, NY, September 1, 2001.

338. Gleicher N: Does Autoimmune—Reproductive Failure Have Evolutionary Implications? 3rd International Congress on Autoimmunity, Geneva, Switzerland, February 20-24, 2002

339. Gleicher N: “Can Ovarian Aging Be Affected After All?” Grand Rounds-CHR, Etoile (restaurant), New York, NY, October 12, 2004.

340. Gleicher N: “The Aging Ovary: Modifying Some Long Standing Dogmas.” Grand Rounds-CHR, Lenox Hill Hospital, New York, NY, October 20, 2004.

341. Gleicher N: Should We Proceed Directly to IVF? Reducing the Multiple Pregnancies Risks. Asian Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility, Bangkok, Thailand, November 25-28, 2004.

342. Gleicher N: Should We Limit The Number of Embryos Transferred: The Review. Asian Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility, Bangkok, Thailand, November 25-28, 2004.

343. Gleicher N: Maternal Autoimmune Disease: Can It Affect Future Generations? Asian Pacific Congress on Controversies in Obstetrics, Gynecology and Infertility, Bangkok, Thailand, November 25-28, 2004.

344. Gleicher N: “The Aging Ovary: Modifying Some Long Standing Dogmas”. Grand Rounds-CHR, Yale OB/GYN, New Haven, CT, January 27, 2005.

345. Gleicher N: Use of Microdose GnRH (Lupron) Ovarian Stimulation Protocol to Improve IVF Outcome in Young Women with Prematurely Aging Ovaries. 8th International Symposium on GnRH Analogues in Cancer and Human Reproduction, Salzburg, Austria, February 10-13, 2005.

346. Gleicher N: PGD for Elective Gender Selection. 12th World Congress on Human Reproduction, Venice, Italy, May 10-13, 2005.

347. Gleicher N: “Does unexplained infertility really exist?” Grand Rounds-CHR, Amuse (restaurant), New York, NY April 12, 2005.

348. Gleicher N, Barad D: Can We Reverse Ovarian Aging After All? 13th World Congress on In Vitro Fertilization, Assisted Reproduction & Genetics, Istanbul, Turkey, May 26-29, 2005.

349. Gleicher N: Dehydroepiandrosterone (DHEA) treatment improves response to ovulation induction: 21st Meeting of The European Society of Human Reproduction and Embryology, Copenhagen, Denmark, June 19-22, 2005.

350. Gleicher N: Can we affect the aging ovary, after all? Refuting some long-held dogmas: Symposium on Anit-Aging in Human Reproduction, Osaka, Japan. September 20, 2005.

351. Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) Pre-Treatment and Ovulation Induction for In Vitro Fertilization among Women with a History of Decreased Ovarian Reserve: ASRM/CFAS 2005, Montreal, Quebec. October 17, 2005.

352. Barad D, Gleicher N: Effect of Race in Ovulation Induction, Oocyte Recovery, and Pregnancy Outcome in In-Vitro Fertilization: ASRM/CFAS 2005, Montreal, Quebec. October 19, 2005.

353. Gleicher N: Can We Treat the Aging Ovary After All? The International Ovarian Conference 2006, Yokohama, Japan. May 13, 2006.

354. Weghofer A, Barad D, Gleicher N: Premature Ovarian Aging (POA) is Not Characterized by an Increase in Aneuploidy rates. The 22nd Annual Meeting of the ESHRE, Prague, Czech Republic June 18-20, 2006.

355. Gleicher N, Barad D: The Effect of Dehydroepiandroserone On Diminished Ovarian Reserve. The 22nd Annual Meeting of the ESHRE, Prague, Czech Republic June 18-20, 2006 The 22nd Annual Meeting of the ESHRE, Prague, Czech Republic June 18-20, 2006.

356. Gleicher N: Selected research update at CHR. Grandrounds, Department of Ob/Gyn, Sheba Medical Center, Tel Haschomer Hospital, Sackler School of Medicine of Tel Aviv University, September 25, 2006.

357. Gleicher N: Selected research update at CHR: Grandrounds, Department of Ob/Gyn,

358. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantitative and

359. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and

360. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished

361. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature aging

362. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at

363. Weghofer A, Munne S, Chen S, Barad D, Cohen J, Gleicher N: Lack of association between polycystic ovary syndrome and embryonic aneuploidy. A 62nd Annual Meeting of the Society for Reproductive Medicine, New Orleans, October 21-25, 2006.

364. Gleicher N: The Aging Ovary. Grandrounds, Department of Ob/Gyn, Hadassah Hospital and Hebrew University School of Medicine, Jerusalem, Israel, March 26, 2007.

365. Gleicher N: The Aging Ovary. Grandrounds, Department of Ob/Gyn, Assuta Hospital, Tel Aviv, Israel and Sackler School of Medicine, Tel-Aviv University, Israel, March 27, 2007.

366. Gleicher N: The Aging Ovary, Grandrounds,NYU Medical Center of NYU School of Medicine, New York, March 2007.

367. Gleicher N: Premature ovarian aging. Grandrounds, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, May 3, 2007.

368. Gleicher N: The aging ovary. By invitation; 1st International Symposium in Genetics and Assisted Reproduction Techniques, King George Palace Hotel, Athens, Greece, May 5th, 2007.

369. Gleicher N: Gynecoradiology. Grandrounds, Southern California Reproductive Center, Beverly Hills, California, May 25, 2007.

370. Gleicher N: Twins in ART-a desirable outcome? A debate: the pro-view. 14th World Congress on In-Vitro Fertilization & 3rd World Congress on In-Vitro Maturation; Montreal, Canada; September 15-19, 2007.

371. Gleicher N: IVF in Older Women. 23rd Annual Congress of the Austrian Society for Reproductive Medicine and Endocrinology, Innsbruck, Austria, September 20-22, 2007.

372. Singer T, Barad D, Gleicher N: A comparison of serum anti-mullerian hormone and cycle baseline follicle stimulating hormone in prediction of IVF outcomes. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

373. Barad D, Weghofer A, Gleicher N: Age-specific cut-offs for FSH assessment of ovarian function: improved diagnosis of premature ovarian aging (POA). American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

374. Gleicher N, Weghofer A, Barad D: Increased euploid embryos after supplementation with DHEA in women with premature ovarian aging. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

375. Gleicher N, Barad D: Does gender selection devalue women? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

376. Weghofer A, Brill H, Barad D, Gleicher N: Does autoimmunity play a causative role in the pathophysiology of premature ovarian aging (POA)? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

377. Gleicher N, Weghofer A, Li JM, Barad D: Increased risk of premature ovarian aging (POA) in Chinese women. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

378. Barad D, Gleicher N, Weghofer A, Chen S, Cohen J: Validation of age-specific cut-offs for ovarian function assessment by FSH levels via a second patient population: inherent differences in patient populations between IVF centers. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

379. Gleicher N, Barad D: The impact of DHEA supplementation on IVF pregnancy rates in women ages 40-47 years. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

380. Barad D, Gleicher N: Implantation rate and pregnancy rates following all freeze cryopreservation cycles compared to those following cryopreservation of excess embryos. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C., October 13-17, 2007.

381. Gleicher N: The Effect of DHEA on IVF Outcome in Women above age 40. 74th Annual Meeting, Program of the Central Association of Obstetricians and Gynecologists, Chicago, IL, October 17-20, 2007.

382. Gleicher N: Age-specific ovarian function testing improves determination of ovarian reserve. The International Ovarian Conference, Hakone, Japan, November 2-3, 2007.

383. Gleicher N: The aging ovary. International Symposium, Genetics and Immunology of Reproduction, Buenos Aires, Argentina, November 7-8, 2007.

384. Gleicher N: Comparison of IVF outcomes between Europe and the USA. International Symposium, Genetics and Immunology of Reproduction, Buenos Aires, Argentina, November 7-8, 2007.

385. Gleicher N: Ovarian Aging. Grandrounds, Department of Obstetrics and Gynecology, New York Medical College, Valhall, New York, March 6, 2008.

386. Gleicher N: Impact of LH-containing gonadotropins on ploidy: Long agonist stimulation. ART Clinical Update. Ferring in Fertility. Toronto, Ontario, Canada, June 19-21, 2008.

387. Gleicher N: Infertility Treatment 2009: as good as it gets. 2009 Annual Patrick Steptoe Memorial Lecture, British Fertility Society, Edinburgh, United Kingdom, January 7, 2009.

388. Gleicher N: Should we ever make a diagnosis of unexplained infertility? Symposium on Unexplained Fertility, British Fertility Society, Edinburgh, United Kingdom, January 8, 2009.

389. Weghofer A, Barad DH, Oktay K, Gleicher N. Why abnormal autoimmune function and number of triple CGG expansions on the FMR1 gene are independent risk factors of premature ovarian senescence. 24th Annual Meeting of ESHRE, Barcelona, Spain, July 7, 2008; O-035.

390. Gleicher N. Improving oocyte selection and embryo quality. In FERRING Company Symposium – “FORUM AUDITORIUM.” Better Together: HCG-driven LH activity matters. 24th Annual meeting of ESHRE, Barcelona, Spain, July 7, 2008.

391. Li JM, Barad DH, Gleicher N. In contrast to prevalent opinion, twin pregnancies after fertility treatments are medically, ethically and economically desirable outcomes. 24th Annual Meeting of ESHRE, Barcelona, Spain, July 7, 2008.

392. Gleicher N. IVF outcomes in Europe and the USA, worth a discussion? In IBSA Company Symposium – “FORUM AUDITORIUM.” Follicular stimulation outcomes, Europe vs. USA: Any lessons to learn? 24th Annual meeting of ESHRE, Barcelona, Spain, July 8, 2008.

393. Gleicher N, Weghofer A, Oktay K, Barad DH. The number of triple CGG repeats on the FMR1 gene: A new test reflective of diminished ovarian reserve and female infertility.

394. Gleicher N. The FMR1 gene as a fertility test. Grandrounds, Yale University School of Medicine, New Haven, Conneticut, October 30, 2008.

395. Oktay K, Sahin G, Ucar F, Barad D, Blanchette H, Gleicher N: Fertility preservation is an emerging discipline extending beyond cancer patients: analysis of a large experience.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (O-141).

396. Oktay K, Oktem O, Barad D, Gleicher N: “Longevity of autologous ovarian transplants: extended experience in humans.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (O-146).

397. Gleicher N, Weghofer A, Oktay K, Barad D. “Relevance of low expansion CGG triple repeat numbers on the FMR1 gene to functional ovarian reserve.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (O-160).

398. Oktay K, Barad D, Gleicher N, Smotkin-Tangorra M. “Retrieval and cryopreservation nof large number of oocytes from a 15 year old with primary amenorrhea and diagnosis of premature ovarian failure.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (O-249).

399. Gleicher N, Weghofer A, Oktay K, Barad D: “Autoimmune function and numbef or triple CGG expansions on the FMR1 gene as independent risk factors for premature ovarian senescence.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-125).

400. Oktay K, Kim JY, Barad D, Gleicher N, Blanchett H: “Serum FSH monitoring improves decision making in women undergoint controlled ovarian hyperstimulation with letrozole and follicle stimulating hormone.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-226).

401. Klein K, Stammler-Safar M, Krampl E, Gleicher N, Barad D, Weghofer A: “The impact of fetal sex on prematurity in dichorial-diamniotic twin pregnancies after assisted reproduction.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-306).

402. Barad DH, Weghofer A, Oktay K, Gleicher N: “Triple CGG expansions on the FMR1 gene and response to ovarian stimulation.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-375).

403. Gleicher N, Ryan E, Weghofer A, Oktay K, Blanco-Mejia S, Barad DH: “Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished ovarian reserve: a multicenter study.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-450).

404. Gleicher N, Weghofer A, Oktay K, Barad D: “The distribution of causative etiologies in infertile women with a diagnosis of spontaneous premature ovarian senescence, exclusive of end-stage premature ovarian failure (POF).” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-452).

405. Barad D, Oktay K, Weghofer A, Gleicher N: “Anti-Mullerian hormone (AMH), but not follicle stimulating hormone (FSH), correlates to oocyte yield in in vitro fertilization.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (P-453).

406. Gleicher N: “Are patients entitled to maximal pregnancy rates with infertility treatments?” 11th World Congress on Controversies in Obstetrics and Gynecology, Paris, France, November 27-30, 2008.

407. Gleicher N. “Infertility treatment 2009: as good as it gets?” Patrick Steptoe Memorial Lecture; Fertility 2009, Bi-Annual Combined Meetings of the British Fertility Society, The Association of Clinical Embryologists and Society for Reproduction and Fertility; Edinburg International Conference Centre, January 7-9, 2009.

408. Gleicher N. “Should we ever make a diagnosis of unexplained infertility?” Fertility 2009, Bi-Annual Combined Meetings of the British Fertility Society, The Association of Clinical Embryologists and Society for Reproduction and Fertility; Edinburg International Conference Centre, January 7-9, 2009.

409. Gleicher N. “The FMR1 gene as a fertility test.” Masterclass in Reproductive Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg, January 9-10, 2009.

410. Gleicher N. “An update on DHEA supplementation.” Masterclass in Reproductive Medicine, Specialist Meeting in Reproductive Medicine; Apex City Hotel, Edinburg, January 9-10, 2009.

411. Gleicher N. “Can we possibly affect follicular recruitment?” New Frontiers in Fertility. Serono Symposia International Foundation, Lisbon, Portugal, February 13-14, 2009.

412. Goyal A, Barad DH Weghofer A, Oktay K, Gleicher N. Predicting improvements in ovarian reserve and pregnancy rates after supplementation of dehydroepiandrosterone (DHEA) in diminished ovarian reserve. Annual Meeting of ESHRE, Amsterdam, The Netherland, June 28 - July 1, 2009.

413. Barad DH, Weghofer A, Oktay K, Gleicher N. What are the effects of race/ethnicity on triple CGG counts on the FMR1 (fragile X) gene? Annual Meeting of ESHRE, Amsterdam, The Netherland, June 28 - July 1, 2009.

414. Oktay K, Turkcuoglu I, Barad DH, Gleicher N, Kim JY. Prospective comparison of letrozole-FSH stimulation followed by hcG vs GnRHa for fertility preservation in women with breast cancer. Annual Meeting of ESHRE, Amsterdam, The Netherland, June 28 - July 1, 2009.

415. Gleicher N, Weghofer A, Oktay K, Barad DH. A potential new function of the FMR1 (fragile X) gene: Regulation of functional ovarian reserve. Annual Meeting of ESHRE, Amsterdam, The Netherland, June 28 - July 1, 2009.

416. Gleicher N. Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range and median. 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

417. Gleicher N, Goyal A, Weghofer A, Barad DH. Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-Müllerian hormone levels. 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

418. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone (AMH) levels discriminate at each age between poorer and better oocytes yields. 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

419. Barad DH, Weghofer A, Goyal A, Gleicher N. Further refinement in defining the effect of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition of distinct subgroup of PCOS patients, based on normal/low genotype. 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

420. Gleicher N, Weghofer A, Barad DH. The FMR1 gene, a regulator of functional ovarian reserve over reproductive life times. 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

421. Barad DH, Weghofer A, Goyal A, Gleicher N. What does discordance between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) mean? 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

422. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are extremely low levels of anti-Müllerian hormone (AMH)? 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

423. Gleicher N. What does DHEA have to do with treating diminished ovarian reserve? The 3rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility, Beijing, China, November 12-15, 2009.

424. Gleicher N. PGS is associated with lower success rate and should not be offered as a screening tool. The 3rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility, Beijing, China, November 12-15, 2009.

425. Gleicher N. Are twins really an adverse outcome in IVF? No. The 3rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility, Beijing, China, November 12-15, 2009.

426. Gleicher N. The FMR1 gene as a regulator of follicular recruitment and ovarian aging. The International Ovarian Conference 2009, Tokyo, Japan, December 5, 2009.

427. Gleicher N. Methods to assess ovarian reserve more timely and more accurately. Meeting of the Japan Infertility Study Group (ISG), Tokyo, Japan, December 6, 2009.

428. Gleicher N, Elkayam U. Peripartum cardiomayopathy is an autoimmune disease. First International Congress on Cardiac Problems in Pregnancy, Valencia, Spain, February 25-28, 2010.

429. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific anti-Mullerian hormone (AMH) in a fertile cohort: not as stable as previously thought. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

430. Barad D, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by heterozygousnormal/low genotype on the FMR1 (fragile X) gene. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

431. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually "young"; it is the ovarian environment in which folliculogenesis occurs that ages. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

432. Gleicher N, Barad DH. Evidence based medicine (EBM): what’s next? Cannot replace clinical judgment. Proceedings of the 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Berlin, Germany, Nov. 4-7, 2010; Ben-Rafael Z ed, Monduzzi Editore 2010, p161-6.

433. Gleicher N, Weghofer A, Barad DH. Preimplantation genetic screening (PGS) is an experimental tool that should be banned from routine clinical use: PGS, as currently practiced, is associated with inferior results and should not be routinely offered. Idem; pp171-5.

434. Gleicher N, Weghofer A, Barad DH. Has anti-Müllerian hormone (AMH) become essential in assessing ovarian reserve? – NO. Idem; pp189-94.

435. Gleicher N, Weghofer A, Barad DH. Can diminished ovarian reserve be treated effectively? – YES. Idem; pp195-201.

436. Lee I, Barad DH, Weghofer A, Gleicher N. New evidence as an explanation for the negative impact of autoimmunity on reproductive success in association with IVF. 27th Annual Meeting of the European Society of Human Reproduction and Embryology, Stockholm, Sweden, July 3-6, 2011.

437. Gleicher N, Weghofer A, Barad DH. The impact of ovarian FMR1 genotypes and sub-genotypes in young oocyte donors on ovarian reserve and recipient pregnancy rates. 27th Annual Meeting of the European Society of Human Reproduction and Embryology, Stockholm, Sweden, July 3-6, 2011.

438. Vidali A, Barad DH, Gleicher N. Successful treatment with intrauterine perfusion of granulocyte colony stimulationg factor (G-CSF) of chronically intractable this endometrium. 27th Annual Meeting of the European Society of Human Reproduction and Embryology, Stockholm, Sweden, July 3-6, 2011.

439. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low anti-Mullerian hormone levels. 27th Annual Meeting of the European Society of Human Reproduction and Embryology, Stockholm, Sweden, July 3-6, 2011.

440. Gleicher N. Are twins an adverse outcome after infertility treatments? Fifth Isala Fertility Syposium, Zwolle, the Netherlands, September 23, 2011.

441. Gleicher N. Genetic issues related to the oocyte: the FMR1 gene. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.

442. Gleicher N. Rejuvenating ovarian function: DHEA improves IVF outcomes and reduces aneuploidy. First meeting of the Ovarian Club, Barcelona, Spain, November 3-6, 2011.

443. Gleicher N. Is measurement of anti-Mullerian hormone (AMH) essential? NO. 14th World Congress on Controversies in Obstetrics, Gynecology and Infertiltiy. Paris, France, November 17-20, 2011.

444. Gleicher N. PGS remains an experimental tool! 14th World Congress on Controversies in Obstetrics, Gynecology and Infertility. Paris, France, November 17-20, 2011.

445. Gleicher N. Preconception counseling for ART: Who should inform the women about the risks? 14th World Congress on Controversies in Obstetrics, Gynecology and Infertility. Paris, France, November 17-20, 2011.

446. Gleicher N. Is what the physician does important in affecting the embryo quality? 4th Asia Pacific Congres on Controversies in Obstetrics, Gynecology and Infertility. Bangkok, Thailand, November 24-27, 2011.

447. Gleicher N. Should DHEA be used more widely? 4th Asia Pacific Congres on Controversies in Obstetrics, Gynecology and Infertility. Bangkok, Thailand, November 24-27, 2011.

448. Gleicher N. Should we always strive to use mild stimulation for IVF? Results are too low and dropout rates are too high to make it a viable option! 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

449. Gleicher N. Preventing all multiple pregnancies by systematic single embryo transfer (SET) for all? No. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

450. Gleicher N. PGS is an experimental tool that should be banned from routine clinical use! PGS, as currently practiced, is associated with inferior results and should not be routinely offered. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

451. Gleicher N. Can diminished ovarian reserve be treated effectively? Yes. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

452. Gleicher N. Treating anovulatory PCOS patients: what should be the first choice? Ovulation induction + IUI and/or IVF. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

453. Gleicher N. Preconception counseling for ART: Who should inform the women about the risks? Patients are ready to take the many risks in their journey to parenthood, and ART specialists are fully trained to weight the risk/benefit in most situations, hence they should be the primary physicians to provide counseling. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

454. Gleicher N. AMH in ART. 15th World Congress on Controersies in Obstetrics, Gynecology and Infertility. Hainan, China, December 8-11, 2011.

455. Gleicher N. Saving ovaries, rescuing eggs. Endometriosis 2012: Tapping the roots for the next generation. New York, NY, March 14 – 15, 2012.

456. Gleicher N. The most important, largely unknown gene in reproductive medicine and beyond: the FMR1 gene. Greater Toronto Area Reproductive Medicine Rounds. Toronto, Canada, March 22, 2012.

457. Gleicher N. Intrauterine administration of granulocyte colony-stimulationg factor (G-CSF) to increase endometrial thickness. The World Congress on Building Consensus in Gynecology, Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.

458. Gleicher N. Panel discussions: Treatment strategies for poor responder patients. The World Congress on Building Consensus in Gynecology, Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.

459. Gleicher N. Debate: What should be the preferred route of progesterone administration? The World Congress on Building Consensus in Gynecology, Infertility and Perinatology (BCGIP), Barcelona, Spain, May 3 – 6, 2012.

460. Gleicher N. “Chromosomes and autoimmunity: The FMR1 gene.” American Autoimmune Related Diseases Association’s Scientific Colloquium “Sex, Gender and Autoimmunity through the Lifespan.” Chicago, IL, USA, May 17, 2012.

461. Gleicher N. “Improvements in infertility techniques leading to increased incidence of pregnancies in women with congenital or acquired heart disease.” Congress on Cardiac Problems in Pregnancy, Berlin, Germany, May 17-20, 2012.

462. Gleicher N. “Twins are ethically and clinically desirable outcome of infertility treatment.” Fertilty Treatment and Multiple Births: Ethical and Policy Issues Workshop, White Plains, NY, June 20-21, 2012.

463. Gleicher N. “IVM does not offer any advantage over current IVF practice, and the associated risks are unknown.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

464. Gleicher N. “Decreased ovarian reserve and early menopause: Can you do something, doctor?” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

465. Gleicher N. “Developing international standards for cross border services, who’s responsibility is it?” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

466. Gleicher N. “Can we improve pregnancy rates of patients with DOR by better stimulation?: Better protocol can improve stimulation and pregnancy rates.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

467. Gleicher N. “EBM has limited value in daily clinical care and cannot replace clinical judgement.” The 16th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Singapore, July 19-22, 2012.

468. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgens on pregnancy potential in women with diminished ovarian reserve. Annual Meeting of the European Society of Human reproduction and Embyrology, Istanbul, Turkey, July 1-4, 2012.

469. Gleicher N. Treating infertility in patients with older ovaries. Austrian IVF Congress, Vienna, Austria, October 19-20, 2012.

470. Gleicher N. Can the addition of androgens affect the results of treatment in poor responders? The 17th World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Lisbon, Portugal, November 8-11, 2012.

471. Gleicher N. Embryonic biopsy is associated with decreased implantation which should be offset by the results to make it a viable option. The 17th World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Lisbon, Portugal, November 8-11, 2012.

472. Gleicher N. What clinicians and biologists should know about each other’s work. The 17th World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Lisbon, Portugal, November 8-11, 2012.

473. Gleicher N. How androgens and genes affect follicle maturation and ovarian aging. Ovarian Club II, Pracue, Czech Republic, November 8-11, 2012.

474. Gleicher N. Autoimmune diseases and premature labor. Maternal and Fetal Medicine Symposium, Bogota, Colombia, November 29 - December 1, 2012.

475. Gleicher N. The current debate about the risk profile of twin pregnancies: Importance of context and correct statistical analysis. Maternal and Fetal Medicine Symposium, Bogota, Colombia, November 29 - December 1, 2012.

476. Gleicher N. Intricate interplay between autoimmunity and pregnancy. Maternal and Fetal Medicine Symposium, Bogota, Colombia, November 29 - December 1, 2012.

477. Gleicher N. Is preeclampsia the equivalent of graft-versus-host-disease (GVHD), seen in allogenic organ transplantation? Maternal and Fetal Medicine Symposium, Bogota, Colombia, November 29 - December 1, 2012.

478. Gleicher N. Poor ovarian reserve and implantation failure: Potential treatments. How to Improve IVF Success Rates Congress, Rome, Italy, December 14th, 2012.

479. Gleicher N. Controversies about single embryo transfer and gender selection. Meeting of the Philadelphia Area Reproductive Endocrine Society and the Obstetrical Society of Philadelphia, January 10, 2013.

480. Gleicher N. Diminished ovarian reserve in breast cancer patients with BRCA1 mutation. International Congress on Oncological Perspectives of Fertility Preservation, Berlin, Germany, March 21-23, 2013.

481. Gleicher N. Dehydroepiandrosterone (DHEA) and its role in female fertility. Eight-city lecture tour of India (Chennai, Kolkota, Mumbai, Bangalore, Hyderabad, Delhi, Lucknow, Nagpur), sponsored by Sun Pharmaceuticals. May 3-10, 2013.

482. Gleicher N. The importance of androgens in follicle maturation. Buenos Aires, Argentina, May 28, 2013.

483. Gleicher N. Treating the “older” ovaries. Buenos Aires, Argentina, May 28, 2013. 484. Gleicher N. The most important, unknown gene in reproduction: the FMR1 gene.

Buenos Aires, Argentina, May 28, 2013. 485. Gleicher N. Role of androgens in the treatment of patients with low ovarian

response. Interational Conference: Meeting the Experts, Alicante, Spain, May 31, 2013. 486. Lee HJ, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Barad DH,

Gleicher N. Is androgen production in association with immune system activation potential evidence for the existence of a functional adrenal/ovarian autoimmune system in women? The Annual Meeting of the ESHRE, London, UK, July 7-10, 2013.

487. Sen A, Prizant H, Light A, Biswas A, Lee HJ, Barad DH, Gleicher N, Hammes SR. Androgen actions regulating follicular development. Annual Meeting of the Society for the Study of Reproduction, Montreal, Quebec, Canada, July 22-26, 2013.

488. Gleicher N. Is low intensity (“mild” or “mini”) ovarian stimulation preferable? No. The 18th World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Vienna, Austria, October 25-27, 2013.

489. Gleicher N. Why don’t we learn from experience? PGS is not a practical option! The 18th World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Vienna, Austria, October 25-27, 2013.

490. Gleicher N. New concepts of ovarian function testing: taking advantage of hormone interactions during early stages of follicle maturation. Ovarian Club III – The Inverse Pyramid: Regulating Follicle Number and Oocyte Quality, Paris, France, November 14-17, 2013.

491. Gleicher N. The use of reproduction technologies in the setting of complex heart disease. Third International Congress on Cardiac Problems in Pregnancy, Venice, Italy, February 20-24, 2014.

492. Gleicher N. Can we prevent congenital heart block in offspring from mothers at risk? Third International Congress on Cardiac Problems in Pregnancy, Venice, Italy, February 20-24, 2014.

493. Gleicher N. Ovarian reserve in women with BRCA mutation. World Sympsium on Endometriosis, Atlanta, GA, March 27-29, 2014.

494. Gleicher N. An Update on CHR research: the Aging Ovary. Grandrounds, Tel-Hashomer Hospital Department of Ob/Gyn and Sackler School of Medicine, tel-Aviv University, Israel, April 7, 2014.

495. Gleicher N. Intrauterine therapies. 2014 Annual Conference in Reproductive Medicine: Implantation: Opening the Black Box. EXCEMED, Budapest, Hungary, May 23-24, 2014.

496. Gleicher N. Is DHEA an answer to low ovarian reserve? A 7-city lecture series organized by Sun Pharmaceuticals, LTD, Mumbai, India, May 26 – June 4, 2014.

497. Barad DH, Khanna P, Kushnir VA, Gleicher N. Clinical in vitro fertilization (IVF) outcomes based on comparative anti-Müllerian hormone (AMH) testing with a standard and new highly sensitive assay. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

498. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. The impact of advancing female age on gene expression of human granulosa cells. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

499. Vega M, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Low functional ovarian reserve (FOR) is in infertile women associated with presence of antiphospholipid antibodies. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

500. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Proliferation and gene expression are affected by advancing female age in cultured human granulosa cells. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

501. Kushnir VA, Sen A, Hammes SR, Barad DH, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Proof of concept in a mouse model for beneficial effects of dehydroepiandrosterone (DHEA) on small growing follicles. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

502. Barad DH, Khanna P, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Differences in amh assessments between standard and new high sensitivity AMH assays and impact on prediction of ivf outcomes. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

503. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Effects of advancing female age on proliferation and gene expression in cultured human

granulosa cells from post-hCG retrieved follicles. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

504. Wu Y-G, Lee HJ, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Sen A, Gleicher N. The effects of dehydroepiandrosterone (DHEA) on cultured human granulosa cells from postovulatory human follicles after in vitro fertilization (IVF). ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

505. Khanna P, Kushnir VA, Barad DH, Gleicher N. Live births rates following oocyte donation reflect performance of IVF centers in autologous IVF cycles. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

506. Kushnir VA, Khanna P, Barad DH, Gleicher N. Assesment of practice in IVF clinics in which success in autologous and donor oocyte cyles do not correlate. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

507. Kushnir VA, Wu Y-G, Chen I-C, Lee H-J, Barad DH, Lazzaroni-Tealdi E, Gleicher N. Mitochondrial DNA abundance declines in human cumulus granulosa cells with age. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

508. Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH, Kushnir VA, Gleicher N. Aging is associated with differential gene expression in human granulosa and cumulus cells leading to rapid progression of meiotic and oocyte maturation competence. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

509. Vega M, Barad DH, Weghofer A, Kushnir VA, Gleicher N. Evidence that a degree of mucosal inflammation is beneficial for pregnancy success in association with IVF. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

510. Gleicher N. Preimplantation genetic screening (PGS), still in search of a clinical application. Middle East Fertility Society 21st Annual Meeting, Abu Dhabi, UAE, September 25-27, 2014.

511. Gleicher N. The FMR1 gene, the most important unknown gene in human reproductiohn. Middle East Fertility Society 21st Annual Meeting, Abu Dhabi, UAE, September 25-27, 2014.

512. Gleicher N. Finding the best egg with the old fashioned molecular biology. Ovarian Club Meeting IV, Paris, France, November 7-8, 2015.

513. Gleicher N. DHEA: Adjuvants are beneficial. COGI Vietnam, Ho Chi Min City, Vietnam, November 20-22, 2014.

514. Gleicher N. Adjusting ovarian stimulation to patient age. COGI Vietnam, Ho Chi Min City, Vietnam, November 20-22, 2014.

515. Gleicher N. How to improve ovarian responses to COS. The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Guilin, China, May 7-10, 2015

516. Gleicher N. Can we pharmacologically affect embryo poidy? The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Guilin, China, May 7-10, 2015

517. Gleicher N. Debate (Con): To maximize the outcome of IVF treatment every embryo should undergo PGS. . The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Guilin, China, May 7-10, 2015

518. Gleicher N. Pitfalls related to the technology. The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Frankfurt, Germany, May 14-16, 2015.

519. Gleicher N. Debate (Con): Should PGS be offered to all IVF patients? The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Frankfurt, Germany, May 14-16, 2015.

520. Gleicher N. “Burning out” PCOS patients. The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Frankfurt, Germany, May 14-16, 2015.

521. Gleicher N. G-CSF: Does it add real value to IVF success? The 21st World Congress on Controversies in Obstetrics, Gynecolgy & Infertility (COGI), Frankfurt, Germany, May 14-16, 2015.

522. Barad D. H., Weghofer A, Latham G.J., Filipovic-Sadic S, Kushnir V.A., Gleicher N. Significant skews in methylation fractions in previously described genotypes and sub-genotypes of the FMR1 gene. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

523. Vega M, Barad, D.H., Seier K, Yu Y, Kushnir V.A., Lazzaroni-Tealdi E, Wu Y-G, Wand Q, Weghofer A, Albertini D.F., Gleicher N. Immunologic and inflammatory markers in prediction models of clinical pregnancy and live birth in association with in vitro. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

524. Weghofer A, Kushnir V.A., Barad D. H., Gleicher N. The impact of thyroid stimulating hormone (TSH) on anti Mullerian hormone (AMH) levels in infertile women. Does TSH affect follicular recruitment? ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

525. Bisplinghoff E., Barad D. H., Weghofer A, Kushnir V.A., Gleicher N. Comparison of FMR1 mutations distribution between Indian and other Asian patients. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

526. Gleicher N, Vidali A, Braverman J, Kushnir V.A, Barad D.H, Albertini D. F. Further Evidence Against Use of PGS in Poor Prognosis Patients: Reports of Normal Births After Transfer of Embroys Reported As Aneupoid. ASRM Annual Meeting, Baltimore, USA, Oct. 17-21, 2015.

527. Gleicher N. Debate: Does DHEA Supplementation for Poor Prognosis Patients Have Real Benefit? Yes! COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.

528. Gleicher N. Debate: To maximize the outcome of IVF treatment, should every embryo undergo PGS? No! COGI Congress, Budapest, Hungary, Sept. 17-19, 2015.

529. Gleicher N. Secondary ovarian insufficiency: How the adrenal can control ovarian function. Ovarian Club, Barcelona, Spain, November 2015.

530. Gleicher N. Why embryo selection is too late. Ovarian Club, Barcelona, Spain, November 2015.

531. Gleicher N. Why embryo selection, as currently practiced, does not work. University School of Vienna. Vienna, Austria, January 2016.

532. Gleicher N. Is PGD/PGS or time lapse benefiting IVF outcome in aging women? Conference of Reproductive Endocrinology and ART. Guangzhou, China, March 2016.

533. Gleicher N. Is PGD/PGS or time lapse benefiting IVF outcome in aging women? Shaoguan Maternal and Child Hospital IVF Center. Guangzhou, China, March 2016.

534. Gleicher N. Debate: Androgen supplementation in women with LFOR?: YES. The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

535. Gleicher N. Debate: Are the days of transferring embryos into a compromised uterus coming to an end?: NO The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

536. Gleicher N. Debate: PGS is now proven, every embryo should undergo PGS: NO. The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

537. Gleicher N. How new infertility treatments negatively affected infertility treatments over the last 10 years. The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

538. Gleicher N. Is there an ideal stimulation for poor ovarian reserve? The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

539. Gleicher N. Is there really clinical value in embryo selection? The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

540. Gleicher N. Modeling IVF results in advanced female age using AMH. The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

541. Gleicher N. Why RCTs are rare in infertility and what to do about it. The 23rd Congress on Controversies in Obstetrics, Gynecology & Infertility. Melbourne, Australia, March 21-23, 2016

542. Gleicher N. Adjuncts for Poor Responders. Ferring Advisory Board Meeting. Austin, TX, April 21-22, 2016.

543. Gleicher N. Best Treatment Protocols for Poor Ovarian Reserve. China Academy IVF Forum. Chengdu, China, May 13-15, 2016.

544. Gleicher N. Is there really clinical value in embryo selection? China Academy IVF Forum. Chengdu, China, May 13-15, 2016.

545. Gleicher N. Debate: PGS is now proven, every embryo should undergo PGS: NO. China Academy IVF Forum. Chengdu, China, May 13-15, 2016.

546. Gleicher N. Treatment of thin endometrium. China Academy IVF Forum. Chengdu, China, May 13-15, 2016.

547. Gleicher N. Can We Affect Oocyte Aging? Ovarian Club VII. Hong Kong, China, May 21-22, 2016.

548. Gleicher N. PGS by Single Trophectoderm Biopsy Cannot Distinguish Aneuploidy from Normal Embryos Ovarian Club VII. Hong Kong, China, May 21-22, 2016.

549. Kushnir VA, et al. Proof of concept in a mouse model for beneficial effects of dehydroepiandrosterone (DHEA) on small growing follicles. Endocrine Society Meeting (ENDO 2016), Boston, MA, April 1- 4, 2016.

550. Bisplinghoff E, et al. Comparison of FMR1 mutations distribution between Indian and other Asian patients. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

551. Wang Q, et al. Reduced mRNA levels and isoforms of the FMR1 gene in infertile women with low CGGnn<26 repeats. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

552. Kushnir VA, et al. World trends in assisted reproductive technology (ART) 2004-2013. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

553. Barad DH, et al. Association of skewed X-Chromosome inactivation with FMR1 CGG repeat length and AMH levels as indictor of functional ovarian reserve in infertile women. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

554. Gleicher N. Elective single embryo transfer: Is it the ultimate goal? Paradigmatically no. Stand-Alone Scientific Symposium for Fertility. Barcelona, Spain, September 16-17, 2016.

555. Gleicher N. The 2015 COGEN statement on PGS was not premature as PGS is advantageous to patients and is not potentially harmful. 2nd World Congress on Controversies in Preconception, Prenatal Genetic Diagnosis. Barcelona, Spain, September 22-24, 2016.

556. Wu YG et al. What is the best lead follicle size for ovulation induction in older women ≥43 years to avoid premature luteinization of follicles? 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

557. Kushnir VA et al. Effects of newly introduced practices over 10 years (2004-2013) on worldwide trends in assisted reproductive technology. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

558. Kushnir VA et al. Utilization and effects of embryo banking on art outcome reporting in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

559. Barad DH et al. Prevalence and effect of preimplantation genetic screening (PGS) on oocyte donation cycles in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

560. Kushnir VA et al. Contribution of third party reproduction to the birth cohort following art in the U.S.A. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

561. Barad DH et al. Contribution of cryopreservation cycles to cumulative live birth outcomes following oocyte donation with preimplantation genetic screening (PGS) in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

562. Shapiro AJ et al. Racial and ethnic disparities in the use of third-party art in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

563. Shapiro AJ et al. Effect of race and ethnicity on live birth rates in third-party art cycles in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

564. Kushnir VA et al. Effect of race and ethnicity on fertility rates and utilization of art in the USA. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

565. Barad DH et al. Effect of time trends of preimplantation genetic screening (PGS) utilization on oocyte donation cycle live birth rates in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

566. Gleicher N et al. Preimplantation genetic screening (PGS) appears unable to correctly determine ploidy of embryos from a single trophectoderm biopsy (TEB). 72nd

Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

567. Barad DH et al. Effect of PGS on IVF outcomes following eSET in oocyte donation in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

568. Gleicher N. What can these studies teach us about PGS? 24th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the Netherlands. November 10-13, 2016.

569. Overcoming the technical gaps will lead to PGS to all embryos. It’s only a matter of time. NO. PGS causes more damage than benefit. 24th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI). Amsterdam, the Netherlands. November 10-13, 2016.

570. Gleicher N. Why timing of ovulation induction matters in women with low functional ovarian reserve. Ovarian Club VIII, Paris, France, November 4-6, 2016.

571. Gleicher N. Live birth rate per oocyte in natural cycles vs. hyper-stimulated cycles. Stimulated cycles. Ovarian Club VIII, Paris, France, November 4-6, 2016.

572. Gleicher N. Accuracy of assessing embryo ploidy of human embryos with PGS in association with IVF. Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

573. Gleicher N. Androgen supplementation, a model for therapeutic interventions into early stages of follicle maturation in humans. Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

574. Gleicher N. Are twins an adverse IVF outcome? No, the single embryo transfer myth. Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

575. Gleicher N. As practiced today, embryo selection, marginally benefits few – while potentially harming many. Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

576. Gleicher N. Is the immune system (i.e., autoimmunity and inflammation) really irrelevant to IVF success – as suggested by some? Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

577. Gleicher N. Immunological pregnancy loss. Translational Reproductive Biology and Clinical Reproductive Endocrinology. New York, NY, November 17-20, 2016.

578. Gleicher N. Intrauterine therapies. Genesis Symposium, Udaipur, India, February 23-24, 2017.

579. Gleicher N. IVF, yesterday, today and tomorrow – through my eyes. Genesis Symposium, Udaipur, India, February 23-24, 2017.

580. Gleicher N. What in IVF represents good, intermediate and poor prognosis at different patient ages? Ferticon, New Delhi, India, February 25-26, 2017.

581. Gleicher N. A new PCOS phenotype: Hypo-androgenic PCOS. Ferticon, New Delhi, India, February 25-26, 2017.

582. Gleicher N. Why PGS is futile and should be abandoned. Ferticon, New Delhi, India, February 25-26, 2017.

583. Hayes E, et al. Regulation of anti-Müllerian hormone (AMH) expression during- follicular development. Annual 2017 Meeting of the Endocrine Society (ENDO 2017), Orlando, FL, April 1-4, 2017.

584. Gleicher N. Impact of environment and lifestyle factors on IVF. EXCEMED Annual Conference in Reproductive Medicine, Milan, Italy, April 21-22, 2017.

585. Gleicher N. Thin endometrium as a cause of RIF. EXCEMED Annual Conference in Reproductive Medicine, Milan, Italy, April 21-22, 2017.

586. Gleicher N. What to do with reported PGS results? Tel-Aviv, Israel, April 26, 2017.

587. Gleicher N. Accuracy of assessing embryo ploidy of human embryos with PGS in association with IVF. AAB College of Reproductive Biology Symposium, Houston, TX, May 15-18, 2017.

588. Albertini DF, et al. Ontogeny of newly described hypo-androgenic PCOS phenotype in infertile women from younger through older ages. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017.

589. Barad DH, et al. Prevalence and impact of elective gender selection in oocyte donor recipient cycles in the United States 2005-2013. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017. ESHRE Meeting, Geneva, Switzerland, July 2-5, 2017.

590. Gleicher N. Day 3 vs. Day 5 Embryo Transfer? Position: Day 3. 54th Mexican Congress of Reproductive Medicine. Caucun, Mexico, July 16-20, 2017.

591. Gleicher N. Targeting the unfavorable infertility patients. 54th Mexican Congress of Reproductive Medicine. Caucun, Mexico, July 16-20, 2017.

592. Gleicher N. Using or not using PGS. 54th Mexican Congress of Reproductive Medicine. Caucun, Mexico, July 16-20, 2017.

593. Gleicher N. Cardiac risks in (older) women undergoing IVF. Heart of the Matter, Atlanta, GA, August 18-19, 2017.

594. Gleicher N. PGS or PGS or Preimplantation Genetic Testing for Aneuploidy, as it is now suddenly renamed: The most controversial add-on in the history of IVF. CHR GrandRounds, New York, NY, September 5, 2017.

595. Gleicher N. Nothing more controversial than PGS. Ovarian Club IX. Barcelona, Spain, September 15-16, 2017.

596. Gleicher N. Androgens in the Aging Process. From Basic Science to Clinical Practice - A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.

597. Gleicher N. New Insights into Disorders of Reproduction: Fragile X (FMR1) and a New Hypoandrogenic PCOS Phenotype. From Basic Science to Clinical Practice - A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.

598. Gleicher N. Time lapse imaging. From Basic Science to Clinical Practice - A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.

599. Gleicher N. Pros and cons of embryo screening. From Basic Science to Clinical Practice - A Translational Approach to Reproductive Medicine. Milan, Italy, September 29-30, 2017.

600. Gleicher N. The abnormal embryos that aren’t. Breast, Ovary and Endometriosis. New York, NY, October 28, 2017.

601. Gleicher N. Debate: PGS: No embryo should be tested. Controversies in Obstetrics Gynecology and Infertility 2017. Vienna, Austria, November 30 – December 2, 2017.

602. Gleicher N. The new hypo-androgenic PCOS phenotype. Vienna University School of Medicine GrandRounds. Vienna, Austria, November 30, 2017.

603. Gleicher N. Evidence based treatment for POF/POI. Ovarian Club X and CoGEN in Asia (OCC 2017). Hong Kong, December 16-17, 2017.

604. Gleicher N. Debate: PGS Needs More Proof. Ovarian Club X and CoGEN in Asia (OCC 2017). Hong Kong, December 16-17, 2017.

605. Gleicher N. Assisted fertilization in older women: Primer on techniques and discussion of cardiac risks. 5th International Congress on Cardiac Problems in Pregnancy. Bologna, Italy, February 22-25, 2018.

606. Gleicher N. Nothing more controversial than PGS/PGT-A. Life Conference: Reducing Time to Live Birth. Taipei, Taiwan, March 4, 2018.

607. Gleicher N. Strategies of implement IVF in women of advanced age. Life Conference: Reducing Time to Live Birth. Taipei, Taiwan, March 4, 2018.

608. Gleicher N. Is the hypothesis of PGS/PGT-A supportable? Dansk Fertilitetsselskabs Arsmode. Middelfart, Denmark, March 10-11, 2018.

609. Gleicher N. How to Treat Women of Very Advanced Age with Use of Their Own Eggs. KARM-Conference, Moscow, Russia, April 19-22, 2018.

610. Gleicher N. PGS/PGT-A: What Is the Real Value? KARM-Conference, Moscow, Russia, April 19-22, 2018.

611. Gleicher N. Optimizing Results in Poor-Responder Patients. International Summit on Assisted Reproduction and Genetics, Tel Aviv, Israel, May 27-29, 2018.

612. Gleicher N et al. Further characterization of a newly described hypo-androgenic PCOS-like phenotype based on adrenal and ovarian hormone profiles. ESHRE 2018, Barcelona, Spain, July 1-4, 2018.

613. Gleicher N et al. ACTH-stimulation in women with low functional ovarian reserve (LFOR) confirms adrenal origin of hypo-androgenism. ESHRE 2018, Barcelona, Spain, July 1-4, 2018.

614. Gleicher N et al. National U.S. utilization patterns and live birth rates of various ovarian stimulation protocols for IVF. ESHRE 2018, Barcelona, Spain, July 1-4, 2018.

615. Gleicher N. The importance of androgens for normal follicle maturation. XXII Brazilian Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.

616. Gleicher N. Why are IVF live birth rates all over the world declining? XXII Brazilian Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.

617. Gleicher N. PGS in the optimization of TRA results: What is the real benefit of PGS/PGT-A? XXII Brazilian Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.

618. Gleicher N. Achieving pregnancies with autologous oocytes beyond age 43. XXII Brazilian Congress of Assisted Reproduction, Brasilia, Brazil, August 2-4, 2018.

619. Gleicher N. Optimal care of the older women. International Haihe Health Conference, Tianjin, China, September 8-9, 2018.

620. Gleicher N. Ovarian stimulation for older women. International Haihe Health Conference, Tianjin, China, September 8-9, 2018.

621. Gleicher N, et al. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in older pre-menopausal infertile women. ASRM, Denver, Colorado, October 6-8, 2018.

622. Gleicher N, et al. A new optical system allows gauging of human oocyte maturation status without cumulus cell removal. ASRM, Denver, Colorado, October 6-8, 2018.

623. Gleicher N. Managing young women approaching menopause, with high FSH and low AMH. Ovarian Club, Paris, France, November 1-3, 2018.

624. Gleicher N. Advanced maternal age: Until what age autologous and until when homologous eggs? 26th COGI, London, UK, November 23-25, 2018.

625. Gleicher N. Social freezing: oocyte survival, pregnancy rates and obstetrical outcomes. Not as good as suggested! 26th COGI, London, UK, November 23-25, 2018.

626. Gleicher N. Reevaluation of genetic testing in light of recent advances. Evidence is completely lacking. 26th COGI, London, UK, November 23-25, 2018.

627. Gleicher N. The future of IVF – Can we be better? Ovarian Club XII, Hong Kong, China, December 15-16, 2018.

628. Gleicher N, et al. Highly individualized egg retrieval (HIER). 2019 Fertility Innovation in Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.

629. Gleicher N, et al. Adjuvants to implantation: Hype or hope? 2019 Fertility Innovation in Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.

630. Gleicher N, et al. Who benefits from PGS/PGT-A? 2019 Fertility Innovation in Reproductive Endocrinology (FIRE) Forum, Melbourne, Australia, February 16, 2019.

631. Gleicher N, et al. Oocyte size and morphology are related to female age, ovarian reserve and body weight in non-polycystic ovary syndrome patients. ESHRE 2019, Vienna, Austria, June 23-26, 2019.

632. Gleicher N, et al. Oocyte size and morphology are predictive of embryo quality. ESHRE 2019, Vienna, Austria, June 23-26, 2019.

633. Gleicher N, et al. The ovarian sensitivity index (OSI) is in infertile patients predictive of live birth chances after IVF. ESHRE 2019, Vienna, Austria, June 23-26, 2019.

634. Gleicher N, et al. Pilot study of novel noninvasive imaging approach for determination of meiotic status in intact human cumulus-oocyte-complexes. ESHRE 2019, Vienna, Austria, June 23-26, 2019.

635. Gleicher N, et al. Premature ovarian aging. Polish Society of Reproductive Medicine and Embryology Meeting, Warsaw, Poland, September 20-23, 2019.

636. Gleicher N, et al. What is too old for IVF? Polish Society of Reproductive Medicine and Embryology Meeting, Warsaw, Poland, September 20-23, 2019.

637. Gleicher N, et al. The future of IVF: Can we do better? ART World Congress, New York, NY, October 10-11, 2019.

Publications

1. Gleicher N: The long-term prognosis of pregnant women with acquired valvular heart disease, based on 25-30 years follow-up. M.D. thesis. December l974, Tel-Aviv University, School of Medicine.

2. Faiferman I, Gleicher N, Cohen C, et al.: Leukocyte migration in ovarian carcinoma: Comparison of inhibitory activity of tumor extracts. J Natl Cancer Inst l977; 59:l593-l597.

3. Gleicher N, Gergely Z, Deppe G: Infected ovarian hematoma as presenting symptom of systemic lupus erythematosus (SLE). J Reprod Med l978; 2l:223-227.

4. Gleicher N, Theofilopoulos A, Beers P: Immune complexes in pregnancy. Lancet l978; 2:ll08.

5. Gleicher N, Cohen C, Kerenyi T, Gusberg S: Familial malignant melanoma of the female genitalia: A case report and review. Obstet Gynecol Surv l979; 34:l-l5.

6. Gleicher N, Cohen C, Kerenyi T, Gusberg S: A blocking factor in amniotic fluid causing leukocyte migration enhancement. Am J Obstet Gynecol l979; l33:386-390.

7. Gleicher N, Theofilopoulos A: Immune complexes in pregnancy. Lancet l979; l:2l6. 8. Sandler R, Knutzen V, Milano C, Gleicher N: Uterine rupture with the use of vaginal

prostaglandin E-2 suppositories. Am J Obstet Gynecol l979; l34:348-349. 9. Gleicher N, Deppe G, Cohen C: Common aspects of immunologic tolerance in pregnancy

and malignancy. Obstet Gynecol l979; 54:335-342. 10. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger’s syndrome and pregnancy.

Obstet Gynecol Surv l979; 34:72l-74l. 11. Gleicher N, Knutzen V, Elkayam U, et al. Rheumatic heart disease diagnosed during

pregnancy: A 30-year follow-up. Int J Gynaecol Obstet l979; l7:5l-57. 12. Gleicher N, Deppe G. Circulating anticoagulants. Am J Obstet Gynecol l979; 133:941. 13. Gleicher N, Beers P, Kerenyi T, et al.: The Beckman Immunochemistry System. A rapid

method for the determination of immunoglobulins (IgG) and complement (C3) in amniotic fluid and plasma. Am J Diagnost Gynecol Obstet l979; l:l65-l70.

14. Roboz J, Gleicher N, Wu K, et al. Does doxorubicin cross the placenta? Lancet l979. 15. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement

as an indicator of immunologic enhancement. I. Pregnancy. Am J Obstet Gynecol l980; l36:l-4

16. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement as an indicator of immunologic enhancement. II. Malignancy. Am J Obstet Gynecol l980; l36:l26-l3l.

17. Gleicher N, Beers P, Kerenyi T, Cohen C, Gusberg S: Leukocyte migration enhancement as an indicator of immunologic enhancement. III. Common denominators of pregnancy and malignancy. Am J Obstet Gynecol l980; l36:5-l0.

18. Gleicher N: Immunologic influence of amniotic fluid. Lancet l980; l:54l. 19. Gleicher N, Jaffin H: Eisenmenger’s syndrome and pregnancy. N Engl J Med l980;

302:75l-752. 20. Milano C, Gleicher N: The termination of septic abortion with vaginal E2 prostaglandin

suppositories. Prostaglandins l980; l9:455-456. 21. Gleicher N, Theofilopoulos A: Immune complexes (ICs) and pregnancy: Pregnancy as an

IC-state or IC-disease and the influence of IC-diseases upon pregnancy. Diagnost Gynecol Obstet l980; 2:7-3l.

22. Gleicher N, Milano C, Rubenstein A, et al.: Phakomatoses in reproductive medicine. Mount Sinai J Med l980; 47:3ll-3l6.

23. Gleicher N, Runowicz C, Brown B: Sinusoidal fetal heart rate in association with intrapartum amnionitis. Obstet Gynecol l980; 56:l09-ll2.

24. Bradley B, Gleicher N: Grand multiparity in association with unilateral renal, ovarian and Mullerian agenesis. Mount Sinai J Med l980; 47:4l8-42l.

25. Gleicher N, Chin J, Brown B, et al.: Intrauterine meconium aspiration syndrome. Diagnost Gynecol Obstet l980; 2:l5l-l55.

26. Kerenyi T, Gleicher N, Meller J, et al.: Transplacental cardioversion of intrauterine supraventricular tachycardia with digitalis. Lancet l980; 2:393-395.

27. Milano C, Gleicher N: A gynecologic presentation of mixed phakomatosis. Diagnost Gynecol Obstet l980; 2:ll7-l26.

28. Gleicher N, Siegel I: The immunologic concept of EPH-gestosis. Mount Sinai J Med l980; 47:442-453.

29. Gleicher N, Siegel I, Francus K: Common denominators of pregnancy and malignancy. Mount Sinai J Med l980; 47:5ll-520.

30. Siegel I, Gleicher N: The development of the fetal immune system. Mount Sinai J Med l980; 47:474-480.

31. Chitkara U, Gleicher N, Kerenyi T, Gergely R, Longi R: Persistent supraventricular tachycardia in utero. Diagnost Gynecol Obstet l980; 2:29l-298.

32. Brown B, Gleicher N: Intrauterine meconium aspiration. Obstet Gynecol l98l; 57:26-29. 33. Siegel I, Gleicher N: Fetal and maternal red cell immune adherence (RCIA) receptors.

Am J Reprod Immunol l98l; l:88-9l. 34. Theofilopoulos A, Gleicher N, Pereira A, Dixon F: The biology of immune complexes

and their possible role in pregnancy. Am J Reprod Immunol l98l; l:92-l05. 35. Tuttleman R, Gleicher N: Central nervous system hemorrhage complicating pregnancy.

Obstet Gynecol l98l; 58:65l-657. 36. Runowicz C, Phillips R, Gleicher N, Beers P: Fluorescence polarization: Comments on

urine contamination. Am J Obstet Gynecol l98l; l39:6l3-6l4. 37. Gleicher N, Meller J, Sandler R, Sullum S: Wolff-Parkinson-White syndrome in

pregnancy. Obstet Gynecol 1981; 58:748-752. 38. Siegel I, Gleicher N: Peripheral white cell alterations in pregnancy. Diagnost Gynecol

Obstet l98l; 3:l23-l26. 39. Siegel I, Gleicher N: Toxic shock syndrome and human platelets. Lancet l98l; i:493. 40. Siegel I, Gleicher N: Red cell immune adherence (RCIA): Its application in cancer and

autoimmune disease. Immunol Commun 1981; 10:443-449. 41. Siegel I, Gleicher N: Phagocytosis: A means for autologous macrophage-lymphocyte

interactions. JAMA l98l; 246:ll27. 42. Siegel I, Liu TL, Gleicher N: The red cell immune system. Lancet l98l; 2:556-559. 43. Epstein H, Waxman A, Gleicher N, Lauersen N: Meperidine induced sinusoidal fetal

heart rate and reversal with neloxone. Obstet Gynecol 1982; 59:22s-25s. 44. Gleicher N, Adelsberg B, Liu TL, Cederquist L, Phillips R, Siegel I: Immune complexes

in pregnancy. III. Immune complexes in immune complex associated conditions. Am J Obstet Gynecol 1982; 142:1011-1015.

45. Gleicher N, Bazile F, Elrad H: Congestive heart failure after ritodrine therapy in conjunction with EPH gestosis. N Eng J Med 1982; 306:174.

46. Gleicher N, Olaya B, Hercule J, Elrad H, Trace P, Giglia RV: The diagnosis of multiple gestation. Diagnost Gynecol Obstet 1982; 4:223-226.

47. Siegel I, Liu TL, Gleicher N: Developmental changes of the red cell immune system in the rabbit. J Clin Laboratory Immunol 1982; 10:41-46.

48. Phillips R, Thornton J, Gleicher N: Physician bias in cesarean sections. JAMA 1982; 248:1082-1084.

49. Gleicher N, Siegel I, Toder V: Decreased levels of helper T cells in pregnancy. N Engl J Med 1982; 307.

50. Gleicher N, Giglia R, Deppe G, Elrad H: The diagnosis of unruptured ectopic pregnancy by realtime ultrasonography. Obstet Gynecol 1982; 61:425-428.

51. Epstein H, Waxman A, Gleicher N, Lauersen N: Meperidine induced sinusoidal fetal heart rate and reversal with neloxone. Obstet Gynecol 1982; 59:22s-25s.

52. Toder V, Blank M, Gleicher N, Nebel L: Immunoregulatory mechanisms in pregnancy. II. Further characterization of suppressor lymphocytes induced by alpha-fetoprotein in lymphoid cell cultures. J Clin Lab Immunol 1983; 11:149-154.

53. Toder V, Blank M, Gleicher N, et al.: Natural killer activity in normal pregnancy and EPH-gestosis. Am J Obstet Gynecol 1983; 145:7-10.

54. Elkayam U, Kawaniski D, Reid C, Chandrarantna A, Gleicher N, Rahimtoola SH: Contrast echocardiography to reduce ionizing radiation associated with cardiac catheterization during pregnancy. Am J Cardiol 1983; 53:213-214.

55. Gleicher N, Siegel I: Immunology of pregnancy. Wiener Klin Wochenschrift 1983; 95:377-382.

56. Gleicher N, Friberg J, Fullan N, Giglia R, Mayden K, Keskey T, Siegel I: Egg retrieval for in vitro fertilization by sonographically controlled vaginal culdocentesis. Lancet 1983; 2:508-509.

57. Toder V, Nebel L, Gleicher N: Studies of natural killer cells in pregnancy. I. Analysis on the single cell level. J Clin Lab Immunol 1984; 14:123-127.

58. Toder V, Nebel L, Elrad H, Blank M, Gleicher N: Studies of natural killer cells in pregnancy. II. The immunoregulatory effect of pregnancy substances. J Clin Lab Immunol 1984; 14:129-133.

59. Young R, Friberg J, Gleicher N, et al: Clinical experiences with in vitro fertilization - embryo transfer at Mount Sinai Hospital Medical Center of Chicago. J Vitro Fert Embryo Transfer 1984; 1:93-94.

60. Gleicher N, Deppe G, Friberg J: The practice of tubal sterilization: Review of a departmental practice pattern. Mount Sinai J Med 1984; 51:157-160.

61. Gleicher N, Dmowski W, Siegel I, Lui TL, Friberg J, Radwanska E, Toder V: Lymphocyte subsets in endometriosis. Obstet Gynecol 1984; 4:463-466.

62. Chawla R, Deppe G, Ahart S, Gleicher N: Hemorrhage following fetal scalp blood sampling. Am J Obstet Gynecol 1984; 149:92.

63. Deppe G, Hercule Y, Gleicher N: Sciatic nerve injury complicating surgical removal of retroperitoneal tumor. Acta Obstet Gynecol Scand 1984; 19:120-124.

64. Elkayam U, Gleicher N: Cardiac problems in pregnancy. 1. Maternal aspects. JAMA 1984; 251:2837-2838.

65. Gleicher N, Elkayam U: Cardiac problems in pregnancy. 2. Fetal aspects. JAMA 1984; 252:78-80.

66. Siegel I, Liu T\L, Janet P, Gleicher N: The effects of parenternal fat emulsion (Intralipid) and triglycerides on immune adherence and red cell morphology in vivo and in vitro. JAMA 1984; 251:1574-1579.

67. Toder V, Elrad H, Durdana A, Gleicher N: Proceedings of the 9th Lymphology Congress. Immunol Hematol Res Monograph 1984; 2:334-335

68. Gleicher N: Cesarean section rates in the United States: The short term failure of the National Consensus Development Conference in 1980. JAMA 1984; 252:3273-3276.

69. Siegel I, Gleicher N: T-cell subsets in patients with preeclampsia. Am J Obstet Gynecol 1984; 149:583-584.

70. Gleicher N: The fetus is a graft, both biologically and legally. Fertil Steril 1984; 42:824-825.

71. Confino E, Gleicher N, Elrad H, et al: The breech dilemma: A review. Obstet Gynecol Surv 1985; 40:330-337.

72. Gleicher N, Vermesh M, Rotmensch S, et al: Cesarean section patterns: Influence of a Perinatology Service. Mt Sinai J Med 1985; 52:100-105.

73. Friberg J, Gleicher N: High dose human menopausal gonadotropin therapy for successful ovulation induction for IVF program in perimenopausal women. Proceedings of the NY Acad Science 1985; 442:168-179.

74. Confino E, Ismajovich B, David M, Gleicher N: Fetal heart rate in maternal hypoglycemic coma. Int J Gynaecol Obstet 1985; 23:59-60.

75. Toder V, Durdana A, Elrad H, Gleicher N: Natural killing (NK) potential of cord blood lymphocytes. J Clin Lab Immunol 1985; 17:29-32.

76. Deppe G, Malviya VK, Hercule J, Gleicher N: Retroperitoneal pelvic lipoma. J Natl Med Assoc 1985; 78:574-576.

77. Elrad H, Mayden K, Erhart S, Giglia R, Gleicher N: Prenatal ultrasound diagnosis of choledochal cyst. A case report. J Ultrasound Med 1985; 4:553-555.

78. Confino E, Friberg J, Giglia R, Gleicher N: Sonographic imaging of intrauterine adhesions. Obstet Gynecol 1985; 66:596-598.

79. Gleicher N, Friberg J: IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. JAMA 1985; 253:3278-3281.

80. Friberg J, Suarez M, Gleicher N, Confino E: Chlamydia on Spermatozoa. J Infect Diseases 1985; 152:854.

81. Friberg J, Gleicher N: High-dose human menopausal gonadotropin therapy for successful ovulation induction for in vitro fertilization in perimenopausal women. In in vitro Fertilization and Embryo Transfer, Seppala M, Edwards RG, Eds: Annals NY Acad Sci 1985; 442:168-177.

82. Keskey T, Suarez M, Gleicher N, Friberg J, Levy HB: Chlamydia trachomatis infections in infants. Mt Sinai J Med 1986; 53:77-79.

83. Confino E, Gleicher N, Keskey I, et al: Comparison between 14” and 16” gauge needles for aspiration of human oocytes. Mt Sinai J Med 1986; 53:250-253.

84. Zbella E, Deppe G, Gleicher N: Outpatient versus inpatient cone biopsy of the cervix. Mt Sinai J Med 1986; 53:80-81.

85. Confino E, Mayden K, Giglia R, Vermesh M, Gleicher N: Pitfalls in sonographic imaging of the incompetent uterine cervix. Acta Obstet Gynecol Scand 1986; 65:593-597.

86. Vermesh M, Mayden K, Confino E, Giglia R, Gleicher N: Prenatal sonographic diagnosis of Hirschsprung’s Disease. J Ultrasound Med 1986; 5:37-39.

87. Friberg J, Suarez M, Confino E, Deppe E, Gleicher N: Mezlocillin in the treatment of acute salpingitis. Mt Sinai J Med 1986; 53:510-513.

88. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: Inhibition of sperm motility and agglutination of sperm cells by free fatty acids in whole semen. Fertil Steril 1986; 45:273-279.

89. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine inseminations with washed human spermatozoa. Fertil Steril 1986; 46:55-60.

90. Gleicher N, Boler L, Norusis M, Del Granado A: Hypertensive diseases of pregnancy and parity. Am J Obstet Gynecol 1986; 154:1044-1049.

91. Mayden K, Confino E, Miller C, Friberg J, Gleicher N: Decreased gestational sac volumes in pregnancies induced by human menopausal gonadotropin. Fertil Steril 1986; 45:879-882.

92. Deppe G, Zbella E, Wall D, Smith P, Gleicher N: Significance of the class II pap smear in a high-risk population. Colposcopy Gynecol Las Surg 1986; 2:5-8.

93. Confino E, Demir R, Friberg J, Gleicher N: The predictive valve hCG B subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: An international collaborative study. Fertil Steril 1986; 45:526-531.

94. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo loss in in vitro fertilization? Fertil Steril 1986; 46:897-902.

95. Zbella E, Vermesh M, Gleicher N: Contraceptive practices of female physicians. Contraception 1986; 33:423-436.

96. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT). Fertil Steril 1986; 46:963-966.

97. Confino E, Friberg J, Gleicher N: A new stirrable catheter for gamete intrafallopian tube transfer (GIFT). Fertil Steril 1986; 46:1147-1149.

98. Gleicher N: Pregnancy and autoimmunity. Acta Haematologica Scand 1986; 76:68-77. 99. Confino E, Vermesh M, Thomas Jr. W, Gleicher N: Non-vascular transplantation of the

rabbit uterus. Int J Gynaecol Obstet 1986; 24:321-325. 100. Frank J, Confino E, Friberg J, Dudkiewicz A, Gleicher N: The effect of

ejaculation frequency on sperm quality. Arch Androl 1986; 16:203-207. 101. Confino E, Friberg J, Vermesh M, Madanes A, Suarez M, Gleicher N: Mezlocillin

versus Doxycyline in the treatment of acute salpingitis. Mt Sinai J Med 1986; 53:510-513. 102. Boler L, Zbella E, Gleicher N: Quantitation of proteinuria in pregnancy by the use

of single voided urine sample. Obstet Gynecol 1987; 70:99-100. 103. Keskey T, Suarez M, Gleicher N, Friberg J, Levy H: Chlamydia trachomatis

infection in sexually abused children. Mt Sinai J Med 1987; 54:129-134. 104. Friberg J, Confino E, Suarez M, Gleicher N: Chlamydia trachomatis attached to

spermatozoa recovered from the peritoneal cavity of patients with salpingitis. J Reprod Med 1987; 32:120-122.

105. Vermesh M, Confino E, Boler L, Friberg J, Gleicher N: Acute salpingitis in sterilized women. Obstet Gynecol 1987; 69:265-267.

106. Myers S, Gleicher N: Breech delivery: Why the dilemma? Am J Obstet Gynecol 1987; 156:6-10.

107. Confino E, Zbella E, Gleicher N: Abscess formation post cesarean section due to a piece of latex glove. Int J Gynaecol Obstet 1987; 25:155-157.

108. Siegel I, Liu TL, Yaghoubzadeh E, Keskey T, Gleicher N: Cytotoxic effects of free fatty acids upon ascites tumor cells. J Natl Cancer Institute 1987; 78:271-277.

109. Giorlandino C, Gleicher N, Nanni C, Vizzone A, Gentili P, Taramanni C: The sonographic picture of endometrium in spontaneous and induced cycles. Fertil Steril 1987; 47:508-511.

110. Confino E, Friberg J, Silverman S, Dudkiewicz A, Goldin M, Gleicher N: Penetration of bacteriae and spermatozoa into bovine cervical mucus. Obstet Gynecol 1987; 70:134-136.

111. El-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A: Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987; 70:163-170.

112. El-Roeiy A, Shoenfeld Y, Gleicher N, Isenberg D, Kennedy R: A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. Clin Exp Immunol 1987; 68:528-534.

113. Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease? Obstet Gynecol 1987; 70:115-122.

114. Holmquist-West A, El-Roeiy A, Gleicher N: An unexplained peak of pregnancy associated thrombocytopenia. Mt Sinai J Med 1987; 54:481-486.

115. Suarez M, Friberg J, Gleicher N: The incidence of chlamydia trachomatis in peripartial fallopian tubes. J Reprod Med 1988; 33:199-201.

116. Confino E, Friberg J, Vermesh M, Thomas W, Gleicher N: Effects of progesterone on postoperative adhesion formation in hysterectomized rabbits. Int J Fert 1988; 33:139-142.

117. El-Roeiy A, Valessini G, Friberg J, Shoenfeld Y, Kennedy R, Tincani A, Balestrieri G, Gleicher N: Autoantibodies and common idiotypes in sperm antibody positive females and males. Am J Obstet Gynecol 1988; 158:596-603.

118. Gleicher N, El-Roeiy A: The reproductive autoimmune failure syndrome (RAFS). Am J Obstet Gynecol 1988; 159:223-227.

119. Confino E, Friberg J, Gleicher N: Spontaneous recanalization of bilateral tubal occlusion following a pregnancy achieved by in vitro fertilization. Fertil Steril 1988; 49:723-725.

120. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon tuboplasty (TBT). Am J Obstet Gynecol 1988; 159:370-375.

121. Friberg J, Confino E, Gleicher N: Erythema multiforme in an IVF pregnancy. J Reprod Med 1988; 33:230-231.

122. El-Roeiy A, Gleicher N: Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1988; 72:596-602.

123. Confino E, Friberg J, Gleicher N: Improved penetration of spermatoza into uterine fluids of women with abnormal postcoital tests. Obstet Gynecol 1988; 72:655-658.

124. Myers S, Gleicher N: A successful program to lower cesarean section rates. N Engl J Med 1988; 319:1511-1516.

125. El-Roeiy A, Dmowski P, Gleicher N, Radwanska E, Harlow L, Binor Z, Tummon I, Rawlins R: Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 1988; 50:864-871.

126. Suarez M, Friberg J, Gleicher N: The incidence of chlamydia trachomatis in peripartial fallopian tubes. J Reprod Med 1988; 33:199-201.

127. Toder V, Madanes A, Gleicher N: Immunologic aspects of IUD action. Contraception 1988; 37:391-403.

128. Confino E, Friberg J, Vermesh M, Madanes A, Suarez M, Gleicher N: Mezlocillin versus Doxycycline in the Treatment of Acute Salpingitis. Mt Sinai J Med 1988; 55:154-157.

129. Siegel I, Liu TL, Nepomuceno N, Gleicher N: Effects of short-term dietary restriction on survival of mammary ascites tumor-bearing rats. Cancer Invest 1988; 6:677-680.

130. Confino E, Gleicher N, Friberg J: Thromboelastogram and circulating lupus anticoagulant. J Reprod Med 1989; 34:289-291.

131. Gleicher N: Breast disease programs in obstetrics and gynecology: A plea for training in mammography. Am J Obstet Gynecol 1989; 161:267-270.

132. Demir R, Gleicher N, Myers S: Atraumatic antepartum subdural hematoma causing fetal death. Am J Obstet Gynecol 1989; 160:619-620.

133. Novas J, Myers S, Gleicher N: Obstetric outcome of patients with more than one previous cesarean section. Am J Obstet Gynecol 1989; 160:364-367.

134. Confino E, Gleicher N: Conservative surgical management of interstitial pregnancy. Fertil Steril 1989; 52:600-603.

135. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989; 160:1376-1385.

136. Tur-Kaspa I, Confino E, Friberg J, Myers S, Dudkiewicz A, Gleicher N: Ovarian stimulation protocol for in vitro fertilization with gonadotropin releasing hormone agonist widens the implantation window. Fertil Steril 1990; 53:859-864.

137. Confino E, Harlow L, Gleicher N: Peritoneal fluid and serum autoantibody levels in patients with endometriosis. Fertil Steril 1990; 53:242-245.

138. El-Roeiy A, Myers S, Gleicher N: The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol 1990; 75:390-396.

139. Gleicher N, Harlow L: Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations. Mt Sinai J Med 1990; 57:242-248.

140. Tur-Kaspa I, Dudkiewicz A, Confino E, Gleicher N: Pooled sequential ejaculates: A way to increase total number of motile sperm from oligozoospermic men. Fertil Steril 1990; 54:906-909.

141. Menchaca A, Akhiyat M, Gleicher N, Gottlieb L, Bernstein J: The rectus abdominis muscle flap in a combined abdominovaginal repair of difficult vesicovaginal fistulae. A report of three cases. J Reprod Med 1990; 35:565-568.

142. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G, Katz E, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A multicenter study. JAMA 1990; 264:2079-2082.

143. El-Roeiy A, Myers S, Gleicher N: The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1991; 164:1253-1261.

144. Myers S, Gleicher N: The Mount Sinai cesarean section reduction program: Automated data collection and peer review. Qual Let 1991; 3:10-17.

145. Gleicher N: Caring for the uninsured and underinsured: Expansion of health care to uninsured and underinsured has to be cost-neutral. JAMA 1991; 265:2388-2390.

146. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and autoantibodies. Mt Sinai J Med 1992; 59:32-37.

147. Gleicher N, Parrilli M, Pratt D: Hysterosalpingography and selective salpingography in the differential diagnosis of chemical intrauterine versus tubal pregnancy. Fertil Steril 1992; 57:553-558.

148. Gleicher N, Harlow L, Zilberstein M: The regulatory effect of antiphospholipid antibodies (APA) on signal transduction: A possible model for autoantibody induced reproductive failure. Am J Obstet Gynecol; 1992; 167:637-42.

149. Gleicher N: Autoantibodies in normal and abnormal pregnancy. Am J Reprod Immunol 1992; 28:269-273.

150. Gleicher N: Endometriosis: A new approach is needed. Hum Reprod 1992; 7:821-824.

151. Confino E, Tur-Kaspa I, Gleicher N: Sonographic transcervical balloon tuboplasty. Hum Reprod 1992; 7:1271-1274.

152. Gleicher N, Thurmond A, Burry K, Coulam C: Gynecoradiology: A new approach to diagnosis and treatment of tubal disease. Fertil Steril 1992; 58:885-887.

153. Gleicher N, Parrilli M, Redding L, Pratt D, Karande V: Standardization of hysterosalpingography and selective salpingography: A valuable adjunct to simple opacification studies. Fertil Steril 1992; 58:1136-41.

154. Ober C., Karrison T, Harlowe L, Elias S, Gleicher N: Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 1993; 169:143-147.

155. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N: Antithyroid antibodies and the association with nonorganspecific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993; 837-841.

156. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson E, Tur-Kaspa I, Vermesh M: The multicenter transcervical tuboplasty (TBT) Study: Conclusions and comparison to alternative technologies. Hum Reprod 1993; 8:1264-1271.

157. Gleicher N, Pratt D: Abnormal (auto)immunity and endometriosis. Int J Gynecol Obstet 1993; 40:S21-S27.

158. Pratt D, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N: The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 1993; 60:1001-1005.

159. Gleicher N, Pratt D, Dudkiewicz A: What do we really know about Autoantibody abnormalities and reproductive failure: A critical review. Autoimmunity 1993; 16:115-140.

160. Gleicher N, Karande V, Rabin D, Pratt D: Laparoscopic removal of twin cornual pregnancy after In Vitro Fertilization. Fertil Steril 1994; 1161-1162.

161. Gleicher N, Pratt D, Karande V, Rabin D, Dudkiewicz A: Pregnancy after intrauterine insemination with sperm retrieved from the rectum. Fertil Steril 1994; 61:554-555.

162. Gleicher N, Redding L, Parrilli M, Karande V, Pratt D: Wire guide cannulation alone is no treatment of proximal tubal occlusion. Hum Reprod 1994; 9:1109-1111.

163. Gleicher N, Liu HC, Dudkiewicz A, Rosenwaks A, Kaberlein G, Pratt D, Karande V: Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994; 170:1145-1149.

164. Gleicher N: Autoantibodies and pregnancy loss: Lancet 1994; 343: 747-748. 165. Gleicher N: The role of humoral immunity in endometriosis. Acta Obstet Gynecol

Scand 1994: 159:15-17.

166. Aoki K, Matsuura E, Sasa H, Yagami Y, Dudkiewicz A, Gleicher N: 2-Glycoprotein I-dependent and -independent anticardiolipin antibodies in healthy pregnant women. Hum Reprod 1994; 9:1849-1851.

167. Cusick W, Gleicher N: Multiple conceptions, implantation, and prematurity: Assisted Reproduction Reviews 1995; 5:4: 246-250.

168. Aoki K, Dudkiewicz A, Matsuura E, Novotny M, Kaberlein G, Gleicher N: Clinical significance of Glycoprotein I - dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody detection systems. Am J Obstet & Gynecol 1995; 172:926-931.

169. Gleicher N, Karande V, Rabin D, Dudkiewicz A, Pratt D: The bubble test: A new tool to improve the diagnosis of endometriosis. Hum Reprod 1995; 10:923-926.

170. Karande V, Pratt D, Rabin D, Gleicher N: The limited value of hysterosalpingography in assessing tubal status and fertility potential. Fertil Steril 1995; 63:1167-1171.

171. Karande V, Pratt D, Rao R, Balin M, Gleicher N: Elevated tubal perfusion pressures during selective salpingography are highly suggestive of tubal endometriosis. Fertil Steril 1995; 64:1070-1073.

172. Gleicher N, Campbell D. Chan C, Karande V, Rao R, Balin M. Pratt D: The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod 1995; 10:1079-1084.

173. Gleicher N, Pratt D, Levrant S, Rao R, Balin M, Karande V: Gynecoradiologic uterine resection (GUR). Hum Reprod 1995; 10:1801-1803.

174. Aoki K, Kajiiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer cell activity as predictor of miscarriage. Lancet 1995; 345:1340-1342.

175. Gleicher N: Immune dysfunction - a potential target for treatment in endometriosis. British J Obstet Gynaecol 1995; 102 (Supplement): 4-7.

176. Karande V, Rao R, Pratt D, Balin M, Levrant S, Morris R, Dudkiewicz A, Gleicher N: A randomized prospective comparison between intrauterine insemination and fallopian sperm perfusion for the treatment of infertility. Fertil Steril 1995; 64:638-640.

177. Mathur S, Butler W, Chihal J, Isaacson K, Gleicher N: Target antigen(s) in endometrial autoimmunity of endometriosis. Autoimmunity 1995; 20:211-222.

178. Gleicher N, VanderLaan B, Pratt D, Karande V: Background pregnancy rates in an infertile population. Hum Reprod 1996; 11:1011-1012.

179. Gleicher N, Karande V: The diagnosis of proximal tubal disease. Hum Reprod 1996; 11:1825-1828.

180. Gleicher N, VanderLaan B, Karande V, Morris R, Nadherney K, Pratt D: Patient drop-out rates during infertility therapy are considerable and vary with coverage. Obstet Gynecol 1996; 88:289-293.

181. Karande V, Pratt D, Gleicher N: The Assessment of Tubal Functional Status by Tubal Perfussion Pressure Measurements. Hum Reprod 1996; 2:429-433.

182. Gleicher N: Antiphospholipid antibodies and reproductive failure: What they do and what they don’t; how to, and how not to treat. Hum Reprod 1997; 12:13-15.

183. Gleicher N, Karande V, Balin M, Levrant S, Morris R, Pratt D.: What is radiation exposure to patients during a gynecoradiologic procedure? Fertil Steril 1997; 2:401-403.

184. Karande V, Levrant S, Hoxsey R., Rinehart J, Gleicher N.: Lysis of intrauterine adhesions using gynecoradiologic techniques. Fertil Steril 1997; 4:658-662.

185. Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N: Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 1997; 67:900-903.

186. Gleicher N, Coulam C: DEBATE - Ovarian Infertility -Are we overlooking (auto) immune ovarian infertility? Hum Reprod 1997; 12:637-639.

187. Gleicher N: Autoantibodies in infertility: current opinion. Hum Reprod 1998; 2:169-176.

188. VanderLaan B, Karande V, Krohm C, Morris R, Pratt D, Gleicher N: Cost considerations with infertility treatment therapy: outcome and cost comparison between HMO and PPO care based on physician and facility cost. Hum Reprod 1998; 5:1200-1205.

189. Gleicher N: Strategies to improve insurance coverage for infertility services. Fertil Steril 1998; 70:1006-1008.

190. Karande V, Korn A, Morris R, Rao R, Balin M, Rinehart J, Dohn K, Gleicher N: Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril 1999; 71: 468-475.

191. Morris S, Karande V, Dudkiewicz A, Morris J, Gleicher N: Octreotide is not useful for chlomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome. Fertil Steril 1999, 71:452-456.

192. Karande V, Morris R, Chapman C, Rinehart J, Gleicher N: Impact of the “physician factor” on pregnancy rates in a large assisted reproductive technology program: do too many cooks spoil the broth? Fertil Steril 1999, 71:1001-1009.

193. Gleicher N: Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology 1999; 38:485-487.

194. Karande V, Gleicher, N: .OPINION – A Rational Approach to the Management of Low Responders in In-Vitro Fertilization. Hum Reprod 1999; 14:1744-1748.

195. Coulam C, Branch D, Clark D, Gleicher N, Kutteh W, Lockshin M, Rote N: Report of the committee for establishing criteria for diagnosis of reproductive autoimmune system, American Journal of Reproductive Immunology 1999; 41:121-132.

196. Gleicher N: Cost effective infertility care. Hum Reprod Update 2000; 6:190-199. 197. Gleicher, N: The Consumer and Provider: Pillars of the New Health Care System.

The Physician Executive 2000; 26:38-43. 198. Gleicher N, Brown T, Dudkiewicz A, Karande V, Rao R, Balin M, Campbell D,

Pratt D: Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles—but only in younger women. Early Pregnancy 2000; 1:64-73.

199. Gleicher N, Oleske D, Tur-Kaspa I, Vidali A, Karande V: Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N.Engl J Med 2000; 343:2-7.

200. Gleicher, N, Karande, V: Generic Human Menopausal Gonadotropin (hMG) in Place of More Costly Follicle-Stimulating Hormone (FSH) for Routine Ovulation Induction. J Assist Reprod Genetics. 2000; 17:489-495.

201. Gleicher N, Vidali A, Karande V: The immunological ‘wars of roses’: Disagreements amongst reproductive immunologists. Hum Reprod 2002; 17:539-542.

202. Gleicher N, Karande V: Gender selection for nonmedical indications. Fertil Steril 2002; 78:460-462.

203. Gleicher N: Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses. Am J. Reprod Immunol 2002; 48(4):252-40

204. Gleicher N: Modern obstetrical and infertility care may increase the prevalence of disease: An evolutionary concept. Fertil Steril 2003; 79:249-252.

205. Rechitsky S, Verlinsky O, Kuliev, A, Orzen, S, Lazluk, K, Beck, R, Gleicher, N, Verlinsky, Y. Preimplantation: Genetic Diagnosis for Early-Onset Torsion Dystonia. RBM Online 2003; 8:224-228.

206. Gleicher N, Vietzke M, Vidali A: Bye-bye urinary gonadotrophins? Hum Reprod 2003; 18:476-482.

207. Gleicher, N: Safety Issues in Assisted Reproduction technology: A rebuttal, Hum Reprod 2003: 18:1765-66.

208. Gleicher N, Tang Y: Blastomere transplantation in human embryos may be a treatment for single gene diseases. Fertil Steril 2004; 81: 977-981.

209. Gleicher N: Is It Time to Limit IVF Transfers to One Embryo? Contemp OB/GYN 2004; 8:73-85.

210. Gleicher N: Ovarian Aging: Is There a Norm? Contemp OB/GYN 2005; 65-75. 211. Barad D, Gleicher N: Increased Oocyte Production After Treatment with

Dehydroepiandrosterone, Fertil Steril 2005; 84: 756.e1-756.e3. 212. Gleicher N, Barad D: Unexplained Infertity: Does it Really Exist? Hum Reprod

2006; 21:1951-5. 213. Gleicher N, Barad D: An Evolutionary Concept of Polycystic Ovarian Disease:

Does Evolution Favor Reproductive Success Over Survival? RBMOnline 2006; 12: 587-589.

214. Gleicher N, Weghofer A, Barad D: A Formal Comparision of the Practice of Assisted Reproductive Technologies Between Europe and the USA. Hum Reprod 2006; 21: 1945-50.

215. Gleicher N, Barad D: The Relative Myth of Elective Single Embryo Transfer. Hum Reprod 2006; 21: 1337-1344.

216. Barad D, Gleicher N: Effects of Dehydroepiandrosterone (DHEA) on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006; 21: 2845-9.

217. Gleicher N, Barad D: “Ovarian Age-Based” Stimulation of Young Women with Diminished Ovarian Reserve (DOR) Results In Excellent Pregnancy Rates with IVF. Fertil Steril 2006; 86: 1621-1625.

218. Gleicher N, Weiner R, Vietzke M: The Impact of Abnormal Autoimmune Function on Reproduction: Maternal and Fetal Consequences. J Autoimmunity 2006; 27:161-65.

219. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantitative and qualitative impact of gonadotropin stimulation on human preimplantation embryos. Fertil Steril 2006; 86 (sup.2):S58 (O-137).

220. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006; 86 (sup.2):S124-5 (O-289).

221. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished ovarian reserve (DOR), resistance to stimulation and diagnosis of premature ovarian aging (POA), based on age-specific baseline. Fertil Steril 2006; 86: (sup.2):S125-6 (O-291).

222. Gleicher N, Weghofer A, Barad D: Adrenqal function in women with premature aging ovaries. Fertil Steril 2006; 86 (sup.2) (O-137). Fertil Steril 2006; 86 (sup.2): S401 (P-722).

223. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at increased risk for chromosomally abnormal embryos? The association between embryonic aneuploidy rates and POA. Fertil Steril 2006; 86: S403-4.

224. Gleicher N, Barad D: Gender as risk factor for autoimmune diseases. J Autoimmunity 2007; 26:1-6.

225. Gleicher N: Why much of the pathophysiology of preeclampsia-eclampsia has to be autoimmune in nature. Am J Obstet Gynecol 2007; 196: 5.e1-5.e7.

226. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 86: S462.

227. Weghofer A, Barad D, Li J, Gleicher N: Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 2007; 88: 90-4.

228. Weghofer A, Schnepf S, Barad D, Gleicher N: The impact of luteinizing hormone in assisted reproduction: a review. Curr Opin Obstet Gynecology 2007; 19:253-257.

229. Gleicher N: Pregnancy-related cell traffic, microchimerism and autoimmunity: the possibility of reducing autoimmune disease prevalence. Expert Rev Obstet, Gynecol 2007; 2: 341-5.

230. Barad D, Weghofer A, Gleicher N: Age-Specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007; 109: 1404-1410.

231. Gleicher N, Barad D: The choice of gender: is elective gender selection, indeed, sexist? Hum Reprod 2007; 11: 3038-41.

232. Gleicher N, Weghofer A, Barad D: Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data. Fertil Steril 2007; 87: 1301-1305.

233. Gleicher N, Weghofer A, Barad D: Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated-part I. Expert Rev Obstet Gynecol 2007; 2: 453-64.

234. Gleicher N, Weghofer A, Barad D: Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated-part II. Expert Rev Obstet Gynecol 2007; 2: 465-75.

235. Gleicher N: Postpartum depression, an autoimmune disease? Autoimmune Rev 2007; 6:572-6.

236. Gleicher N, Barad D, Weghofer A: Functional autoantibodies, a new paradigm in autoimmunity? Autoimmune Rev 2007; 7: 42-5.

237. Gleicher N, Weghofer A, Li J-M, Barad D: Differences in ovarian function parameters between Chinese and Caucasian oocyte donors: do they offer an explanation for lower IVF pregnancy rates in Chinese women? Hum Reprod 2007; 22: 2879-82.

238. Gleicher N: Twins in art a desireable outcome: the ‘pro’ position. International Proceedings of the 14th World Congress, Montreal, Canada 2007; 277-282.

239. Weghofer A, Munne S, Brannath W, Chen S, Tomkin G, Cekleniak N, Garrisi M, Barad D, Cohen J, Gleicher N: The impact of LH-containing gonadotropins on euploidy rates in preimplantation embryos-I. long protocol stimulation. Hum Reprod 2008;23(3):499-503.

240. Gleicher N, Weghofer A, Barad D: Too old for IVF: are we discriminating against older women? J Assist Reprod Genet 2007; 24: 639-44.

241. Barad D, Brill H, Gleicher N: Update on the use of dehydroepiandrosterone supplementation and pregnancy rates among women with diminished ovarian function. J Assist Reprod Genet 2007; 24: 629-634.

242. Gleicher N: Graft-versus-host disease and immunologic rejection: implications for diagnosis and treatments of pregnancy complications. Expert Rev Obstet Gynecol 2008;3(1): 37-49.

243. Gleicher N: Missed immunological opportunities in pregnancy. Expert Rev. Clin. Immunol. 2008; 4: 1-3.

244. Gleicher N, Weghofer A, Barad D: Preimplantation Genetic Screenig: established and ready for prime time? Fertil Steril 2008; 89: 780-788.

245. Gleicher N, Weghofer A, Barad D: A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on FMR1 gene to ovarian reserve parameters FSH and AMH. Fertil Steril 2009; 5: 1700-06.

246. Gleicher N, Weghofer A, Barad D: A pilot study of premature ovarian senescence: II. Different genotype and phenotype foe genetic and autoimmune etiologies. Fertil Steril 2009; 5: 1707-11.

247. Gleicher N, Barad D: Single versus twin embryo implantation: evidence, cost-effectiveness, and patient satisfaction. Gynecol & Obstet. 2008; 13: 77-83.

248. Weghofer A, Brill H, Feichtinger R, Barad D, Gleicher N: Does autoimmunity play a role in the pathophysiology of premature ovarian ageing? RBM Online. 2008; 16: 830-834.

249. Singer T, Barad D, Weghofer A, Gleicher N: Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril. 2009; 6: 2616-19. doi:10.1016/j.fertnstert.2008.03.034.

250. Gleicher N, Barad D: Twin pregnancy, contrary to consensus, is a desirable outcome in infertility. Fertil Steril. 2009; 6: 2426-31. doi:10.1016/j.fertnstert.2008.02.160.

251. Gleicher N, Oktay K, Barad D: Patients are entitled to maximal IVF pregnancy rates. RBM Online. 2009; 5: 599-602.

252. Gleicher N, Weghofer A, Barad D: Age-specific ovarian function testing: a concept whose time has come. Expert Rev Obstet Gynecol 2008;3:595-600.

253. Gleicher N, Barad D: Arguments against elective single-embryo transfer. Expert Rev Obstet Gynecol. 2008; 3: 481-486.

254. Weghofer A, Munne S, BrannathW, Chen S, Barad D, Cohen J, and Gleicher N: The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: antagonist cycles. Fertil Steril. 2009;92(3):937-42.

255. Gleicher N, Weghofer A, Oktay K, Barad D: Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause. 2009;16(4):760-4.

256. Gleicher N, Weghofer A, Oktay K, Barad D: Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation? Reprod Sci. 2009; 5: 462-7.

257. Weghofer A and Gleicher N: Ovarian function: a theory of relativity. Hum Reprod. 2009; 24: 17-19.

258. Gleicher N, Weghofer A and Barad D. Age-specific ovarian function. Expert Rev Obstet Gynecol. 2008; 3(5): 595-600.

259. Gleicher N and Elkayam Uri. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev (2008), doi: 10.1016/j.autrev.2008.12.003.

260. Gleicher N, Weghofer A, Oktay K, Barad D: Relevance of low triple CGG repeats on the FMR1 gene to ovarian reserve: Is there a normal range? RBMOnline. 2008;19(3):385-90.

261. Barad D, Weghofer A, Gleicher N: Comparing anti-Mullerian hormone (AMH) and follicle-stimulationg hormone (FSH) as predictors of ovarian function. Fertil Steril 2009;91(supl 4):1553-5.

262. Gleicher N. Should a woman undergoing IVF be allowed to select the baby’s gender? Controversies in Obstetrics and Gynecology. 2009, 64(8):46-48.

263. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test? Acta Obstetrica et Gynecologica Scandinavica. 2009;88(9):1024-30.

264. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. RBMOnline 2009:3:385-390.

265. Weghofer A and Gleicher N: Ovarian function: a theory of relativity. Hum Reprod 2009;24:17-9.

266. Gleicher N et al.: Patients are entitled to maximal IVF pregnancy rates. Reprod Biomed Online 2009;18:599-602.

267. Gleicher N et al.: Can the FMR1 (fragil X) gene serve as predictor of response to ovarian stimulation? Reprod Sci 2009;16:462-7.

268. Gleicher N et al.: Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod 2009;24:2395-400.

269. Gleicher N et al.: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrionol 2009:7;108.

270. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P and Gleicher N: Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective study. Reprod Biol Endocrionol 2009;7:136.

271. Weghofer A, Klein K, Stammler-Safar M, Barad DH, Worda C, Husslein P and Gleicher N. Severity of prematurity risk in spontaneous and in vitro fertilization twins: does conception mode serve as a risk factor? Fertil Steril 2009:92(6):2116-2118.

272. Gleicher N. Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases. Clinical Rev Allerg Immunol 2010;39(3):194-206.

273. Gleicher N, Barad D. “Patient-friendly” IVF. Expert Rev Obstet Gynecol 2010:5(1);1-4.

274. Gleicher N, Barad D. Can the FMR1 gene predict early ovarian aging? Women’s Health 2010;6(2):165-9.

275. Barad DH, Weghofer A, Goyal A, Gleicher N. Utility of age-specific serum anti-Mullerian hormone concentrations. RBMOnline 2011;22:284-91.

276. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian aging. RBMOnline 2010;20(6):768-775.

277. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P, Gleicher N. The impact of fetal gender on prematurity in dichorial twin gestations after in vitro fertilization. Reprod Bio Endocrin 2010, 8:57.

278. Gleicher N, Barad DH. Further comments on the Suleman case. Expert Rev Obstet Gynecol 2010;5(5):501-2.

279. Gleicher N, Barad DH. Misplaced obsession with prospectively randomized studies. RBMOnline 2010;21(4):440-443.

280. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrionol 2010; 8:64.

281. Gleicher N, Weghofer A, Barad DH. Can egg donor selection be improved? A pilot study. Reprod Biol Endocrinol 2010;8:76.

282. Klein K, Worda C, Stammler-Safar M, Husslein P, Gleicher N, Weghofer A. Does fetal sex influence the risk of preterm delivery in dichorionic twin pregnancies after spontaneous conception? Twin Res Hum Genet. 2010 Oct;13(5):495-500. doi: 10.1375/twin.13.5.495.

283. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. RBMOnline 2010;20:485-491.

284. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. RBMOnline 2010;21:360-365.

285. Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstetrical and Gynecological Survey 2010;65(8):523-30.

286. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010; 8:140.

287. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One 2010 Dec 16;5(12):e15303.

288. Gleicher N. Conflicts of interest in submission and peer review: no less important than author/investigator conflicts. Expert Rev Obstet Gynecol 2011. In Press.

289. Gleicher N, Weghofer A, Barad DH. Do chromosomally abnormal pregnancies really preclude autoimmune etiologies of spontaneous miscarriages? Autoimmun Rev 2011; 10(6):361-3.

290. Gleicher N, Weghofer A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril 2011;95(6):2123.e-13-7.

291. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 2011;9:23.

292. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 Genotypes with In Vitro Fertilization (IVF) Outcomes Based on Ethnicity/Race. PLoS One 2011;6(4):e18781.

293. Gleicher N, Barad DH. Gestational dermatosis shortly after implantation associated with parental class II HLA compatibility and maternal immune activation: preliminary report of a prospective case series. Dermatology 2011. DOI: 10.1159/000327377.

294. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67.

295. Gleicher N, Weghofer A, Barad DH. Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmunity 2012, 38(2-3):J74-80..

296. Weghofer A, Dietrich W, Ortner I, Bieglmayer C, Barad DH and Gleicher N. Anti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery. Reprod Biol Endocrionol 2011; 9(1):98.

297. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9(1):116.

298. Gleicher N, Kim A, Weghofer A, Barad DH. Towards a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo), hormone ratios per retrieved oocyte. J Clin Endocrinol Metab 2012; 97(3):995-1004.

299. Gleicher N, Weghofer A, Barad DH. A case-control pilot study of low intensity in vitro fertilization (LI-IVF) in good prognosis patients. Reprod Biomed Online 2012; 24(4):396-402.

300. Gleicher N. Eliminating multiple pregnancies: an appropriate target for government intervention? Reprod Biomed Online 2011;23(4):403-6.

301. Gleicher N, Weghofer A, Barad DH. Low-intensity IVF: Real progress? Reprod Biomed Online 2011;23(3):247-8.

302. Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;3(7):e33638.

303. Gleicher N, Weghofer A, Kim A, Barad DH. Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women. J Assist Reprod Genet 2012; 29(6):529-532.

304. Gleicher N and Barad DH. “Hype” or “hope”: Ethical and practical considerations in association with clinical research in women with diminished ovarian reserve. Reprod Biomed Online 2012; 25(2):98-102.

305. Gleicher N, Kim A, Weghofer A, Barad DH. Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol 2012;10:48.

306. Weghofer A, Tea M-K, Barad DH, Kim A, Singer CF, Wagner K, Gleicher N. BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGGn<26) FMR1 sub-genotypes: Explanation for the “BRCA paradox”? PLoS ONE 2012;7(4):e44753.

307. Weghofer A, Kim A, Barad DH, Gleicher N. Follicle stimulating hormone and anti-Mullerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study. PLoS ONE 2012;7(4):e34290.

308. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod 2012; 27(11):3287-93.

309. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol 2012;10:77.

310. Gleicher N, Barad DH. A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) into routine IVF practice. J Assist Reprod Genet 2012; 29(11):1159-66.

311. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, Barad DH. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod 2013; 28(1):172-7.

312. Gleicher N. Irrational attraction of elective single embryo transfer (eSET). Hum Reprod 2012; 28(2):294-7.

313. Gleicher N. Why are reproductive cancers more common in nulliparous women? Reprod Biomed Online 2013; 26(5):416-9.

314. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet 2013;30(1):49-62.

315. Gleicher N. Avoiding currently unavoidable conflicts of interest in medical publishing by transparent peer review. Reprod Biomed Online 2013; 26(5):411-5.

316. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DB. Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod 2013; 28(4):1084-91.

317. Gleicher N, Kim A, Kushnir VA, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Clinical relevance of combined FSH and AMH observations in infertile women. J Clin Endocrinol Metabol 2013; 98(5):2136-2145.

318. Gleicher N, Barad DH. Mistaken advocacy against twin pregnancies following IVF. J Assist Reprod Genet 2013; 30(4):575-9.

319. Barad DH, Kim A, Kubba H, Weghofer A, Gleicher N. Do hormonal contraceptions prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study. Reprod Biol Endocrinol 2013;11:28.

320. Kushnir VA, Kim A, Gleicher N, Barad DH. A pilot trial of large versus small diameter needles for oocyte retrieval. Reprod Biol Endocrinol 2013; 11:22.

321. Gleicher N, Elkayam U. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun Rev 2013; 12(11):1039-45.

322. Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women? Reprod Biol Endocrinol 2013;11:58.

323. Kushnir VA, Vidali A, Barad DH, Gleicher N. The Status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril 2013;100(3):736-41.

324. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Kushnir VA, Weghofer A. FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Reprod Biol Endocrinol 2013;11(1):80.

325. Gleicher N. For some ART patients, twins are the best outcome. Contemporary Obgyn 2013; In press.

326. Gleicher N, Kushnir VA, Barad DH. Therapeutic interventions into early stages of follicle maturation: a new treatment paradigm after over 50 years of modern infertility therapy. Endocrinol 2013;154(10):3498-501.

327. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening is alive and very well: Really? Fertil Steril 2013;100(5):e36.

328. Gleicher N, Elkayam U. Some more on preventing congenital heart block. Autoimmun Rev 2014;13(1):73-4.

329. Gleicher N, Weghofer A, Barad DH. Do BRCA1/2 mutations and low FMR1 alleles interact or not? Eur J Hum Genet 2014; 22(2):155-6.

330. Weghofer A, Kim A, Barad DH, Gleicher N. Age at menarche: a predictor of diminished ovarian function? Fertil Steril 2013;100(4):1039-43.

331. Gleicher N, Kushnir VA, Barad DH. What ‘misguided campaign’ against single embryo transfer? Hum Reprod 2014 ;29(2):380-1.

332. Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Revs Endocrinol 2014; 10: 37-50.

333. Gleicher N. Maternal autoimmunity and adverse pregnancy outcomes. J Autoimmun 2014; 50:83-6.

334. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril 2014;100(3):710-715.

335. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol 2014; 12:22.

336. Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee H-J, Wu Y-G, Shohat-Tal A, Lazzaroni-Tealdi E, Gleicher N. Utilizing FMR1 gene mutations as predictors of treatment success in human in vitro fertilization. PLoS ONE 2014; 9(7):e102274.

337. Gleicher N, McAlpine JN, Gilks CB, Kushnir VA, Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH. Absence of BRCA/FMR1 correlations in women with ovarian cancers. PLoS ONE 2014; 9(7):e102370.

338. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The “graying” of infertility services: an impending revolution nobody is ready for. Reprod Biol Endocrinol 2014; 12:63.

339. Gleicher N, Kushnir VA, Weghofer A, Barad DH. How the FMR1 gene became relevant to female fertility and reproductive medicine. Frontiers Genet 2014; 5:284.

340. Kushnir VA, Gleicher N. Prediciton models for assisted reproductive technology. Nat Rev Urol 2014; 11(9):492-3.

341. Barad DH, Kushnir VA, Lee H-J, Lazzaroni-Tealdi E, Gleicher N. Effects of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study. Reprod Biol Endocrinol 2014; 12:68.

342. Kushnir VA, Barad DH, Gleicher N. Ovarian reserve screening before contraception? Reprod Biomed Online 2014; 29(5):527-9.

343. Prizant H, Gleicher N, Sen A. Androgen actions in the ovary: balance is key. J Endocrinol 2014; 222:3:R141-151.

344. Kushnir VA, Khanna P, Barad DH, Gleicher N. Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles. Reprod Biol Endocrinol 2014; 12:122.

345. Gleicher N, Barad DH, Kushnir VA, Sen A, Weghofer A. Poor responders and androgen adjuvant treatment: Still haven't found what I'm looking for. Reprod Biomed Online 2014; 29(5):650-2.

346. Gleicher N, Kushnir VA, Barad D. Fertility treatments and multiple births in the United States. NEJM 370(11):1069.

347. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes SR. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc Natl Acad Sci U S A 2014; 111(8):3008-13.

348. Gleicher N, Kushnir VA, Barad DH. Is it time for a paradigm shift in understanding embryo selection? Reprod Biol Endocrinol 2015; 13:3.

349. Weghofer A, Himaya E, Kushnir VA, Barad DH, Lazzaroni-Tealdi E, Yu Y, Wu Y-G, Gleicher N. Some aspects of inferactivity between endocrine and immune systems required for successful resproduction. Reprod Biol Endocrinol 2015; 13:29.

350. Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol 2015; 13:34.

351. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case control study. Reprod Biol Endocrinol 2015. 13:43

352. Gleicher N. McCulloh DH, Kushnir VA, Ganguly N, Barad DH, Goldman KN, Kushnir MM, Albertini DF, Grifo JA. Is there an androgen level threshold for aneuploidy risk in infertile women? Reprod Biol Endocrinol 2015;6:13:38.

353. Shohat-Tal A, Sen A, Barad DH, Kushnir V, Gleicher N. Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol 2015;.

354. Barad DH, Kushnir VA, Albertini D, Gleicher N. CDC analysis of ICSI/autism: association is not causation. Hum Reprod. 2015 Jul;30(7):1745-6. doi: 10.1093/humrep/dev104

355. Gleicher N, Kushnir VA, Barad DH. Why prospectively randomized clinical trials have been rare in reproductive medicine and will remain so? Reprod Sci 2016;23(1):6-10.

356. Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol 2015;226(3)):167-80.

357. Kushnir VA, Barad DH, Albertini DF, Sarmon SK, Gleicher N. Outcomes of fresh and cryopreserved oocyte donation. JAMA 2015;314(6)623-4.

358. Gleicher N, Yu Y, Himaya E, Barad DH, Weghofer A, Wu YG, Albertini DF, Want VQ, Kushnir VA. Early decline in functional ovarian reserve in young women with low (CGGn<26) FMR1 gene alleles. Trans Res 2015;166(5):502-7.

359. Shohat-Tal A, Sen A, Barad DH, Kushnir VA, Gleicher N. More on the conversion of DHEA to testosterone. Nat Rev Endocrinol 2015;11(9):521.

360. Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome. J Ovarian Res 2015;8(1):45.

361. Lee HJ, Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni-Tealdi E, Wu YG, Gleicher N. Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR). Endocrine 2015;9 (1-7).

362. Gleicher N, Vega, Darmon SK, Weghofer A, Barad DH, Wu YG, Wang Q, Zhang L, Albertini D, Kushnir VA. Live-birth rates in very poor prognosis patients who are defined as poor responders under the Bologna criteria with nonelective single embryo, two-embryo, and three or more embryos transferred. Fertil Steril 2015;104(6):1435-41.

363. Albertini, N Gleicher A detour in the quest for oogonial stem cells: methods matter. Nat Med 2015;21(10):1126-7.

364. Lazzaroni-Tealdi E, Barad DH, Albertini DF, Yu Y, Kushnir VA, Russell H, Wu YG, Gleicher N. Oocyte scoring enhances embryo-scoring in predicting pregnancy chances with IVF where it counts most. PLoS ONE 2015;10(12:e014362.

365. Weghofer A, Barad DH, Darmon S, Kushnir VA, Gleicher N. What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol 2016;14(1):26.

366. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates. PLoS One 2016;11(5):e0154620.

367. Gleicher N, Kushnir V, Albertini D, Barad DH. Improvements in IVF in women of advanced age. J Endocrinol 2016;pii: JOE-16-0105. [Epub ahead of print]

368. Gleicher N, Kushnir VA, Barad DH. Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET). Reprod Biol Endocrinol 2016;14(1):25.

369. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod Biol Endocrinol 2016;0.599305555555556

370. Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011-2012. Fertil Steril 2016;pii: S0015-0282(16)00140-0. doi: 10.1016/j.fertnstert.2016.02.026. [Epub ahead of print]

371. Kushnir VA, Solouki S, Sarig-Meth T, Vega MG, Albertini DF, Darmon SK, Deligdisch L, Barad DH, Gleicher N. Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis. Am J Reprod Immunol 2016;doi: 10.1111/aji.12508. [Epub ahead of print]

372. Gleicher N. Randomised controlled trials on dehydroepiandrosterone supplementation in female infertility still not conclusive. BJOG 2016;doi: 10.1111/1471-0528.13945. [Epub ahead of print]

373. Gleicher N, Kushnir VA, Barad DH. The impact of patient preselection on reported IVF outcomes. J Assist Reprod Genet 2016;33(4):455-9.

374. Gleicher N, Seier K, Kushnir VA, Weghofer A, Wu YG, Wang Q, Albertini DF, Barad DH. Associations between peripheral androgens and cortisol in infertile women. J Steroid Biochem Mol Biol 2016;158:82-9.

375. Gleicher N, Kushnir VA, Barad DH. Randomized controlled trial of minimal stimulation versus conventional in vitro fertilization. Am J Obstet Gynecol 2016;214(3):412-3.

376. Gleicher et al. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields. Endocrine 2016;54(2):476-483.

377. Kushnir VA and Gleicher N. Fresh versus cryopreserved oocyte donation. Curr Opin Endocrinol Diabetes Obes 2016;23(6):451-457.

378. Orvieto R and Gleicher N. Should preimplantation genetic screening (PGS) be implemented to routine IVF practice? J Assist Reprod Genet 2016;33(11):1445-1448.

379. Gleicher N et al. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol 2016;14(1):514.

380. Gleicher N et al. In reference to 'Strategies to manage refractory endometrium: state of the art 2016'. Reprod Biomed Online 2016;33(5):604.

381. Wu YG et al. Different effectiveness of closed embryo culture system with time-lapse imaging (EmbryoScope(TM)) in comparison to standard manual embryology in good and poor prognosis patients: a prospectively randomized pilot study. Reprod Biol Endocrinol 2016;14(1):49.

382. Vega M et al. Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies. Am J Reprod Immunol 2016;76(4):333-337.

383. Barad DH et al. The importance of redundancy of functional ovarian reserve when investigating potential genetic effects on ovarian function. J Assist Reprod Genet 2016;33(9):1157-1160.

384. Vega MG et al. IVF outcomes in average- and poor-prognosis infertile women according to the number of embryos transferred. Reprod Biomed Online 2016;33(3):370-375.

385. Gleicher N et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med 2016;14(1):172.

386. Sermon K et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod 2016;22(8):845-857.

387. Hayes E et al. Intra-cellular mechanism of Anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol 2016;433:56-65.

388. Gleicher N et al. Response to comment on: Gleicher N et al., 2016. Reprod biol endocrinol Sep 5;14(1):54. Reprod Biol Endocrinol 2017;15(1):23.

389. Gleicher N and Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review. J Ovarian Res 2017;10(1):21.

390. Gleicher N et al. Elective single-embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances: FOR: The statistically flawed model of eSET. BJOG 2017;124(5):755.

391. Kushnir VA et al. Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL. Reprod Sci 2017; epub ahead of print.

392. Gleicher N. Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance. J Assist Reprod Genet 2017;124(5):755.

393. Kushnir VA et al. Systematic review of worldwide trends in assisted reproductive technology 2004-2013. Reprod Biol Endocrinol 2017;15(1):6.

394. Gleicher N et al. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. J Steroid Biochem Mol Biol 2017;167:144-152.

395. Barad DH et al. Focus on recurrent miscarriage phenotypes. Fertil Steril 2017;107(1):64-65.

396. Kushnir VA et al. Utilization of third-party in vitro fertilization in the United States. Am J Obstet Gynecol 2017;216(3):266.e1-266.e10.

397. Kushnir VA et al. CDC-reported assisted reproductive technology live-birth rates may mislead the public. Reprod Biomed Online 2017;35(2):161-164.

398. Adashi EY, Gleicher N. Is a Blanket Elective Single Embryo Transfer Policy Defensible? Rambam Maimonides Med J 2017;8(2).

399. Barad DH et al. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study. Reprod Biol Endocrinol 2017;15(1):34.

400. Gleicher N et al. A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use. Reprod Biol Endocrinol 2017;15(1):33.

401. Gleicher N, Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review. J Ovarian Res 2017;10(1):21.

402. Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States. Am J Obstet Gynecol 2017; 217(5):576.

403. Orvieto R, Vanni VS, Gleicher N. The myths surrounding mild stimulation in vitro fertilization (IVF). Reprod Biol Endocrinol 2017;15(1):48.

404. Kushnir VA, Seifer DB, Barad DH, Sen A, Gleicher N. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine. J Assist Reprod Genet 2017; 34(9):1105-1113.

405. Shapiro AJ, Darmon SK, Barad DH, Albertini DF, Gleicher N, Kushnir VA. Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA. Reprod Biol Endocrinol 2017;15(1):44.

406. Gonda KJ, Domar AD, Gleicher N, Marrs RP. Insights from clinical experience in treating IVF poor responders. Reprod Biomed Online 2017;36(1):12-19.

407. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D, Raanani H, Dirnfeld M, Patrizio P. Medical egg freezing: the importance of patient-centered approach to fertility preservation. J Assist Reprod Genet 2017;35(1):49-59.

408. Gleicher N, Kushnir VA, Barad DH. How PGS/PGT-A laboratories succeeded in losing all credibility. Reprod Biomed Online 2018;37(2):242-245.

409. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D, Dirnfeld M, Seidman D, Kahane A, Patrizio P. Ten pathways to elective egg freezing: a binational analysis. J Assist Reprod Genet 2018;35(11):2003-2011.

410. Roy S, Gandra D, Seger C, Biswas A, Kushnir VA, Gleicher N, Kumar TR, Sen A. Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3k27AC in granulosa cells. Endocrinology 2018;159(9):3433-3445.

411. Inhorn MC, Birenbaum-Carmeli D, Birger J, Westphal LM, Doyle J, Gleicher N, Meirow D, Dirnfeld M, Seidman D, Kahane A, Patrizio P. Elective egg freezing and its underlying socio-demography: a binational analysis with global implications. Reprod Biol Endocrinol 2018;16(1):70.

412. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D, Raanani H, Dirnfeld M, Patrizio P. Medical egg freezing: How cost and lack of insurance cover impact women and their families. Reprod Biomed Soc Online 2018;5:82-92.

413. Gleicher N, Kushnir VA, Darmon SK, Albertini DF, Barad DH. Older women using their own eggs? Issue framed with two oldest reported IVF pregnancies and a live birth. Reprod Biomed Online 2018;37(2):172-177.

414. Gleicher N. Expected advances in human fertility treatments and their likely translational consequences. J Transl Med 2018;16(1):149.

415. Gleicher N, Kushnir VA, Barad DH. Impact of androgen supplementation on the follicular endocrine milieu in women with hypoandrogenism. Reprod Biomed Online 2018;36(6):719-720.

416. Wu YG, Barad DH, Kushnir VA, Wang Q, Zhang L, Darmon SK, Albertini DF, Gleicher N. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization. J Ovarian Res 2018;11(1):23.

417. Meldrum DR, Adashi EY, Garzo VG, Gleicher N, Parinaud J, Pinborg A, Van Voorhis B. Prevention of in vitro fertilization twins should focus on maximizing single embryo transfer versus twins are an acceptable complication of in vitro fertilization. Fertil Steril 2018;109(2):223-229.

418. Gleicher N, Caplan AL. An alternative proposal to the destruction of abandoned human embryos. Nat Biotechnol 2018;36(2):139-141.

419. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Degree of mosaicism in trophectoderm does not predict pregnancy potential: a corrected analysis of pregnancy outcomes following transfer of mosaic embryos. Reprod Biol Endocrinol 2018;16(1):6.

420. Gleicher N, Kushnir VA, Darmon SK, Wang Q, Zhang L, Albertini DF, Barad DH. Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age. Endocrine 2018;59(3):661-676.

421. Kushnir VA, Darmon SK, Barad DH, Gleicher N. New national outcome data on fresh versus cryopreserved donor oocytes. J Ovarian Res 2018;11(1):2.p

422. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation. BMJ Open 2018;8(11):e023124.

423. Kushnir VA, Darmon SK, Barad DH, Weghofer A, Gleicher N. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women. Endocrine 2018; Epub ahead of print.

424. Shapiro AJ, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Vitamin D levels are not associated with ovarian reserve in a group of infertile women with a high prevalance of diminished ovarian reserve. Fertil Steril 2018;110(4):761-766.e1.

425. Rosenwaks Z, Handyside AH, Fiorentino F, Gleicher N, Paulson RJ, Schattman GL, Scott RT Jr, Summers MC, Treff NR, Xu K. The pros and cons of preimplantation genetic testing for aneuploidy: clinical and laboratory perspectives. Fertil Steril 2018; 110(3):353-361.

426. Gleicher N, Kushnir VA, Barad DH. Unexplained infertility. Lancet 2018; 392(10157):1516-1517.

427. Patrizio P, Shoham G, Shoham Z, Leong M, Barad DH, Gleicher N. Worldwide live births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results of a worldwide web-based survey. J Assist Reprod Genet 2019;36(8):1599-1607.

428. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, Doyle J, Gleicher N, Meirow D, Dirnfeld M, Seidman D, Kahane A, Patrizio P. Patient-centered elective egg freezing: a binational qualitative study of best practices for women's quality of care. J Assist Reprod Genet 2019;36(6):1081-90.

429. Gleicher N, Barad DH. Assessing in-vitro fertilization at age 40 years. Lancet 2019;393(10177):1181-3.

430. Capalbo A, Chokoshvili D, Dugoff L, Franasiak J, Gleicher N, Pennings G, Simon C. Should the reproductive risk of a couple aiming to conceive be tested in the contemporary clinical context? Fertil Steril 2019;111(2):229-38.

431. Wang Q, Barad DH, Darmon SK, Kushnir VA, Wu YG, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Gleicher N. Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats. PLoS ONE 2018;13(12): e0209309.

432. Gleicher N, Barad DH. Not even noninvasive cell-free DNA can rescue preimplantation genetic testing. Proc Natl Acad Sci USA 2019; Epub ahead of print.

433. Gleicher N, Kushnir VA, Barad DH. Worldwide decline of IVF birth rates and its probable causes. Hum Reprod Open 2019; 2019(3):hoz017.

Abstracts 1. Beers, P, David S, Reyniak J, Gleicher N: Antibodies to autologous gonadotrophins.

Proceedings of the Society for Gynecologic Investigations, 27th Annual Meeting; Denver, Colorado, March l9-22, l980.

2. Siegel I, Gleicher N: Red cell immune adherence (RCIA) in the rabbit: An animal model for the study of red cell immunocyte function. Clin Res l98l; 29:530A.

3. Smolen J, Chuset T, Leierson W, Weintraub B, Gleicher N, Steinberg A: T-cell phenotypes in normal pregnancy and in pregnant patients with autoimmune diseases. Am J Reprod Immunol l98l; l:273.

4. Gleicher N, Adelsberg B, Siegel I, Siegel F, Liu TL: Immune complex disease in pregnancy. Idem l98l; l:273.

5. Siegel I, Liu TL, Gleicher N: Red cell immune adherence (RCIA) in the developing rabbit. Idem l98l; l:275.

6. Adelsberg B, Liu TL, Phillips R, Cederquist L, Siegel I, Gleicher N: Immune complexes in all stages of pregnancy. Idem l98l; l:278.

7. Toder V, Nebel L, Gleicher N: Interferon activation of natural killer (NK) lymphocyte precursors in human pregnancy. Idem 1982; 2:169.

8. Siegel I, Lubicz, S, Deppe G, Liu TL, Gleicher N: Serum dependent regulation of RCIA (red cell immune adherence) by oxygen. Idem 1982; 2:184.

9. Siegel I, Liu TL, Gleicher N: Enhanced red cell immune function in early development. Idem 1982; 2:184.

10. Toder V, Nebel H, Elrad H, Blank M, Gleicher N: Human natural killer (NK) activity: Regulatory effect of some pregnancy markers. Idem 1982; 2:169.

11. Gleicher N, Siegel I: Additional evidence for an immunologic etiology of the pre-eclampsia/eclampsia syndrome (EPH gestosis). Clin Exp Hypertension 1982; B1:215.

12. Gleicher N, Toder V: Comparison of natural killer activity in normal pregnancy EPH-gestosis. Idem 1982; B1:218.

13. Gleicher N: Immunologic factors in hypertension of pregnancy. Idem 1982; B1:348. 14. Deppe G, Lubicz S, Siegel I, Liu TL, Gleicher N: The effect of corticosteroids on the red

cell immune adherence (RCIA) in rabbit. Proceedings, ASCO C-151, 1982; 38. 15. Siegel I, Liu TL, Gleicher N: The effects of lipids upon the immune system. The

immune adherence connection. Fed Proc 1983; 43:1186. 16. Gleicher N, Dmowski P, Siegel I, Liu TL, Toder V: Peripheral white blood cells subsets

in endometriosis. Am J Reprod Immunol 1983; 3:192-193. 17. Siegel I, Liu TL, Gleicher N: Regulation of red cell immune adherence (RCIA) and

neutrophil immune adherence (NIA) by dietary lipids. Idem 1983; 3:197. 18. Siegel I, Liu TL, Elrad H, Gleicher N: Defense against infection - A selective role for

unsaturated fatty acid. Idem 1983; 3:197. 19. Siegel I, Liu TL, Wissner R, Gleicher N: Red cell immune adherence (RCIA) co-factors

in adult and cord serums. Idem 1983; 3:197. 20. Friberg J, Gleicher N: High dose menopausal gonadotropin therapy for successful

ovulation induction for IVF program in perimenopausal females. J Vitro Fert Embryo Transfer 1984; 1:109.

21. Gleicher N, Friberg J: The effect of aspiration needles on oocyte recovery rates and the need for follicular irrigation. Idem 1984; 1:110.

22. Gleicher N: Cesarean section rates in the USA: The short term failure of the Consensus Development Conference. Proceedings of the 31st Annual Meeting of the Society for Gynecologic Investigations, San Francisco, March 21-24, 1984, p.40.

23. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: Chain reaction (CR) fatty acid toxicities affecting human red cells and human sperm cells. Am J Reprod Immunol 1984; 5:96.

24. Siegel I, Elrad H, Gleicher N: Toxicity of term amniotic fluid to human red cells. Idem 1984; 5:98.

25. Gleicher N: Autoimmunity and pregnancy. Idem 1984; 6:55. 26. Siegel I, Dudkiewicz A, Friberg J, Gleicher N: The effect of free fatty acids on human

sperm cells. Idem 1984; 6:59.

27. Siegel I, Gleicher N: The selective toxicities of non-saturated fatty acids upon mammary ascites tumor cells. Idem 1984; 6:74.

28. Confino E, Friberg J, Dudkiewicz A, Gleicher N: Intrauterine inseminations with washed human spermatozoa in couples with circulating sperm agglutinating anti-bodies. Am J Reprod Immunol Microbiol 1985; 7:138-139.

29. Siegel I, Dudkiewicz A, Friberg J, Suarez M, Gleicher N: The effect of unsaturated free fatty acids (FFA) on sperm motility. Idem 1985; 7:139.

30. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo loss in in vitro fertilization? J Vitro Fert Embryo Transfer 1986; 3:74.

31. Gleicher N, El-Roeiy: Autoantibodies in follicular fluids of IVF patients. Idem 1986; 3:71.

32. El-Roeiy A, Gleicher N, Isenberg D, Kennedy R, Goldenberg M, Mashiach S, Shoenfeld Y: Autoantibodies and common anti-DNA idiotype in pregnancies of mothers with systemic lupus erythematous. J Reprod Immunol 1986; Supplement:99.

33. Gleicher N, El-Roeiy A, Confino E, Friberg J: Abnormal antibodies in endometriosis: Is endometriosis an autoimmune disease? Idem 1986; Supplement:99.

34. Confino E, El-Roeiy A, Demir R, Friberg J, Gleicher N: Thromboelastogram, lupus anticoagulant and anti-nuclear antibodies in patients with endometriosis and repeated abortions. Idem 1986; Supplement:99.

35. Confino E, Demir R, Friberg J, Gleicher N: Does cyclic hCG secretion indicate embryo loss in in vitro fertilization? An international collaborative study. Fertil Steril 1986; Supplement:68.

36. Gleicher N, El-Roeiy A, Friberg J, Confino E, Dudkiewicz A: Reproductive failure due to abnormal autoantibodies. II:Wastage. 12th World Congress on Fertility and Sterility Handbook, 1986, p 732.

37. Confino E, Friberg J, Gleicher N: A newly developed stirrable gift catheter (Friberg Catheter). 12th World Congress on Fertility and Sterility Handbook, 1986, p 754.

38. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT): A new method to recanalize obstructed fallopian tubes. 12th World Congress on Fertility and Sterility Handbook, 1986, p 732.

39. Confino E, Friberg J, Gleicher N: Transcervical balloon tuboplasty (TBT). Fertil Steril 1986; Supplement:45.

40. Confino E, Vermesh M, Boler L, Friberg J, Gleicher N: Acute salpingitis in sterilized women. Adv Contraception 1986; 2:282.

41. Gleicher N, El-Roeiy A, Friberg J, Confino E, Dudkiewicz A: Reproductive failure due to abnormal autoantibodies. II: Wastage. 12th World Congress on Fertility and Sterility Handbook, 1986, p 732.

42. Confino E, Friberg J, Gleicher N: A newly developed stirrable gift catheter (Friberg Catheter). 12th World Congress on Fertility and Sterility Handbook, 1986, p 754.

43. Myers S, Gleicher N: A prospective program to reduce cesarean section rates: A preliminary report. Society of Perinatal Obstetricians, 1986, p 300.

44. El-Roeiy A, Myers S, Gleicher N: Autoantibodies in normal pregnancy: Comparison to non-pregnant patients. Proceedings of the Seventh Annual Meeting of the Society of Perinatal Obstetricians, 1987, p 301.

45. Dudkiewicz A, Friberg J, Confino E, Madanes A, Gleicher N: The relationship between

46. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of hypertensive and normotensive pregnancy. Am J Reprod Immunol Microbiol 1987; 14:1.

47. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune failure syndrome (RAFS). Idem 1987; 14:2.

48. Confino E, Friberg J, Gleicher N: Cervical mucus-uterine fluid cross penetration of spermatozoa in patients with circulating sperm agglutinating antibodies. Idem 1987; 14:4.

49. El-Roeiy A, Friberg J, Valessini G, Shoenfeld Y, Kennedy R, Gleicher N: The presence of autoantibodies and common idiotypes in sera and seminal plasma of patients with anti-sperm antibodies. Idem 1987; 14:4.

50. El-Roeiy A, Dmowski W, Friberg J, Binor Z, Gleicher N: Habitual abortion versus endometriosis. Fertil Steril 1987; supplement:54.

51. Confino E, Friberg J, Gleicher N: Preliminary experience with transcervical balloon tuboplasty (TBT). Idem 1987; supplement:66.

52. Confino E, Gleicher N, Friberg J: Cervical mucus-uterine fluid cross penetration of spermatozoa. Idem 1987; supplement:68.

53. El-Roeiy A, Myers S, Gleicher N: A comparison of the autoantibody profile of hypertensive and normotensive pregnancy. Am J Reprod Immunol Microbiol 1987; 14:1.

54. Gleicher N, El-Roeiy A, Confino E, Friberg J: Autoantibodies in patients with unexplained infertility and recurrent pregnancy loss: The reproductive autoimmune failure syndrome (RAFS). Idem 14:2, 1987.

55. Gleicher N, Harlow L, El-Roeiy A: The correlation between autoantibodies in women with reproductive failure. Idem 1988; 16:3.

56. Gleicher N, Harlow L, El-Roeiy A: The correlation between lupus anticoagulant and autoantibodies. Idem 1988; 16(3) :32-37.

57. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen parameters from sequentially produced ejaculates. Fertil Steril 1988; supplement:S109.

58. Confino E, Harlow L, Friberg J, Gleicher N: The correlation between serum and peritoneal fluids autoantibody levels in patients with endometriosis. Am J Reprod Immunol Microbiol 1988; 16:3.

59. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy. 1988 Fertil Steril supplement:S109.

60. Dudkiewicz A, Friberg J, Confino E, Gleicher N: Comparison of semen parameters from sequentially produced ejaculates. Annual Meeting of the American Fertility Society 1988; Program supplement:175.

61. Confino E, Friberg J, Gleicher N: Conservative management of interstitial pregnancy. Idem 1988; Program supplement:197.

62. Myers S, Gleicher N: A successful program to lower cesarean section rates. Proceeding of The Society of Perinatal Obstetricians 1988; Program supplement:125.

63. Gleicher N, El-Roeiy A: Autoantibody profiles in normal female and males. Proceeding of The Annual Meeting of The Society for Gynecologic Investigation, Salt Lake City, Utah, September 22-21, 1988.

64. Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure due to autoantibodies: Unexplained infertility and pregnancy wastage. 56th Annual Meeting of CAOG, Salt Lake City, Utah, September 22, 1988.

65. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: A GnRH-agonist/hMG/hCG stimulation protocol for IVF increases pregnancy rates by widening the implantation window. Proceedings of The Annual Meeting of The Society for Gynecologic Investigation, March 15-18, 1989, San Diego, CA; 404:303.

66. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E, Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical balloon tuboplasty: A multicenter study. Idem O-004:S2.

67. Confino E, Gleicher N: Peritoneal fluid autoantibodies in endometriosis. Idem 499:31. 68. Tur-Kaspa I, Confino E, Friberg J, Dudkiewicz A, Novotny M, Gleicher N: GnRH-

agonist/ HMG/ HCG stimulation for IVF increased endometrial receptiveness for 69. Tur-Kaspa I, Dudkiewicz A, Friberg J, Confino E, Logan R, Gleicher N: Pooled

sequential ejaculates - a way to increase number of motile spermatoza from oligozoospermic males. Idem P-011:S66.

70. Dudkiewicz A, Novotny M, Friberg J, Gleicher N: Biochemical enhancement of sperm penetration: Effects on subsequent development. Idem p 54.

71. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: The implantation window and early pregnancy loss. Proceedings of the International Meeting on Pregnancy Loss Tel- Aviv, Israel, April 1989; p 21.

72. Tur-Kaspa I, Confino E, Zilberstein M, Friberg J, Dudkiewicz A, Gleicher N: Low pregnancy wastage in IVF-ET pregnancies achieved with a GnRH-Agonist/hMG/hCG stimlation protcol. Idem p 21.

73. Toder, V, Kochavi E, Altaratz H, Shepshelovic J, Gleicher N: Steroid hormones regulate functioning of growth factors at materno-fetal interface. Idem.

74. Zilberstein M, Solan N, Choh J, Gleicher N, Das C: Antibodies to epidermal growth factor receptor (EGF) inhibits basal and EFG stimulated hCG production in human term placental cells. Proceedings of The Endocrine Society Meeting Prout’s Neck, Maine, June 1989; 1037:282.

75. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune failure syndrome (RAFS) 1. Immunization with phospholipid antigens. 8th Annual Symposium of The American Society for the Immunology of Reproduction Portland, Maine, June 14-18, 1989; p 80.

76. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune failure syndrome (RAFS) 2. Effects on fertility. Idem p 81.

77. Gleicher N, Harlow L, Dudkiewicz A: A mouse model for the reproductive autoimmune failure syndrome (RAFS) 3. The response to pregnancy. Idem p 81.

78. Zilberstein M, Solan N, Das C, LeRoith D, Gleicher N, Catt K: Regulation of insulin-like growth factor (IGF) gene expression in cultured cytotrophoblasts. Proceedings of The Society for The Study of Reproduction (SSR) Meeting San Francisco, CA, August 1989; 74:72.

79. Myers S, Gleicher N: The Mount Sinai Cesarean Section Reduction Program: An update and recommendations. Proceedings of The 117th Annual Meeting for The American Public Health Association Chicago, IL, October 22-26, 1989.

80. Zilberstein M, Puryear T, Gibori G, Gleicher N: Epidermal growth factor receptor (EGF-R) gene expression in cultured human trophoblast cells. Proceedings of The 45th Annual Meeting of The American Fertility Society San Francisco, CA, November 11-16, 1989; O-027:S11.

81. Tur-Kaspa I, Confino E, Logan R, Myers S, Dudkiewicz A, Friberg J, Gleicher N: The effect of sequential ejaculation on total motile sperm count in normozoospermic and oligozoospermic males.Idem p S66.

82. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E, Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical Balloon Tuboplasty - A multicenter study. Price paper of the General Program. Idem O-004:S2.

83. Confino E, Tur-Kaspa I, Gleicher N: Opening pressure of normal and proximally obstructed fallopian tubes. Idem O-016:S7.

84. Confino E, Tur-Kaspa I, Friberg J, Gleicher N: Sonographic Transcervical Balloon Tuboplasty. Idem O-129:S54.

85. Confino E, DeCherney A, Corfman R, Coulam C, Robinson E, Friberg J, Haas G, Katz E, Tur-Kaspa I, Vermesh M, Gleicher N: Transcervical Balloon Tuboplasty: Description of a technique to recanalize proximal tubal obstruction. A video presentation. Idem FP-03:S161.

86. Zilberstein M, Harlow L, Gleicher N: Human Sera containing anti-phospholipid autoantibodies (APA) inhibit phospholipase induced hCG secretion in human term placenta villi explants. Proceedings of the 46th Annual Meeting of the American Fertility Society Washington, D.C., October 13-18, 1990; 0-047:S20.

87. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G, Katz E, Vermesh M, Gleicher N: Follow-up of the Multicenter Transcervical Balloon Tuboplasty (TBT) Study. Idem 0-091:S39.

88. Confino E, Tur-Kaspa I, Gleicher N: Selective ultrasound salpingography (SVS). Idem P-105:S109.

89. Dudkiewicz A, Confino E, Friberg J, Tur-Kaspa I, Novotny M, Wright J, Gleicher N: What can we learn from chemical pregnancies. Idem P-218:S156.

90. Gleicher N: Advances in reproductive immunology. Keio J Med 1990; 39-119. 91. Gleicher N, Confino E, Corfman R, Coulam C, DeCherney A, Haas G, Katz E, Robinson

E, Tur-Kaspa I, Vermesh M: Transcervical balloon tuboplasty: Multicenter Conclusions and follow up. Proceedings of the 47th Annual Meeting of the American Fertility Society Orlando, Florida, October 21-24, 1991 0-103:545.

92. Gleicher N, Parrilli M, Redding L, Pratt D: Hysterosalpingography (HSG) and Selective Salpingography (SS) as therapeutic procedures. Idem P-066;S142.

93. Gleicher N, Dudkiewicz A, Parrilli M, Pratt D: Do low luteal phase estradiol (E) levels prevent implantation in IVF cycles? Idem. p 204, S170.

94. Gleicher N, Pratt D, Kaberlein G, Dudkiewicz A: Danazol does not suppress sperm antibodies in males. Twelfth National Meeting of the American Society for the Immunology of Reproduction, Charleston, South Carolina; June 10-13, 1992, Am J Reprod Immunol 27:51.

95. Mathur S, Chihal H, Isaacson K, Gleicher N, Patrick R, Bleiler J: Endometrial autoimmunity in endometriosis: Immunogenicity and specificity of the target antigens. Idem p 132.

96. Gleicher N, Pratt D, Kaberlein G, Honea K, Dudkiewicz A: The Correlation of IL-4 and IL-6 levels to the presence of autoantibodies in infertile females. Idem p 137.

97. Gleicher N, Liu HC, Rosenwaks Z, Pratt D: Antibody profiles as predictor of IVF success. 48th Annual Meeting of the American Fertility Society New Orleans, Louisiana; November 2-5, 1992, 0-087, S39.

98. Gleicher N, Parrilli M, Pratt D: A trial guide of wire cannulation as treatment of proximal tubal occlusion. Idem. P-179, S101.

99. Gleicher N, Redding L, Gurniak R, Parrilli M, Pratt D: The presentation of ampullary tubal pregnancies during salpingography. Idem. P-189, S103.

100. Gleicher N: Immunologic theories of endometriosis: Role of humoral immunity. VIII World Congress on Human Reproduction Joint IV World Conference on Fallopian Tube in Health and Disease. April 4-9, 1993. SY04-6.

101. Gleicher N: Immune dysfunction - A potential target for treatment in endometriosis. 4th World Congress on Endometriosis, Salvador, Bahia, Brazil, May 26, 1994. Program.

102. Karande V, Pratt D, Rabin D, Gleicher N: Elevated Tubal Perfusion Pressures (TP) During Selective Salpingography (SS) Are Highly Suggestive of Tubal Endometriosis. 50th Annual Meeting of the American Fertility Society, November 5-10, 1994.

103. Dudkiewicz A, Kaberlein G, Favero L, Novotny M, Pratt D, Karande V, Levrant S, Morris R, Minhas B, Gleicher N: Do increasing sperm concentrations effect abnormal fertilization rates within current IVF stimulation regimens? (Abstract OC84) IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995. J Assist Reprod Genet; Supplement 1995; 12:47S.

104. Karande V, Pratt D, Dudkiewicz A, Gleicher N: Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles Fertil Steril Program Supplement (Abstract OC208). 1995 Idem; 12:78S.

105. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B: Egg factor: Is intracytoplasmic sperm injection (ICSI) efficacious therapy? Fertil Steril Program Supplement (Abstract OC225). 1995 Idem; 12:83S.

106. Gleicher N: What infertility patients think about multiple conceptions: Is it time to reevaluate current practice patterns? Fertil Steril Program Supplement (Abstract PS73) 1995 Idem; 12:P12S.

107. Dudkiewicz A, Kaberlein G, Zhu Y, Dudkiewicz A, Novotny M, Gleicher N: A novel method of centralized semen analysis from a satellite office high-resolution video recording Fertil Steril Program Supplement (Abstract OC374) 1995 Idem; 12:P120S.

108. Morris R, Gleicher N, Pratt D, Dudkiewicz A, Karande V, Levrant S, Minhas B: Intracytoplasmic Sperm Injection (ICSI) Is Only Beneficial When Fertilization Failure Is Due To Sperm Defects: American Society for Reproductive Medicine, Seattle WA, October 7-12, 1995 (Abstract 0-160) Fertil Steril Program Supplement S79.

109. Morris R, Dudkiewicz A, Gleicher N: The Presence of Autoantibodies (ABS) Does Not Predict Elevations in Follicle Stimulating Hormone (FSH) Fertil Steril Program Supplement (Abstract P219) 1995 Idem; S193.

110. Cusick W, Buttino L, Vintzileos A, Gleicher N: Fetal down syndrome detection: A cost analysis of alternative screening programs Fertil Steril Program Supplement (Abstract 90) Am J Obstet Gynecol 1996;174(1)part 2:338.

111. Karande V, Rinehart J, Pratt D, Gleicher N: Is the inadvertent administration of leuprolide acetate in early human pregnancy truly associated with normal outcomes? The Pacific Coast Fertility Society, April 17-21, 1996 (Abstract P-34) Fertil Steril Program Supplement. a27.

112. Gleicher N, Karande V, Pratt D, Morris R, VanderLaan B: Surgical Utilization and

113. Rao R, Karande V, Balin M, Levrant S, Morris R, Pratt D, Ferguson R, Gleicher N: The

114. Morris R, Ferguson R, Dudkiewicz A, Brown T, Minhas B, Rao R, Balin M, Levrant

115. Morris R, Ferguson R, Weing C, Dudkiewicz A, Gleicher N: Single Follicle Simulating

116. Levrant S, Ferguson R, Karande V, Pratt D, Morris R, Rao R, Balin M, Dudkiewicz A, Gleicher N: Cycle Parameters Predictive of Multiple Pregnancy Risk in Women Undergoing COII with Gonadotropins. Idem

117. Levrant S, Ferguson R, Rinehart J, Karande V, Pratt D, Rao R, Balin M, Gleicher N: Multivariate Logistic Analysis of Factors Predictive of Clinical Pregnancy in Women Undergoing Gonadotropin Ovulation Induction. Idem.

118. Gleicher N, Vanderlaan B: Victim of Ones Own Success: Selective Patient Enrollment in a Capitated Managed Care Infertility Program as a Consequence of High Patient Satisfaction. Idem.

119. Morris R, Ewing C, Carey R, Dudkiewicz A, Gleicher N: Prevalence and Importance of Occult Ovarian Failure in Oocyte Donors. Idem.

120. Rao R, Karande V, Balin M, Levrnt S, Morris R, Pratt D, Ferguson R, Gleicher N: The Association of Cytomegalovirus (CMV) with Immunological Abnormalities in a Female Infertility Population Undergoing ART. Idem.

121. Karande V, Rinehart J, Morris R, Miller C, Gleicher N: Improved Pregnancy Rates in Poor Responder Patients with Cessation of Gonadotropin Releasing Hormone Agonist (GnRH-a) Down-Regulation Prior to Stimulation with High Dosage of Gonadotropins, J Assist Reprod Genetics, 1997; 14: 62S.

122. Wang L, Cui H, Roussev R, Dudkiewicz A, Gleicher N: “Mosaicism” Artifact in Fluorescent In-Situ Hybridization in Human Leukocyte Nuclei with X/Y Chromosome and 21-DNA Probes, J Assist Reprod Genetics, 1997; 14: 87S.

123. Cui H, Matthews C, Rudzki Z, Wang L, Dudkiewicz A, Gleicher N: Diagnosis of Sickle Cell Anemia Following Amplification of the Whole B-Globin Gene for Preimplantation Diagnosis, J Assist Reprod and Genetics, 1997; 14: 89S.

124. Karande V, Rinehart J, Morris J, Gleicher N: Does the Clomiphene Challenge Test (CCT) have any Value in Screening Poor Responder Patients Undergoing IVF-ET? J Assist Reprod Genetics, 1997; 14: 211S.

125. Levrant S, Wang L, Miller C, Rinehart J, Karande V, Coulam C, Pratt D, Gleicher N: Human Leukocyte Antigen DQA1 Genotyping in Women with Endometriosis, 17th ASRI Meeting, Am J Reprod Immunol, 1997; 37.

126. Karande V, Korn A, Morris R, Rao R, Balin M, Rinehart J, Larner B, Dohn K, Gleicher N: A Prospective Randomized Trial Assessing Outcome and Cost of IVF as a First Choice Treatment versus a Traditional Infertility Treatment Algorithm, 53rd ASRM Annual Meeting Program Supplement Fertil Steril, 1997; O-078: S35.

127. Levrant S, Wang L, Coulam C, Larner B, Miller C, Rinehart J, Karande V, Pratt D, Gleicher N: Evidence for Human Leukocyte Antigen DQA1 Association with with Endometriosis. Abstract from the 53rd ASRM Annual Meeting Program Supplement, Fertil Steril 1997; P-005: S94.

128. Karande V, Coulam C, Morris R, Gleicher N: A Prospective Comparison of Imaging versus Endoscopic Techniques for the Evaluation of the Infertile Patient. Abstract from the 54th ASRM Annual Meeting Program Supplement, Fertil Steril1998: O-290: S108.

129. Gleicher N, Karande V, Pratt D, Rinehart J, Miller C: What is the Real Utilization of Infertility Services in an Average Patient Population with Generous Infertility Benefits? Abstract from the 54th ASRM Annual Meeting Program Supplement, Fertil Steril 1998 P-140: S170.

130. Gleicher N, Miller C, Pratt D, Rinehart J: Is there Value to a Utilization Review Program (URP) for Injectable Fertility Medications? 54th ASRM Annual Meeting Program Supplement, Fertil Steril 1998: P-141: S170-S171.

131. Gleicher N, Miller C, Pratt D, Coulam C, Leman C: The Routine Use of hMG Stimulation for Standard Ovulation Induction Results in Pregnancy Rates Superior to Results Obtained from Routine Use of FSH Products. 54th ASRM Annual Meeting Program Supplement, Fertil Steril 1998; P-1138: S477.

132. Gleicher N, Coulam C: Autoantibodies in Reproduction.VII the International Congress of Reproductive Immunology, Ame J Reprod Immun, 1998; 34: 249.

133. Gleicher N, Kaberlein G, Pratt D, Rinehart J, Morris R, Rao R, Karande V: Definition of High Risk Patients for High-Order Multiple Pregnancies With Ovarian Stimulation by Gonadotripns. Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: O-155.

134. Pratt D, Coulam C, Karande V, Gleicher N: What Are the True Cumulative Pregnancy Rates of Patients Entering a Standard Treatment Algorithm for Infertility? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: O-172.

135. Karande V, Chapman C, Gleicher N: Is There Any Value in Splitting Sibling Oocytes Between Intracytoplasmic Sperm Injections (ICSI) and Conventional In Vitro Fertilization? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-175.

136. Karande V, Chapman C, Gleicher N: A Prospective Evaluation of the Value of Blastocyst Transfere in Low Responders Undergoing IVF-ET. Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-176.

137. Gleicher N, Rinehart J, Pratt D, Morris R, Rao R, Balin M, Karande V: How Does Female Age Affect Medication Utilization in IVF? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-177.

138. Gleicher N, Coulam C, Pratt D, Rinehart J, Morris R, Rao R, Balin M, Karande V: Comparison of Utilization Patterns in Consecutive Years: Is There Value in a Formal Utilization Review Program for Infertility Services? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-347.

139. Gleicher N, Kaberlein G, Rinehart J, Morris R, Pratt D, Rao R, Balin M, Karande V: High Order Multiples, A Preventable or Unpreventable Complication of Controlled Ovarian Stimulation with Gonadotropins? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999: P-452.

140. Chapman C, Karande V, Rinehart J, Gleicher N: Does the Production of Blastocysts from Supernumerary Embryos Predict Pregnancy Outcome After 3 Days ET? Conjoint Annual ASRM/CFAS Meeting Program Supplement, Fertil Steril 1999:P-476.

141. Gleicher, N: How does the immune system affect IVF? J Assist Reprod Genetics, 1999; 16:144.

142. Gleicher, N: Quality & Management Control. J Assist Reprod Genet, 1999; 16:144.

143. Gleicher N: What do abnormal autoantibodies in pregnancy really mean? Abstract frp, the 2nd International Congress on Autoimmunity Supplement, Tel-Aviv, Israel, March 7-11, 1999: 46.

144. Gleicher N: Gynecoradiology. Abstract from the 8th Annual Congress of the International Society for Gynecological Endoscopy, Montreal, Canada, April 25-28, 1999: 75.

145. Gleicher, N: What is the Most Cost Effective Algorithm for Infertility Treatment. Second World Conference of APART, Budapest, Hungary, September 14-17, 2000. J Assist Reprod Genetics, 2000; 17:8

146. Gleicher, N: Criteria for the Prevention of High Order Multple Births Following Ovulation Induction with Gonadotropins. ASRM 2000, 56th Annual Meeting San Diego, CA October 21-26, 2000: Fert Steril: 2000; 74:S90

147. Gleicher N., I. Tur-Kaspa, C. Chapman, V. Karande, D. Hazlett, W. Skoog: Can We Predict Patient’s Chance to Conceive at the Time of Embryo Transfer? ASRM 2000, 56th Annual Meeting, San Diego, CA October 21-26, 2000 Fert Steril: 2000; 74:S111

148. Gleicher, N, I. Turkaspa, A. Vidali, V. Karande, The Changing Practice Pattern of Infertility Care in the U.S.: ASRM 2000, 56th Annual Meeting, San Diego, CA: Oct 21-26, 2000; Fertil Steril; 2000; 74:S248

149. Gleicher, N: The Reproductive Autoimmune Failure Syndrome: VIII International Congress of Reproductive Immunology, Opatija, Croatia, July 2-6, 2001, AJRI, 2001; 46:31-32

150. Gleicher, N: Cost-Effective IVF: 4th World Conference of A Part, Vienna, Austria, June 28-30 2002, Journal of Assisted Reproduction and Genetics, May 2002; 19:253

151. Gleicher, N: Dehydroepiandrosterone (DHEA) treatment improves response to ovulation induction: 21st Meeting of The European Society of Human Reproduction and Embryology, Copenhagen, Denmark, June 19-22, 2005; 20:S1:i74

152. Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) Pre-Treatment and Ovulation Induction for In Vitro Fertilization among Women with a History of Decreased Ovarian Reserve: Fertility and Sterility: ASRM/CFAS 2005, American Society for Reproductive Medicine, Montreal, Quebec, September 2005, Vol 84, Sup 1.

153. Barad D, Gleicher N: Effect of Race in Ovulation Induction, Oocyte Recovery, and Pregnancy Outcome in In-Vitro Fertilization: Fertility and Sterility: ASRM/CFAS 2005, American Society for Reproductive Medicine, Montreal, Quebec, September 2005, Vol 84, Sup 1.

154. Gleicher N: Can we affect the aging ovary, after all?: 8th Annual Meeting of the Japan Society of Assisted Reproduction, Osaka, Japan, September 2005, Issn 1880-4950, Vol 8.

155. Gleicher N, Barad D: Effect of Transdermal Testosterone Application. Hum Reprod 2006; 21: 3027-3031.

156. Gleicher N: Decision Models and their Application. Fertil Steril 2006; 85:813-814.

157. Weghofer A, Munne S, Brannath W, Chen S, Cohen J, Gleicher N: The quantative and qualitative impact of gonadotropin stimulation on human preimplantation embryos. Fertil Steril 2006; 86: S124-5.

158. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished ovarian reserve (DOR), resistance to stimulation and diagnosis of premature ovarian aging (POA), based on age-specific baseline. Fertil Steril 2006; 86:S125-6.

159. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature again ovaries. Fertil Steril 2006; 86:S401.

160. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at risk for chromosomally abnormal embryos? The association between embryonic aneuploidy rates and POA. Fertil Steril 2006; 86:S403-4.

161. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006; 86: S124-5.

162. Weghofer A, Barad D, Gleicher N: Premature Ovarian Aging (POA) is not characterized by an increase in aneuploidy rates. Hum Reprod Abstract Book 2006; 21: Supplement 1: i8.

163. Gleicher N, Barad D: The effect of dehydroepiandroserone on diminished ovarian reserve. Hum Reprod Abstract Book 2006; 21: Supplement 1: i69.

164. Gleicher N: A difficult decision. J Asst Reprod Genet 2007; 23: 3-4. 165. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association

between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 86:S462.

166. Singer T, Barad D, Gleicher N: A comparison of serum anti-mullerian hormone and cycle baseline follicle stimulating hormone in prediction of ivf outcomes. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

167. Barad D, Weghofer A, Gleicher N: Age-specific cut-offs for FSH assessment of ovarian function: improved diagnosis of premature ovarian aging (POA). American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

168. Gleicher N, Weghofer A, Barad D: Increased euploid embryos after supplementation with DHEA in women with premature ovarian aging. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

169. Gleicher N, Barad D: Does gender selection devalue women? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

170. Weghofer A, Brill H, Barad D, Gleicher N: Does autoimmunity play a causative role in the pathophysiology of premature ovarian aging (POA)? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

171. Gleicher N, Weghofer A, Li J-M, Barad D: Increased risk of POA in Chinese women. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

172. Barad D, Gleicher N, Weghofer A, Chen S, Cohen J: Validation of age-specific cut-offs for ovarian function assessment by FSH levels via a second patient population: inherent differences in patient populations between IVF centers. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

173. Gleicher N, Barad D: The impact of DHEA supplementation on IVF pregnancy rates in women ages 40-47 years. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

174. Barad D, Gleicher N: Implantation rate and pregnancy rates following all freeze cryopreservation cycles compared to those following cryopreservation of excess embryos. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

175. Oktay K, Sahin G, Ucar F, Barad D, Blanchette H, Gleicher N: Fertility preservation is an emerging discipline extending beyond cancer patients: analysis of a large experience.” Fertil Steril 2008; 90(Supl): S51.

176. Oktay K, Oktem O, Barad D, Gleicher N: “Longevity of autologous ovarian transplants: extended experience in humans.” Fertil Steril 2008; 90(Supl): S53.

177. Gleicher N, Weghofer A, Oktay K, Barad D. “Relevance of low expansion CGG triple repeat numbers on the FMR1 gene to functional ovarian reserve.” Fertil Steril 2008; 90(Supl): S58.

178. Oktay K, Barad D, Gleicher N, Smotkin-Tangorra M. “Retrieval and cryopreservation of large number of oocytes from a 15 year old with primary amenorrhea and diagnosis of premature ovarian failure.” Fertil Steril 2008; 90(Supl): S91.

179. Gleicher N, Weghofer A, Oktay K, Barad D: “Autoimmune function and numbef or triple CGG expansions on the FMR1 gene as independent risk factors for premature ovarian senescence.” Fertil Steril 2008; 90(Supl): S151.

180. Oktay K, Kim JY, Barad D, Gleicher N, Blanchett H: “Serum FSH monitoring improves decision making in women undergoint controlled ovarian hyperstimulation with letrozole and follicle stimulating hormone.” Fertil Steril 2008; 90(Supl): S183.

181. Klein K, Stammler-Safar M, Krampl E, Gleicher N, Barad D, Weghofer A: “The impact of fetal sex on prematurity in dichorial-diamniotic twin pregnancies after assisted reproduction.” Fertil Steril 2008; 90(Supl): S209.

182. Barad DH, Weghofer A, Oktay K, Gleicher N: “Triple CGG expansions on the FMR1 gene and response to ovarian stimulation.” Fertil Steril 2008; 90(Supl): S233.

183. Gleicher N, Ryan E, Weghofer A, Oktay K, Blanco-Mejia S, Barad DH: “Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished ovarian reserve: a multicenter study.” Fertil Steril 2008; 90(Supl): S258-259.

184. Gleicher N, Weghofer A, Oktay K, Barad D: “The distribution of causative etiologies in infertile women with a diagnosis of spontaneous premature ovarian senescence, exclusive of end-stage premature ovarian failure (POF).” Fertil Steril 2008; 90(Supl): S259.

185. Barad D, Oktay K, Weghofer A, Gleicher N: “Anti-Mullerian hormone (AMH), but not follicle stimulating hormone (FSH), correlates to oocyte yield in in vitro fertilization.” Fertil Steril 2008; 90(Supl): S259-260.

186. Goyal A, Barad DH, WEghofer A, Oktay K, Gleicher N. Predicting improvements in ovaian reserve and pregnancy rates after supplementation of dehydroepiandrosterone (DHEA) in diinihshed ovarian reserve. Hum Reprod 2009;24 (Suppl1):i79.

187. Barad DH, Wefhtoer A, Oktay K, Gleicher N. What are the effects of race/ethnicity on triple CGG counts on the FMR1 (fragile X) gene? Hum Reprod 2009;24(Suppl 1):i100.

188. Oktay K, Turkcuoglu I, Barad DH, Gleicher N, Kim JY. Prospective comparison of letrozole-FSH stimulation followed by hCG vs GnRH for fertility preservation in women with breast cancer. Hum Reprod 2009;24(Suppl 1):i119-i120.

189. Gleicher N, Weghofer A, Oktay K, Barad DH. A potential new function of the FMR1 (fragile X) gene: Regulation of functional ovarian reserve. Hum Reprod 2009;24(Suppl1):i97.

190. Gleicher N. Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range and median. Fertil Steril 2009;92(Suppl):S13.

191. Gleicher N, Goyal A, Weghofer A, Barad DH. Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-Müllerian hormone levels. Fertil Steril 2009;92(Suppl):S54-5.

192. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone (AMH) levels discriminate at each age between poorer and better oocytes yields. Fertil Steril 2009;92(Suppl):S101.

193. Barad DH, Weghofer A, Goyal A, Gleicher N. Further refinement in defining the effect of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition of distinct subgroup of PCOS patients, based on normal/low genotype. Fertil Steril 2009;92(Suppl):S105.

194. Gleicher N, Weghofer A, Barad DH. The FMR1 gene, a regulator of functional ovarian reserve over reproductive life times. Fertil Steril 2009;92(S174-5).

195. Barad DH, Weghofer A, Goyal A, Gleicher N. What does discordance between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) mean? Fertil Steril 2009;92(Suppl):S178.

196. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are extremely low levels of anti-Müllerian hormone (AMH)? Fertil Steril 2009;92(Suppl):S178-9.

197. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific anti-Mullerian hormone (AMH) levels in a fertile cohort: not as stable as previously thought. Hum Reprod 2010;25(suppl1):i2-3.

198. Barad DH, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by heterozygous-normal/low genotype on the FMR1 (fragile X) gene. Hum Reprod 2010;25(Suppl1):i82-83.

199. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually "young"; it is the ovarian environment in which folliculogenesis occurs that ages. Hum Reprod 2010;25(Suppl1):i295.

200. Lee I, Barad DH, Weghofer A, Gleicher N. New evidence as an explanation for the negative impact of autoimmunity on reproductive success in association with IVF. Hum Reprod 2011;26 (Suppl 1):i20-21.

201. Gleicher N, Weghofer A, Barad DH. The impact of ovarian FMR1 genotypes and sub-genotypes in young oocyte donors on ovarian reserve and recipient pregnancy rates. Hum Reprod 2011;26 (Suppl 1):i72-73.

202. Vidali A, Barad DH, Gleicher N. Successful treatment with intrauterine perfusion of granulocyte colony stimulating factor (G-CSF) of chronically intractable thin endometrium. Hum Reprod 2011;26 (Suppl 1):i222-223.

203. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low anti-Mullerian hormone levels. Hum Reprod 2011;26 (Suppl1):i335.

204. Gleicher N, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Barad DH. Androgen dynamics in women with diminished functional ovarian reserve (DOR) after dehydroepiandrosterone (DHEA) supplementation. Fertil Steril 2012;98 (Suppl 3):S201.

205. Weghofer A, Kim A, Barad DH, Gleicher N. Increased recipient pregnancy rates are associated with CGGn on donors’ FMR1 genes. Fertil Steril 2012;98 (Suppl 3): S269-S270.

206. Weghofer A, Himaya E, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Is immune system activation/systemic inflammation a prerequesite for successful reproduction? Association of immune system activation with embryo quality during in vitro fertilization (IVF) ? Fertil Steril 2013;100(3): S329.

207. Weghofer A, Himaya E, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Further evidence for an association between immune system activation/systemic inflammation and androgen levels in infertile women. Fertil Steril 2013;100(3): S329.

208. Kushnir VA, Himaya E, Barad DH, Shohat-Tal A, Gleicher N. Adrenal response to cosyntropin (ACTH) stimulation in patients with premature ovarian senescence. Fertil Steril 2013;100(3): S161-162.

209. Kushnir VA, Vidali A, Barad DH, Gleicher N. Transparency of public reporting fo clinical outcomes in assisted reproductive technology. Fertil Steril 2013;100(3): S146.

210. Himaya E, Barad DH, Kushnir VA, Shohat-Tal A, Lee HJ, Gleicher N. Does the FMR1 gene affect IVF pregnancy rate via oocytes or embryo quality? Fertil Steril 2013;100(3): S93.

211. Lazzaroni E, Gelicher N, Yu Y, Kushnir VA, Shohat-Tal A, Barad DH. A new oocyte scoring system with better predictability for clinical pregnancy than day 3 embryo quality. Fertil Steril 2013;100(3): S502.

212. Lee HJ, Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Gleicher N. Differences observed during in vitro maturation (IVM) of immature oocytes from women with diminished functional ovarian reserve (DFOR) and women with normal ovarian reserve (NOR). Fertil Steril 2013;100(3): S232.

213. Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Synergistic effects of androgen supplementation and follicle stimulating hormone (FSH) on 3 consecutive IVF cycles in women with diminished functional ovarian reserve (DFOR). Fertil Steril 2013;100(3): S519-520.

214. Lee HJ, Sen A, Barad DH, Kushnir VA, Shohat-Tal A, Gleicher N. NPR2, SMAD2/3, BMP and GDF-9 expressions in human granulosa and cumulus cells during oocyte maturation. Fertil Steril 2013;100(3): S233.

215. Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. Prospective randomized study of endometrial perfusion with granulocyte colony-stimulating factor (G-CSF) in unselected IVF cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril 2013;100(3): S144.

216. Shohat-Tal A, Kushnir VA, Barad DH, Gleicher N. Genetics of exogenous dehydroepiandrosterone (DHEA) conversion to testosterone (T) in hypoandrogenic women as tool to individualized infertility treatments. Fertil Steril 2013;100(3): S162.

217. Kushnir VA, Himaya E, Barad DH, Weghofer A, Gleicher N. Functional ovarian reserve assessments in young oocyte donors based on FMR1 genotypes and sub-genotypes. Fertil Steril 2013;100(3): S114.

218. Elkayam U, Gleicher N. Preventing congenital neonatal heart block in offspring of mothers with anti-ssa/ro and anti-SSB/La antibodies: review of literature and registered trials. Fertil Steril 2013;100(3): S375.

219. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. The impact of thyroid function on embryo quality for in vitro fertilization (IVF). Fertil Steril 2013;100(3): S333.

220. Himaya E, Weghofer A, Kushnir VA, Shohat-Tal A, Barad DH, Gleicher N. Association of FMR1 sub-genotypes with embryo aneuploidy and miscarriage rates following in-vitro fertilization (IVF). Fertil Steril 2013;100(3): S190.

221. Shohat-Tal A, Lazzaroni E, Kushnir VA, Barad DH, Gleihcer N. Correlation between fragile-x mental retardation protein (FMRP) levels in peripheral blood lymphocytes and in granulosa cells of preovulatory follicles in IVF cycles. Fertil Steril 2013;100(3): S230.

222. Barad DH, Lahtam GJ, Filipovic-Sadic S, Kushnir VA, Shohat-Tal A, Gleicher N. Following previously described ovarian phenotypes of the FMR1 gene, methylation fractions were significantly skewed between FMR1 genotypes and sub-genotypes. Fertil Steril 2013;100(3): S345.

223. Barad DH, Khanna P, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Differences in amh assessments between standard and new high sensitivity AMH assays and impact on prediction of ivf outcomes. Fertil Steril 2014. 10:77.

224. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Effects of advancing female age on proliferation and gene expression in cultured human granulosa cells from post-hCG retrieved follicles. Fertil Steril 2014. 101(3): e331-e332.

225. Wu Y-G, Lee HJ, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Sen A, Gleicher N. The effects of dehydroepiandrosterone (DHEA) on cultured human granulosa cells from postovulatory human follicles after in vitro fertilization (IVF). Fertil Steril 2014. 102(3): e272.

226. Khanna P, Kushnir VA, Barad DH, Gleicher N. Live births rates following oocyte donation reflect performance of IVF centers in autologous IVF cycles. Fertil Steril 2014. 102(3): e340.

227. Kushnir VA, Khanna P, Barad DH, Gleicher N. Assesment of practice in IVF clinics in which success in autologous and donor oocyte cyles do not correlate. Fertil Steril 2014. 102(3): e113-e114.

228. Kushnir VA, Wu Y-G, Chen I-C, Lee H-J, Barad DH, Lazzaroni-Tealdi E, Gleicher N. Mitochondrial DNA abundance declines in human cumulus granulosa cells with age. Fertil Steril 2014. 102(3): e331.

229. Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH, Kushnir VA, Gleicher N. Aging is associated with differential gene expression in human granulosa and cumulus cells leading to rapid progression of meiotic and oocyte maturation competence. Fertil Steril 2014. 102(3): e200-e201.

230. Vega M, Barad DH, Weghofer A, Kushnir VA, Gleicher N. Evidence that a degree of mucosal inflammation is beneficial for pregnancy success in association with IVF. Fertil Steril 2014. 102(3): e279-e280.

231. Kushnir VA, Barad DH, Albertini, DF, Darmon SK, Gleicher N, Cryopreserved Donor Oocytes Yield Significantly Lower Birth Rates Than Fresh Oocytes. ASRM Annual Meetings, Baltimore, USA, 10/20/2015

232. Wu Y, Albertini DF, Wang Q, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N, Functional Characterization Of Cultured Human Granulosa Cells In Serum Free Culture System. ASRM Annual Meetings, Baltimore, USA, 10/21/2015

233. Vega M, Barad DH, Darmon SK, Kushnir VA, Gleicher N, Utility Of Autologous Fresh IVF Cycles In Extremely Poor Prognosis Patients. ASRM Annual Meetings, Baltimore, USA, 10/21/2015

234. Vega M, Barad DH, Darmon SK, Kushnir VA, Gleicher N, Live Birth Rates In Very Poor Prognosis Patients With Non-Elective Single (neSET), 2-Embryo (2-ET) And ≥3-Emrbyo Transfers (≥3-ET). ASRM Annual Meetings, Baltimore, USA, 10/21/2015

235. Wu Y, Lazzaroni-Tealdi E, Wang Q, Albertini DF, Barad DH, Kushnir VA, Gleicher N, Randomized Comparison Of Embryo Development In Closed Time-Laspse Photography System With Traditional Standard Embryology Culture With Day-3 Embryo Transfers. ASRM Annual Meetings, Baltimore, USA, 10/21/2015.

236. Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, Wu YG, Wang Q, Zhang L, Albertini DF. Mosaicism in human embryos compromises accuracy of preimplantation genetic screening (PGS). Reprod Sci Suppl. 2016;O-162.

237. Wu YG et al. What is the best lead follicle size for ovulation induction in older women ≥43 years to avoid premature luteinization of follicles? Fertil Steril 2016;106(3):e349–e350.

238. Kushnir VA et al. Effects of newly introduced practices over 10 years (2004-2013) on worldwide trends in assisted reproductive technology. Fertil Steril 2016;106(3):e365.

239. Kushnir VA et al. Utilization and effects of embryo banking on art outcome reporting in the U.S. Fertil Steril 2016;106(3):e333.

240. Barad DH et al. Prevalence and effect of preimplantation genetic screening (PGS) on oocyte donation cycles in the United States: 2005 to 2013. Fertil Steril 2016;106(3):e330.

241. Kushnir VA et al. Contribution of third party reproduction to the birth cohort following art in the U.S.A. Fertil Steril 2016;106(3):e108.

242. Barad DH et al. Contribution of cryopreservation cycles to cumulative live birth outcomes following oocyte donation with preimplantation genetic screening (PGS) in the United States: 2005 to 2013. Fertil Steril 2016;106(3):e321.

243. Shapiro AJ et al. Racial and ethnic disparities in the use of third-party art in the U.S. Fertil Steril 2016;106(3):e108-e109.

244. Shapiro AJ et al. Effect of race and ethnicity on live birth rates in third-party art cycles in the U.S. Fertil Steril 2016;106(3):e367.

245. Kushnir VA et al. Effect of race and ethnicity on fertility rates and utilization of art in the USA. Fertil Steril 2016;106(3):e367-e368.

246. Barad DH et al. Effect of time trends of preimplantation genetic screening (PGS) utilization on oocyte donation cycle live birth rates in the United States: 2005 to 2013. Fertil Steril 2016;106(3):e326.

247. Gleicher N et al. Preimplantation genetic screening (PGS) appears unable to correctly determine ploidy of embryos from a single trophectoderm biopsy (TEB). Fertil Steril 2016;106(3):e371.

248. Barad DH et al. Effect of PGS on IVF outcomes following eSET in oocyte donation in the United States: 2005 to 2013. Fertil Steril 2016;106(3):e209.

249. Albertini DF, et al. Ontogeny of newly described hypo-androgenic PCOS phenotype in infertile women from younger through older ages. Hum Reprod 2017;32(Supp1):i447.

250. Barad DH, et al. Prevalence and impact of elective gender selection in oocyte donor recipient cycles in the United States 2005-2013. Hum Reprod 2017;32(Supp1):i481.

251. Barad DH, Kushnir VA, Albertini DF, Darmon SK, Gleicher N. Does gender selection in donor-recipient cycles affect IVF cycle outcomes? Fertil Steril 2017;108(3):e342-343.

252. Kushnir VA, Choi J, Darmon SK, Albertini DF, Barad DH, Gleicher N. CDC reported assisted reproductive technology (art) live birth rates are misleading to the public. Fertil Steril 2017;108(3):e333.

253. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Declining birth rates from IVF over the last decade due to commoditization and industrialization. Fertil Steril 2017;108(3):e344.

254. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Deterioration of inherent treatment prognosis of infertility patients over the last 5 years (2012-2016). Fertil Steril 2017;108(3):e344-345.

255. Shapiro A, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Do serum vitamin d and anti-mullerian hormone levels correlate in reproductive-age women? Fertil Steril 2017;108(3):e219-220.

256. Wang Q, Kushnir VA, Darmon SK, Barad DH, Wu Y-G, Zhang L, Albertini DF, Gleicher N. Reduced mRNA levels of the FMR1 gene and changes of gene expression of cyp19 and FSHR in infertile women with low (CGGn < 26) repeats. Fertil Steril 2017;108(3):e143.

257. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Barad DH, Gleicher N. Oocyte size and morphology predict embryo quality. Fertil Steril 2018;110(4):e309-e310.

258. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Barad DH, Gleicher N. Association between characteristics of infertile patients and oocyte measurements. Fertil Steril 2018;110(4): e310.

259. Kushnir VA, Hu J, Barad DH, Weghofer A, Gleicher N. Sexual function in older premenopausal infertile women does not correlate with patient demographics and endocrine parameters. Fertil Steril 2018;110(4): e157.

260. Weghofer A, Darmon SK, Kushnir VA, Albertini DF, Barad DH, Gleicher N. The ovarian sensitivity index (OSI) predicts embryo quality in oocyte donors. Fertil Steril 2018;110(4): e317.

261. Weghofer A, Darmon SK, Kushnir VA, Gleicher N, Barad DH. Euploid miscarriage is associated with elevated serum C-reactive protein levels in infertile women. Fertil Steril 2018;110(4): e129-e130.

Letters 1. Gleicher N: Letter of response. JAMA, 1985; 254:3247-3249 2. Gleicher N: The fetus is a graft, both biologically and legally. Fertil Steril, 1985; 44:280 3. Gleicher N: Hypertensive diseases of pregnancy: Nulliparity, primiparity, multiparity,

and gravidy. Am J Obstet Gynecol, 1987; 157:1011 4. Gleicher N: Cesarean section rates in the United States. JAMA, 1985; 253:3248-3249 5. Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease?

Obstet Gynecol, 1988; 71:280-282 6. Boler L, Zbella E, Gleicher N: Quantitation of proteinuria in pregnancy by the use of

single voided urine samples. Obstet Gynecol, 1988; 71:143 7. Myers S, Gleicher N: A program to lower cesarean section rates. N Engl J Med, 1989;

320:1694 8. El-Roeiy A, Dmowski W, Radwanska E, Harlow L, Binor Z, Tummon I, Rawlins R,

Gleicher N: Endometriosis and autoantibodies. Fertil Steril, 1989; 51:1069 9. Confino E, Gleicher N: Letter in response. Fertil Steril, 1990; 53:581 10. Gleicher N, El-Roeiy A: Letter in response. Am J Obstet Gynecol, 1990; 162:867 11. Myers S, Gleicher N: 1988 U.S. cesarean-section rate: Good news or bad? N Eng J Med,

1990; 323-200 12. Gleicher N: Mandatory trial of Labor after cesarean delivery: An alternative viewpoint.

N Eng J Med, 1991; 78:727 13. Gleicher N, Pratt D, Dudkiewicz A: The association of antiphospholipid antibodies with

pregnancies complicated by fetal growth restriction. Obstet Gynecol, 1992; 79:637-638 14. Gleicher N, Dudkiewicz A, Pratt D: Biochemical pregnancies or heterophil antibodies?

Fertil Steril, 1992; 57:1363-1366 15. Gleicher N, Pratt D, Dudkiewicz A: Autoantibodies in in vitro fertilization patients.

Fertil Steril, 1992; 58:863 16. Gleicher N, Liu H, Rosenwaks Z: Autoantibody profiles as a predictor of in vitro

fertilization-embryo success. Am J Obstet Gynecol, 1995; 172: 1637-1638 17. Gleicher N, Karande V, Rao R, Balin M, Pratt D: Multiple births in couples with

infertility problems. Hum Reprod, 1995; 10: 2748-2749 18. Karande V, Rao R, Pratt D, Balin M, Levrant S, Morris R, Dudkiewica A, Gleicher N:

The efficacy of “tubal sperm perfusion”? Fertil Steril, 1996; 66: 169-170 19. Karande V, Rao R, Pratt D, Levrant S, Balin M, Morris R, Dudkiewicz A, Gleicher N:

Reply to the reply on IUI, Fertil Steril, 1997; 67: 1178-1179 20. Gleicher N, Zbella E: Case reports- spam or ham? Fertil Steril, 1998; 70:388-389 21. Gleicher N, Coulam C: Relationship of anti-FSH antibodies to ovarian failure? Fertil

Steril, 1998; 70: 1185 22. Karande V, Gleicher N: Response to letter to the editor. Fertil Steril, 1999; 72: 566-567 23. Karande V, Gleicher N: The diameter of the proximal tube – large enough for a single

sperm or do you need more? Fertil Steril, 1999; 72(5): 950 24. Gleicher N, Brown T, Dudkiewicz A, Karande V, Rao R, Balin M, Campbell D, Pratt D:

Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles – but only in younger women. Early Pregnancy, 2000; 4:064-073

25. Gleicher N, Vidali V, Karande V: Risks of multiple pregnancy – the decision belongs to whom? Fertil Steril, August 2001; 76(2): 423-24

26. Gleicher N: Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses. American Journal of Reproductive Immunology, 2002; 48: 252-254

27. Gleicher N: Mixed opinions on egg sharing. The Lancet, 2003; 362: 1502 28. Gleicher, N: Sex presentation and full disclosure. Fertil Steril, 2003; 80:469-470 29. Gleicher N: Pessimism and optimism. Fertil Steril, 2004; 81: 221 30. Gleicher N: A step backward or forward to somatic cell hybrids? Fertil Steril, 2005; 83:

1585-1586 31. Gleicher N: Prediction models for high-order multiple pregnancy. Fertil Steril, 2005; 83:

1888-1889. 32. Gleicher N: Measure of diagnostic accuracy for hysterography? Fertil Steril, 2005; 84;

1059-1060. 33. Gleicher N: Decision models and their applications. Fertil Steril 2006; 85: 813-814;

(author reply 813-4). 34. Gleicher N: Appropos Political Editorials. The Lancet 2006; 368:1325-6. 35. Gleicher N, Barad D: Effects of transdermanl testosterone application on the ovarian

response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized double-blind study. Hum Reprod. 2006; 21; 3027-3031.

36. Gleicher N, Weghofer A, Barad D: On the benefit of assisted reproduction techniques, a comparision of the USA and Europe. Hum Reprod, 2006; 10: 1093.

37. Gleicher N, Weghofer A, Barad D: Letters to the Editor. Hum Reprod 2006; 624-626. 38. Gleicher N, Barad D: Correspondance, To the Editor. NEJM 2007; 6: 636. 39. Gleicher N: (Postpartum) Depression, an autoimmune disease? AutoImm Reviews 2007;

6(8): 572-6. 40. Gleicher N, Barad D: Mild versus standard in-vitro fertilization techniques. Lancet 2007;

369: 1855. 41. Weghofer A, Barad D, Gleicher N: Quality of residual follicles may depend on the

etiology of ‘declining’ ovarian function? Reply of the authors. Fertil Steril 2007; 88: 1481.

42. Gleicher N: Letter to the editor. Hum Reprod 2008. 43. Gleicher N and Weghofer A. Letter to the editor: topic/ Hum Reprod. 2009. 44. Oktay K, Sonmezer M, Barad D, Gleicher N: Trying to reduce ovarian damage in

patients with Hodgkin lymphoma using GnRH agonists? Fertil Steril 2009; 91: 298-299. 45. Gleicher N and Barad D: Androgen priming before ovarian stimulation for IVF. Hum

Reprod 2008; 2868-71. 46. Gleicher N and Weghofer A: Why depression is associated with increased risk toward

premature labor. Hum Reprod 2009. 47. Barad D, Weghofer A, Gleicher N: Premature ovarian failure and

dehydroepiandrosterone. Fertil Steril 2009;91(5):e16. 48. Barad D, Gleicher N: Less may, indeed, be less: multi-collinearity in studies of ovarian

reserve. Fertil Steril 2009;91(5):e16. 49. Gleicher N, Barad DH: Androgen priming before ovarian stimulation for IVF. Hum

Reprod 2009;23:2868-70. 50. Barad DH et al.: Premature ovarian failure and dehydroepiandrosterone. Fertil Steril

2009;91 (5):e14.

51. Weghofer et al.: Reply: Possible impact of LH-contaning gonadotrophins on diploidy rates in preimplantataion embryos. Hum Reprod doi: 10.1093/humrep/den478.

52. Gleicher N and Weghofer A. Why depression is associated with increased risk towards premature labor. Hum Reprod 2009, doi: 10.1093/humrep/den470.

53. Gleicher N Weghofer A and Barad DH. To the Editor, on Sunkara et al. Hum Reprod 2011 [http://humrep.oxfordjournals.org/content/early/2011/04/18/humrep.der106/reply#humrep_el_182].

54. Gleicher N, Weghofer A, Barad DH. Letter to the editor, Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum Reprod 2012 [http://humrep.oxfordjournals.org/content/early/2012/05/21/humrep.des161.extract].

55. Kushnir VA, Vidali A, Barad DH, Gleicher N. Reply of the authors. Fertil Steril 2013;100(3):e18.

56. Kushnir VA, Barad DH, Gleicher N, Vidali A. Reply of the authors. Fertil Steril 2013;100(4):e26.

57. Kushnir VA, Barad DH, Gleicher N. Defining assisted reproductive technology success. Fertil Steril 2013;100(4):e30.

58. Kushnir VA, Barad DH, Gleicher N. Association of abnormal obarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol 2013;121(6):1361.

59. Gleicher N, Kushnir VA, Barad DH. The danger of ignoring pregnancy and delivery rates in ART. Hum Reprod 2014; 29(8):1828-9.

60. Gleicher N, Kushnir VA, Barad DH. What misguided campaign against SET? Hum Reprod 2014;29(2):380-382.

61. Gleichier N, Kushnir VA, Barad DH. Fertiliy treatments and multiple births in the United States, NEJM 2014;370:1069-1071.

62. Gleicher N, Barad DH, Kushnir VA, Sen A, Weghofer A. Poor responders and androgen ajuvant treatment: “Still haven’t found what I’m looking for...” Reprod Biomed Online 2014;29(5):650-652.

63. Gleicher N, Kushnir VA, Barad DH. Euploid single-embryo transfer is not the new IVF paradigm. Contemporary OBGYN 2014.

64. Barad DH, Kushnri VA, Albertini DF, Gleicher N. CDC analysis of ICSI/autism: association is not causation. Hum Reprod 2015;30(7):1745-6.

65. Kushnir VA, Barad DH, Gleicher N. Intracytoplasmic sperm injection and reproductive outcomes. JAMA 2015;313(16):1672.

66. Kushnir VA, Barad DH, Gleicher N. Advanced reproductive age and maternal mortality. Obstet Gynecol 2015;125(4):984.

67. Kushnir VA, Barad DH, Gleicher N. Intracytoplasmic sperm injection and reproductive outcomes. JAMA. 2015;313:1672.

68. Kushnir VA, Barad DH, Gleicher N. Fresh vs Cryopreserved Donor Oocytes--Reply. JAMA 2015;314(23):2570.

69. Gleicher N, Kushnir VA, Albertini DF, Barad DH. Letter to the Editor: Including the Zona Reticularis in the Definition of Hypoadrenalism and Hyperadrenalism. J Clin Endocrinol Metab 2017;102(9):3569-70.

70. Gleicher N, Kushnir VA, Albertini DA, Barad DH. First birth following spindle transfer. Reprod Biomed Online 2017;35(5):542-543.

Invited Editorials and Book Chapters

1. Gleicher N: Editorial; Am J Reprod Immunol l980; l:l. 2. Gleicher N, Siegel I: The immunologic concept of EPH gestosis. In Reproductive

Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:229-243. 3. Gleicher N, Siegel I: Common denominators of pregnancy and malignancy. In

Reproductive Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:339-353. 4. Siegel I, Gleicher N: Fetal and maternal red cell immune adherence (RCIA) receptors.

In Reproductive Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:ll5-l20. 5. Siegel I, Gleicher N: The development of the fetal immune system. In Reproductive

Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:31-40. 6. Theofilopoulos A, Gleicher N, Pereira A, Dixon F: The biology of immune complexes

and their possible role in pregnancy. In Reproductive Immunology, Gleicher N, ed., Alan R. Liss, Inc; l98l:93-ll4.

7. Siegel I, Gleicher N. Changes in peripheral mononuclear cells in pregnancy. Am J Reprod Immunol l98l; l:l54-l55.

8. Gleicher N, Siegel I, Cederquist LL: Do glucocorticosteroids affect the fetal immune system? Am J Reprod Immunol l98l; l:l85.

9. Gleicher N, Elkayam U: Intrauterine dysrhythmias. In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:5-26.

10. Gleicher N, Elkayam U: Intrauterine congestive heart failure. In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:61-78.

11. Gleicher N, Elkayam U: When should pregnancy be contraindicated in cardiac patients? In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:153-160.

12. Elkayam U, Gleicher N: Primary pulmonary hypertension and pregnancy. In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:305-316.

13. Elkayam U, Gleicher N: Physiologic changes during normal pregnancy and the puerpurium A. Cardiovascular. In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:535-564.

14. Elkayam U, Gleicher N: Endocardial endocarditis and pregnancy. In Cardiac Problems in Pregnancy, Gleicher N and Elkayam U, eds., Alan R. Liss, Inc; 1982:565-578.

15. Toder V, Blank M, Gleicher N, Voljovich I, Mashiash S, Nebel H: The suppression of natural killer (NK) activity by pregnancy. Immunology of Reproduction, Proceedings of the 5th Symposium on the Immunology of Reproduction Varna, Bulgaria, May 25-29, 1982; 445-448.

16. Gleicher N, Siegel I: Pregnancy and the immune state. In Autoimmune Endocrine Disease, Davies TF, ed., John Wiley & Sons, Inc; 1983:225-245.

17. Siegel I, Liu TL, Gleicher N: Red cell immune adherence(picture & test). Yearbook of Science and the Future. Chicago: Encyclopedia Britannica, Inc., 1982.

18. Siegel I, Gleicher N: The red army. The Sciences: Official Organ of the New York Academy of Sciences, 1983 (January/February) 30-34.

19. Gleicher N, Friberg J: In Vitro fertilization in Illinois. The Female Patient October 1983; 8:3811-3816.

20. Adelsberg B, Gleicher N: Immune Complexes. Am J Reprod Immunol 1983; 3:152.

21. Elkayam U, Rotmensch H, Gleicher N: Treating the arrhythmias of pregnant patients. Contemp Ob/GYN June 1984; pp 55-70.

22. Confino E, Zbella E, Elkayam U, Gleicher N: Using cardiac drugs during pregnancy. Drug Therapy 1985; 15:131-145.

23. Gleicher N: In Vitro Fertilization. Carl Wood and Alan Trounson, eds., Book Review, JAMA 1984; 252:3189.

24. Elrad H, Wall D, Agrawala G, Stankeyvych G, Elkayam U, Gleicher N: Mother without cardiac history bears second child with heart block. Hospital Practice March 15, 1985; pp 100A-100E.

25. Gleicher N, Elkayam U: Principles of internal medicine in pregnancy. In Principles Of Medical Therapy In Pregnancy, Gleicher N and Elkayam U, eds., Plenum Publishing Corp.; 1985:3-7.

26. Gleicher N, Elkayam U: Fertility control in female patients with medical disease. In Principles Of Medical Therapy In Pregnancy, Gleicher N and Elkayam U, eds., Plenum Publishing Corp.; 1985:7-19.

27. Elrad H, Gleicher N: Physiologic changes during pregnancy. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:33-56.

28. Mayden K, Elrad H, Gleicher N: Obstetrical ultrasound in the management of pregnancy complicated by maternal and fetal disease. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:64-77.

29. Confino E, Gleicher N: Drug abuse during pregnancy. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:90-102.

30. Boler L Jr., Gleicher N: Maternal versus fetal rights. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:141.

31. Zbella E, Gleicher N: The pineal gland. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985: 269-271.

32. Confino E, Gleicher N: Metabolism during pregnancy. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:281-2.

33. Vermesh M, Gleicher N: Disorders of amino acid metabolism. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:283-285.

34. Smith P, Gleicher N: Disorders of nucleic acid metabolism. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp; 1985:289-294.

35. Zbella E, Gleicher N: Disorders of metals and metallo proteins. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:295-300.

36. Boler L Jr, Gleicher N: Disorders of carbohydrate metabolism. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:301-303.

37. Confino E, Gleicher N: Disorders of lipid metabolism pregnancy. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:303-308.

38. Vermesh M, Gleicher N: Disorders of connective tissue. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:308-311.

39. Elkayam U, Gleicher N: The evaluation of the cardiac patient during pregnancy. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:639-643.

40. Zbella E, Gleicher N: The oral cavity. In Principles of Medical Therapy in Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985: 811-813.

41. Gleicher N: Principles of autoimmunity in pregnancy. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:990-994.

42. Vermesh M, Gleicher N: Disorders of bone and bone mineral metabolism. In Principles Of Medical Therapy In Pregnancy, Gleicher N, ed., Plenum Publishing Corp.; 1985:1027-1033.

43. Elkayam V, Gleicher N: Cardiac arrhythmia during pregnancy. JAMA 1985; 254:1511 (answer to question).

44. Gleicher N: In Vitro Fertilization and Embryo transfer. Alan Trounson and Carl Wood eds., Book review; JAMA 1985; 254:2974.

45. Zaffaro N, Gleicher N: Making miracles: In Vitro Fertilization. Nan and Todd Tilton 46. Confino E, Mayden K, Gleicher N: Sonographic diagnosis of ectopic pregnancy. In

Ectopic Pregnancy, DeCherney AH, ed., Aspen Publishers, Inc; 1986: 35-51. 47. Gleicher N: The cesarean section epidemic. Mt Sinai J Med 1986; 53:563-565. 48. Elkayam U, Gleicher N: Pregnancy in the patient with heart disease. In Current Therapy

in Cardiovascular Disease - 2, Fortain NJ, ed., B.C.Decker, Inc; 1987:301-305. 49. Elkayam U, Gleicher N: Anticoagulation in pregnant women with artifical heart valves.

JAMA 1987; 316:1663. 50. El-Roeiy A, Gleicher N: The immunologic concept of pre-eclampsia (EPH Gestosis). In

Handbook of Hypertension, Rubin PC (ed), Elsevier Science Publishers B.V.; 1988:257-266.

51. El-Roeiy A, Gleicher N: Endometriosis and Autoimmunity. In Perspectives in Immunoreproduction: Conception and Contraception, Mathur S (ed), Hemisphere Publishing Corp.; 1988:177-191.

52. Gleicher N: A potential animal model for autoimmune reproductive failure. Am J Reprod Immunol Microbiol 1987; 14:122.

53. Gleicher N: Progress in infertility. Behrman ed, Book Review, JAMA 1988; Volume: 3628-3629.

54. Gleicher N: The physiological role of autoantibodies in reproduction. Proceedings of the 4th International Congress of Reproductive Immunology, Kiel, FRG, July 26-29, 1989. J Reprod Immunol (Suppl).

55. Gleicher N: IVF and immunological infertility. In Advances in Assisted Reproductive Technologies, Mashiach S, Ben-Rafael Z, Laufer N, Schenker J, eds., Plenum Press, New York; 1989:459-463.

56. Elkayam U, Gleicher N: Hemodynamics and cardiac function during normal pregnancy and the puerperium. In Cardiac Problems in Pregnancy, 2nd Edition, Elkayam U, Gleicher N, eds., Alan R. Liss, Inc, New York; 1990:5-24.

57. Elkayam U, Gleicher N: Changes in cardiac findings during normal pregnancy. Idem 1990:31-38.

58. Elkayam U, Gleicher N: Diagnostic approaches to maternal heart disease during pregnancy. Idem 1990:41-45.

59. Elkayam U, Cobb T, Gleicher N: Congenital heart disease and pregnancy. Idem 1990:73-98.

60. Elkayam U, Gleicher N: Primary pulmonary hypertension and pregnancy. Idem 1990:189-197.

61. Gleicher N, Elkayam U: Fertility control in the cardiac patient. Idem 1990:453-460. 62. Gleicher N, Elkayam U: Fetal heart rate and rhythm disorders. Idem 1990:723-748.

63. Gleicher N, Elkayam U: Intrauterine therapy of rhythm and rate disorders. Idem 1990:749-763.

64. Confino E, Gleicher N: Pregnancy wastage with abnormal autoimmunity. In Immunology and Allergy Clinics of North America 1990:103-108.

65. Tur-Kaspa I, Gleicher N: Diagnosis Eclampsia. Hospital Med 1990; 26:55-68. 66. Gleicher N: Immunology of pregnancy: The relationship to autoimmune pathology. In

Pregnancy, Autoimmunity and Connective Tissue Disorders, Scott JS and Bird HA, eds., Oxford University Press; 1991:1-14.

67. Gleicher N: Autoimmunity and Reproductive Failure. In Frontiers in Human Reproduction, Vol 626, Markku Seppala, Lars Hamberger, eds., New York Academy of Sciences; 1991: 537-544.

68. Tur-Kaspa I, Gleicher N: Immunology of the uterus. In The Uterus Altcheck A, Deligdisch L, eds., Springer-Verlag Publishers; 1991:27-38.

69. Gleicher N: Discussion of Martin Jr JN, Blake PG, Perry Jr KG, McCaul JF, Hess LW, Martin RW: The material history of HELPP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164:1509-1510.

70. Gleicher N, Elkayam U: Fertility Control in the Female Patient with Medical Disease. In Principles and Practice of Medical Therapy in Pregnancy, 2d Edition, Gleicher N, ed., Appleton & Lange, Stamford, Connecticut; 1992:1-10.

71. Gleicher N, Elkayam U: Principles of Medical Care. Idem 1992:11-14. 72. Myers S, Gleicher N: Medical Records and Statistics. Idem 1992: 14-34. 73. Myers S, Gleicher N: Physiologic Changes in Normal Pregnancy. Idem 1992: 35-52. 74. Confino E, Gleicher N: Metabolism. Idem 1992:251-253. 75. Vermesh M, Gleicher N: Disorders of Amino Acid Metabolism. Idem 1992:253-255. 76. Boler L, Gleicher N: Disorders of Carbohydrate Metabolism. Idem 1992: 270-272. 77. Confino E, Gleicher N: Disorders of Lipid Metabolism. Idem 1992:272-276. 78. Tur-Kaspa I, Gleicher N: Disorders of Connective Tissue. Idem 1992:277-280. 79. Zilberstein ME, Gleicher N: Endocrinology. Idem 1992:281-300. 80. Tur-Kaspa I, Gleicher N: Disorders of the Hypothalamus and Pituitary. Idem 1992: 314-

321. 81. Zilberstein M, Feingold M, Gleicher N: Adrenal Disorders. Idem 1992:345-356. 82. Gleicher N: Autoimmunity. Idem 1992:413-421. 83. Gleicher N: The Pneumonias. Idem 1992:746-748. 84. Elkayam U, Gleicher N: The Evaluation of the Cardiac Patient. Idem 1992:759-762. 85. Vermesh M, Gleicher N: Disorders of Bone and Cartilage. Idem 1992:1170-1191. 86. Confino E, Gleicher N: Drug Abuse. Idem 1992:1214-1224. 87. Gleicher N: What’s New in Obstetrics and Gynecology. In Bulletin American College of

Surgeons 1992, 77:32-35. 88. Gleicher N: Autoimmunity in Obstetrics and Gynecology. In Immunological Obstetrics,

Coulam C, Faulk P, McIntyre J eds., Norton Medical Books. 1992:404-411. 89. Gleicher N. Pratt D: Transvaginal Procedures for Infertility. In Progress in Infertility (4th

edition), Behrman FJ, Patton GW, Holtz G eds., Little Brown & Co. 1994:225-248. 90. Gleicher N: Immunological Infertility and Its Diagnosis. In Infertility Male and Female,

Lunenfeld B, Insler V eds., Churchill Livinstone. 1993:353-368. 91. Gleicher N, Pratt D, Parrilli M: Diagnosis of Tubal Disease by Hysterosalpingography.

In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss; 1992:27-54.

92. Gleicher N, Pratt D, Parrilli M: Treatment of Tubal Disease by Hysterosalpingography and Selective Salpingography. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss; 1992:55-68.

93. Pratt D, Gleicher N, Parrilli M: Transvaginal Tubal Catheterization for Intratubal Insemination. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss; 1992:117-125.

94. Gleicher N: Doctors heal thyselves by making moral commitments. In Physicians Financial News ; supplement June 1992: S9-S10.

95. Gleicher N, Tur-Kaspa I: Transcervical Balloon Tuboplasty. Female Patient 1993;18:65-68.

96. Gleicher N: Autoantibodies and pregnancy loss: Lancet 1994; 343:747-748. 97. Gleicher N, Pratt D, Karande V, Rabin D, Dudkiewicz A: The autoimmune system in

assisted reproductive technology (ART). In Frontiers in Endocrinology, Vol 4, Mori T, Tominaga T, Aono T, Hiroi M eds., Ares-Symposia Publications 1994:199-204.

98. Gleicher N: Autoimmunity in reproduction. In Immunology and Allergy Clinics of North 99. Gleicher N: Unexplained infertility, endometriosis, and adenomyosis. In Allergy Clinics 100. Gleicher N: Editorial; Introduction - The worldwide collaborative observational

study and MULTI-Analysis on allogeneic leukocyte immunotherapy for recurrent abortion. Am J Reprod Immunol 1994; 32: 53-54.

101. Gleicher N, Pratt D, Dudkiewicz A: Que savons-nous vraiment des anomalies des auto-anticorps et de la maladie reproductive? Une revue critique. Contraception, Fertilité, Sexualité 1995; 23: 239-254.

102. Gleicher N: The credibility of the profession (Editorial). J Assist Reprod Genet 1995; 12: 661-662.

103. Karande V, Gleicher N: A comparison of abnormal findings during a GynecoRadiologic procedure. In Diagnostic Pelvic Imaging and Endoscopy in Gynecology. Brosen I, Wamsteker K, eds.; 1997 W.B. Saunders Co.

104. Morris R, Gleicher N: Genetic abnormalities, male infertility and ICSI (editorial). Lancet 1996; 347:1277.

105. Cusick W, Gleicher N: Multiple Conceptions, Implantation, and Prematurity, Assisted Reproduction Reviews, Copyright 1995 by Williams & Wilkins, Volume 5, No. 4.

106. Gleicher N, Demir R, Novas J, Myers S: Methods for Safe Reduction of Cesarean Section Rates, Cesarean Section - Guidelines for Appropriate Utilization by Bruce I. Flamm and Edward J. Quilligan, Editors.

107. Karande V, Gleicher N: Selective salpingography, Diagnostic Pelvic Imaging and Endoscopy in Gynecology. Brosen I, Wamsteker K, eds.; 1997 W.B. Saunders Co.

108. Gleicher N: The Subspecialty Contract. In Managed Care: Infertility and Reproductive Medicine Clinics of North America. Gleicher N, ed; W.B. Saunders Co. 1998; 9:61-69.

109. Gleicher N: The Need to Re-engineer Medical Care. Idem 1998; 9:97-106. 110. Gleicher N, Miller C, Pratt D: How to Evaluate Infertility Programs. Idem 1998;

9: 107-111. 111. Gleicher N: The Concept of Physician Practice Management Companies. Idem

1998; 9: 113-121.

112. Gleicher N: Be Aware of the Second Revolution: The Need to Expand the Market for Infertility Care and How to do it. (Editorial). J Assist Reprod Genet 1998; 4: 165.

113. Gleicher N: Forward - To Intrauterine Insemination. Allahbadia, ed; Rotunda Medical Technologies Pvt. Ltd. 1998.

114. Dmowski W, Gleicher N: Does Endometriosis Have an Adverse Effect on the Fertilization In Vitro and the IVF Outcome? J Assist Reprod Genet 1998; 9: 527-529.

115. Elkayam U, Gleicher N: Hemodynamics and Cardiac Function During Normal Pregnancy and the Puerperium. In Cardiac Problems in Pregnancy, 3rd Edition, Elkayam U, Gleicher N, eds. Wiley-Liss, New York, New York; 1998: 3-20.

116. Elkayam U, Gleicher N: Cardiac Evaluation During Pregnancy. Idem 1998: 23-32.

117. Cusick W, Buttino L Jr., Gleicher N: The Normal and Abnormal Fetal Heart Rate. Idem 1998: 553-560.

118. Buttino L Jr., Cusick W, Gleicher N: Fetal Heart Rate and Rhythm Disorders. Idem 1998: 583-602.

119. Cusick W, Buttino L Jr., Gleicher N: Intrauterine Therapy of Rhythm and Rate Disorders and Heart Failure. Idem 1998: 603-614.

120. Buttino L Jr., Gleicher N: Environmental Causes of Congenital Heart Abnormalities. Idem 1998: 721-724.

121. Buttino L Jr., Gleicher N: Fertility Control in the Female Patient with Medical Disease. In Principles & Practice of Medical Therapy in Pregnancy, 3rd Edition, Gleicher N, ed. Appleton & Lange, Stamford, Connecticut; 1998: 1-11.

122. Gleicher N, Elkayam U: Principles of Medical Care. Idem 1998: 12-15. 123. Buttino L Jr., Gleicher N: Effect of Managed Care on Obstetrics. Idem 1998:

120-122. 124. Coulam C, Gleicher N: Autoimmunity. Idem 1998: 521-528. 125. Gleicher N: History of Infectious Diseases in Pregnancy. Idem 1998: 567. 126. Elkayam U, Gleicher N: Evaluating the Cardiac Patient. Idem 1998: 908-910. 127. Gleicher N: Breast Implants. Idem 1998: 1358-1360. 128. Gleicher N: Reproductive Failure Prior to the Onset of Clinical Autoimmune

Disease. Rheumatology 1999; 38:485-487. 129. Gleicher N: Assessing Outcome. J Assist Reprod Genet 2001; 18:71-72 130. Gleicher N: High-Order Multiples. OB.GYN. NEWS September 1, 2001; 7 131. Gleicher N, Karande V: Forget About Ovulation Induction! Proceed Directly to

IVF. In 2nd World Congress on Controversies in Obstetrics Gynecology & Infertility Paris, France September 6-9, 2001: Ovulation Induction and Insemination; 211-215

132. Gleicher N: Reducing the Incidence of Multiple Births. In The Journal of the Bellevue Obstetrical & Gynecological Society 2001; XVII: 26-28.

133. Weghofer, A. Barad, D. Gleicher, N. Premature Ovarian Aging (POA) is Not Characterized by an Increase in Aneuploidy rates. Hum. Reprod. Abstract Book 2006; 21: i8.

134. Gleicher, N. Barad, D. The Effect of Dehydroepiandroserone on Diminished Ovarian Reserve. Hum. Reprod. Abstract Book 2006, 21: i69.

135. Gleicher N. A difficult decision. J Assist Reprod Genet 2007; 23:3-4. 136. Gleicher N. JARG Blog. J Assist Reprod Genet 2007; 24: 557-59.

137. Gleicher N and Barad D. Update on In Vitro Fertilization Approaches. US Obstetrics and Gynecology. 2008; 27-31.

138. Gleicher N and Barad DH. Dehydroepiandrosterone. How to Improve Your ART Success Rates: An Evidence-Based Review of Adjuncts to IVF. 2011;93-98.

139. Gleicher N. Autoimmunity and Pregnancy. In Immunology of Pregnancy 2013. Chaouat G, Sandra O and Ledee N eds. 2013;800-826.

140. Shohat-Tal A, et al. Anti-Müllerian hormone. Biology, role in ovarian function and clinical significance, Obstetrics and Gynecology Advances, Nova Biomedical, Nova Sciences Publishes Inc., 2016. 291-308.

Book Reviews

1. Dudkiewicz A, Gleicher N: Male Infertility. Comhaire FH (ed). London: Chapman and Hall. 1995. Pp 395. ISBN 0-4132-57250-8. Lancet 1996:347:1028.

2. Coulam C, Gleicher N: Reproductive Immunology. Olding LB (ed). Berlin & Heidelberg, Germany: Springer-Verlag. 1997 Pp 219. ISBN: 3-540-61888-0. Orgyn 1998;3:28.

Videos

1. Gleicher N: Diagnosis and Treatment of Tubal Disease by Hysterosalpingography and Selective Salpingography. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley Liss; 1992.

2. Gleicher N: Transcervical Balloon Tuboplasty. In Tubal Catheterization Procedures, N. Gleicher ed., Wiley-Liss; 1992.

3. Gleicher N: The bubble test: A new tool in the diagnosis of endometriosis. The American Fertility Society Annual Meeting, Montreal Canada, October 11, 1993.

4. Oktay K, Oktem O, Barad D, Gleicher N: “Oocyte retrieval from subcutaneous transplanted frozen-thawed ovarian tissue.” 64th Annual Meeting of the ASRM, San Francisco, CA, November 8-12, 2008 (V-2).